
<html lang="en"     class="pb-page"  data-request-id="e7a8e6ca-6656-4836-911e-2492a2063669"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm300234t;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-12;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Novel Mithramycin Analogue with High Antitumor Activity and Less Toxicity Generated by Combinatorial Biosynthesis" /></meta><meta name="dc.Creator" content="Luz E.  Núñez" /></meta><meta name="dc.Creator" content="Stephen E.  Nybo" /></meta><meta name="dc.Creator" content="Javier  González-Sabín" /></meta><meta name="dc.Creator" content="María  Pérez" /></meta><meta name="dc.Creator" content="Nuria  Menéndez" /></meta><meta name="dc.Creator" content="Alfredo F.  Braña" /></meta><meta name="dc.Creator" content="Khaled A.  Shaaban" /></meta><meta name="dc.Creator" content="Min  He" /></meta><meta name="dc.Creator" content="Francisco  Morís" /></meta><meta name="dc.Creator" content="José A.  Salas" /></meta><meta name="dc.Creator" content="Jürgen  Rohr" /></meta><meta name="dc.Creator" content="Carmen  Méndez" /></meta><meta name="dc.Description" content="Mithramycin is an antitumor compound produced by Streptomyces argillaceus that has been used for the treatment of several types of tumors and hypercalcaemia processes. However, its use in humans ha..." /></meta><meta name="Description" content="Mithramycin is an antitumor compound produced by Streptomyces argillaceus that has been used for the treatment of several types of tumors and hypercalcaemia processes. However, its use in humans ha..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 7, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300234t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300234t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300234t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300234t" /></link>
        
    
    

<title>A Novel Mithramycin Analogue with High Antitumor Activity and Less Toxicity Generated by Combinatorial Biosynthesis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300234t" /></meta><meta property="og:title" content="A Novel Mithramycin Analogue with High Antitumor Activity and Less Toxicity Generated by Combinatorial Biosynthesis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0001.jpeg" /></meta><meta property="og:description" content="Mithramycin is an antitumor compound produced by Streptomyces argillaceus that has been used for the treatment of several types of tumors and hypercalcaemia processes. However, its use in humans has been limited because of its side effects. Using combinatorial biosynthesis approaches, we have generated seven new mithramycin derivatives, which differ from the parental compound in the sugar profile or in both the sugar profile and the 3-side chain. From these studies three novel derivatives were identified, demycarosyl-3D-β-d-digitoxosylmithramycin SK, demycarosylmithramycin SDK, and demycarosyl-3D-β-d-digitoxosylmithramycin SDK, which show high antitumor activity. The first one, which combines two structural features previously found to improve pharmacological behavior, was generated following two different strategies, and it showed less toxicity than mithramycin. Preliminary in vivo evaluation of its antitumor activity through hollow fiber assays, and in subcutaneous colon and melanoma cancers xenografts models, suggests that demycarosyl-3D-β-d-digitoxosylmithramycin SK could be a promising antitumor agent worthy of further investigation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300234t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300234t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300234t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300234t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300234t&amp;href=/doi/10.1021/jm300234t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5813-5825</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300544c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300268s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Novel Mithramycin Analogue with High Antitumor Activity and Less Toxicity Generated by Combinatorial Biosynthesis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luz+E.++N%C3%BA%C3%B1ez">Luz E. Núñez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+E.++Nybo">Stephen E. Nybo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Javier++Gonz%C3%A1lez-Sab%C3%ADn">Javier González-Sabín</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa++P%C3%A9rez">María Pérez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nuria++Men%C3%A9ndez">Nuria Menéndez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alfredo+F.++Bra%C3%B1a">Alfredo F. Braña</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Khaled+A.++Shaaban">Khaled A. Shaaban</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++He">Min He</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco++Mor%C3%ADs">Francisco Morís</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+A.++Salas">José A. Salas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%BCrgen++Rohr">Jürgen Rohr</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++M%C3%A9ndez">Carmen Méndez</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Departamento de Biología Funcional e Instituto Universitario de Oncología del Principado de Asturias (I.U.O.P.A), Universidad de Oviedo, 33006 Oviedo, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, Kentucky 40508, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">EntreChem, S.L., Edificio Científico Tecnológico, Campus El Cristo, Oviedo, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States</span></div><div class="corresp-info"><strong>*</strong>For J.R.: phone, (859) 323-5031; e-mail, <a href="/cdn-cgi/l/email-protection#acc6dec3c4de9eecc9c1cdc5c082d9c7d582c9c8d9"><span class="__cf_email__" data-cfemail="355f475a5d4707755058545c591b405e4c1b505140">[email protected]</span></a>. For C.M.: phone, +34 985 103558; e-mail, <a href="/cdn-cgi/l/email-protection#f6959b939892938c90b683989f99809fd89385"><span class="__cf_email__" data-cfemail="553638303b31302f3315203b3c3a233c7b3026">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300234t&amp;href=/doi/10.1021%2Fjm300234t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5813–5825</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 14, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 February 2012</li><li><span class="item_label"><b>Published</b> online</span>7 June 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300234t" title="DOI URL">https://doi.org/10.1021/jm300234t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5813%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLuz%2BE.%2BN%25C3%25BA%25C3%25B1ez%252C%2BStephen%2BE.%2BNybo%252C%2BJavier%2BGonz%25C3%25A1lez-Sab%25C3%25ADn%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D12%26contentID%3Djm300234t%26title%3DA%2BNovel%2BMithramycin%2BAnalogue%2Bwith%2BHigh%2BAntitumor%2BActivity%2Band%2BLess%2BToxicity%2BGenerated%2Bby%2BCombinatorial%2BBiosynthesis%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5825%26publicationDate%3DJune%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300234t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1394</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300234t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Novel Mithramycin Analogue with High Antitumor Activity and Less Toxicity Generated by Combinatorial Biosynthesis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Luz&quot;,&quot;last_name&quot;:&quot;E. Núñez&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;E. Nybo&quot;},{&quot;first_name&quot;:&quot;Javier&quot;,&quot;last_name&quot;:&quot;González-Sabín&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Pérez&quot;},{&quot;first_name&quot;:&quot;Nuria&quot;,&quot;last_name&quot;:&quot;Menéndez&quot;},{&quot;first_name&quot;:&quot;Alfredo&quot;,&quot;last_name&quot;:&quot;F. Braña&quot;},{&quot;first_name&quot;:&quot;Khaled&quot;,&quot;last_name&quot;:&quot;A. Shaaban&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Morís&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;A. Salas&quot;},{&quot;first_name&quot;:&quot;Jürgen&quot;,&quot;last_name&quot;:&quot;Rohr&quot;},{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Méndez&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;5813-5825&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300234t&quot;},&quot;abstract&quot;:&quot;Mithramycin is an antitumor compound produced by Streptomyces argillaceus that has been used for the treatment of several types of tumors and hypercalcaemia processes. However, its use in humans has been limited because of its side effects. Using combinatorial biosynthesis approaches, we have generated seven new mithramycin derivatives, which differ from the parental compound in the sugar profile or in both the sugar profile and the 3-side chain. From these studies three novel derivatives were identified, demycarosyl-3D-β-d-digitoxosylmithramycin SK, demycarosylmithramycin SDK, and demycarosyl-3D-β-d-digitoxosylmithramycin SDK, which show high antitumor activity. The first one, which combines two structural features previously found to improve pharmacological behavior, was generated following two different strategies, and it showed less toxicity than mithramycin. Preliminary in vivo evaluation of its antitumor activity through hollow fiber assays, and in subcutaneous colon and melanoma cancers xenografts mode&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300234t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300234t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300234t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300234t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300234t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300234t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300234t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300234t&amp;href=/doi/10.1021/jm300234t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300234t" /></input><a href="/doi/pdf/10.1021/jm300234t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300234t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300234t%26sid%3Dliteratum%253Aachs%26pmid%3D22578073%26genre%3Darticle%26aulast%3DN%25C3%25BA%25C3%25B1ez%26date%3D2012%26atitle%3DA%2BNovel%2BMithramycin%2BAnalogue%2Bwith%2BHigh%2BAntitumor%2BActivity%2Band%2BLess%2BToxicity%2BGenerated%2Bby%2BCombinatorial%2BBiosynthesis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D12%26spage%3D5813%26epage%3D5825%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=291828" title="Biosynthesis">Biosynthesis</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291098" title="Antitumor activity">Antitumor activity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jmcmar.2012.55.issue-12/production/jmcmar.2012.55.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mithramycin is an antitumor compound produced by <i>Streptomyces argillaceus</i> that has been used for the treatment of several types of tumors and hypercalcaemia processes. However, its use in humans has been limited because of its side effects. Using combinatorial biosynthesis approaches, we have generated seven new mithramycin derivatives, which differ from the parental compound in the sugar profile or in both the sugar profile and the 3-side chain. From these studies three novel derivatives were identified, demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SK, demycarosylmithramycin SDK, and demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SDK, which show high antitumor activity. The first one, which combines two structural features previously found to improve pharmacological behavior, was generated following two different strategies, and it showed less toxicity than mithramycin. Preliminary in vivo evaluation of its antitumor activity through hollow fiber assays, and in subcutaneous colon and melanoma cancers xenografts models, suggests that demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SK could be a promising antitumor agent worthy of further investigation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>⊥</span> Author Contributions</h4><p class="last">These two authors contributed equally to this work.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer is one of the most threatening illnesses in Western countries, being the second cause of death. One of the therapies used for treating cancer is chemotherapy. Although there are a high number of anticancer drugs for clinical use, there is still a demand for novel drugs with less toxicity and higher activity and/or active against tumors that lack an appropriate treatment.</div><div class="NLM_p">Transcription factors (TFs) are nodal points in signal transduction pathways that have to lead to transcriptional changes in order to affect cell behavior. Aberrant activity of TFs is a hallmark in many cancers, as result of direct genetic events (e.g., gene translocations) or being secondary to other events (e.g., kinase/receptor mutations). There is proof of concept evidence, using both in vitro and in vivo models, that targeting TFs has clear therapeutic benefit in cancer, such as STAT3 inhibitors, p53 targeted small molecules (to restore the transcriptional activity of mutated p53), NF-κB, myc targeted oligonucleotides, and much more.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Limited evidence of efficacy in clinical trials exists, although some TF antagonists (STAT3, NF-κB) are progressing through phase 1–2 trials.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">Sp1 is a TF that controls many critical processes in cells (proliferation, survival, stress responses). It is present in many normal cells but is abnormally expressed or activated in many cancers.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Some researchers are looking for Sp1 transcriptional signatures in cancers (like prostate, ovarian cancer). Preliminary data show up-regulation of many Sp1 target genes in tumors compared to normal cells, even if Sp1 itself is not up-regulated, indicating activation of Sp1.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Similar to other TFs, proof of concept exists that targeting Sp1 with antisense oligonucleotides, siRNA, and decoy oligonucleotides has therapeutic benefit. Also, indirect targeting of Sp1 with drugs like cox2 inhibitors and others has been shown to have therapeutic effects.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Mithramycin (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) is a DNA binding agent with relative specificity for Sp1, based on their preferential binding to GC-rich sites in DNA. It was discovered in 1961 and approved for use as anticancer drug in 1970.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Despite showing strong response rates, it has not been in use in recent years for cancer treatment because of its adverse effects. The problems with <b>1</b> are derived from the lack of a suitable therapeutic window, so the active doses are those that unfortunately cause toxic side effects. Notwithstanding, in recent years there has been a renewed interest in <b>1</b>, since new uses and activities have been ascribed to it, including inhibition of apoptosis or antiangiogenic activity, in both cancer and noncancer related processes.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> For example, it has been shown that <b>1</b> selectively blocks expression of cell proliferation and transforming growth factor β (TGF-β) signaling clusters in human gingival fibroblasts, and in glioma cells it was found to suppress and delay tumor cell migration.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Also, <b>1</b> suppresses the growth of Ewing sarcoma family of tumors (ESFTs) xenografts-bearing mice. In this context, <b>1</b> was identified in a screening of 50 000 compounds as the lead compound for the inhibition of aggressive ESFTs and for its in vitro and in vivo inhibition of the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) TF, a protein that had previously been thought to be undruggable.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This indicates that <b>1</b> could be a viable drug for certain indications, despite its very narrow therapeutic window.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of (A) mithramycin (<b>1</b>) and demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin (<b>2</b>) and (B) mithramycin SK (<b>3</b>) and mithramycin SDK (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The mithramycin mode of action involves its interaction in a noncovalent way with GC-rich DNA regions located at the minor groove of DNA.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19">(15-19)</a> By doing so, it prevents transcription factor Sp1 from binding to a variety of promoters of proto-oncogenes, genes involved in angiogenesis, antiapoptotic genes, p53-mediated transcriptional responses, as well as multidrug resistant gene 1 (MDR-1).<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24">(20-24)</a> Recent work has shown that <b>1</b> does not equally bind all Sp1 binding sites: it inhibits Sp1 binding to a subset of genes associated with oncogenesis but selectively ignores Sp1 binding sites in other promoters such as p21<sup>cip1/waf1</sup>, which are classically linked with tumor suppression.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Most important, the recent work of Grohar et al. also shows that mithramycins can target cancer-related TFs, which adds a novel component of potential selectivity to the aureolic acids class of anticancer drugs.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Structurally, <b>1</b> consists of a tricyclic aglycone, with two aliphatic side chains attached at C3 and C7, and a trisaccharide (<span class="smallcaps smallerCapital">d</span>-olivose-<span class="smallcaps smallerCapital">d</span>-oliose-<span class="smallcaps smallerCapital">d</span>-mycarose) and a disaccharide (<span class="smallcaps smallerCapital">d</span>-olivose-<span class="smallcaps smallerCapital">d</span>-olivose) chain attached at positions 2 and 6 of the aglycone, respectively.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The mithramycin gene cluster of <i>Streptomyces argillaceus</i> has been cloned and characterized, and its biosynthesis pathway has been established (see ref  <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a> for a review). The aglycone is synthesized through the condensation of one acetyl-CoA and nine malonyl-CoA units to render a carbon chain, which is then aromatized, cyclized, oxygenated, and methylated. Then the resultant tetracyclic intermediate is sequentially glycosylated followed by the oxidative cleavage of the fourth ring and the reduction of the carbon side chain attached at the 3-position to render the final compound <b>1</b>. We have applied different strategies of combinatorial biosynthesis in order to generate novel derivatives of <b>1</b> with antitumor activity.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32">(28-32)</a> Some of these compounds (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, compounds <b>2</b>–<b>4</b>) showed high antitumor activity and either exhibited new glycosylation profiles<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> or contained structural changes affecting the pentyl side chain attached at the 3-position.<a onclick="showRef(event, 'ref5 ref29 ref33'); return false;" href="javascript:void(0);" class="ref ref5 ref29 ref33">(5, 29, 33)</a> Interestingly, analogues with modifications at the 3-carbon side chain showed higher antitumor activity than the parental compound and delayed growth of ovarian tumor xenografts.<a onclick="showRef(event, 'ref5 ref6 ref29 ref33'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref29 ref33">(5, 6, 29, 33)</a></div><div class="NLM_p last">Here we further explored the generation of new mithramycin analogues by applying combinatorial biosynthesis strategies to <i>S. argillaceus</i>, aiming for new compounds that differ either from the parental compound in the sugar profile or in both the sugar profile and the 3-side chain. From these studies three novel derivatives emerged, named demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SK, demycarosylmithramycin SDK, and demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SDK, which show high antitumor activity. The first one, which combines two structural features previously found to improve mithramycin pharmacological behavior, was less toxic than the parental compound and was evaluated on tumor growth in hollow fiber assays and for treatment of colon and melanoma cancers using human tumors xenografts in murine models in nude mice.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Generation of novel mithramycin analogues</h3><div class="NLM_p">Two types of mithramycin analogues were generated: mithramycins with modified glycosylation profile and compounds with both specific modifications in the glycosylation pattern and at the 3-carbon side chain. It has been shown that sugars in <b>1</b> participate in the binding process of this compound to DNA<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> and that changes in the glycosylation profile of <b>1</b> can affect its activity.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Modifications in the glycosylation pattern of a molecule by combinatorial biosynthesis can be achieved using different approaches, such as expressing plasmids directing the biosynthesis of a different sugar into the producer organism.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Moreover, the use of a mutant affected in the biosynthesis of a normal component sugar of the compound as host can increase the chances to generate compounds with new glycosylation profiles.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">In order to facilitate the generation of mithramycins with different glycosylated profiles, we used as a host the <i>S. argillaceus</i> mutant M7C1 in which the <i>mtmC</i> gene had been inactivated.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This mutant accumulates some compounds lacking the <span class="smallcaps smallerCapital">d</span>-mycarose residue and possessing a 4-keto sugar moiety instead of the <span class="smallcaps smallerCapital">d</span>-olivose at the beginning of the trisaccharide chain, since in this mutant <span class="smallcaps smallerCapital">d</span>-mycarose biosynthesis is blocked and the biosynthesis of <span class="smallcaps smallerCapital">d</span>-olivose is altered.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> To endow this mutant with the capability of synthesizing new sugars, we expressed pFL845<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> in mutant M7C1. This plasmid encodes the biosynthesis of <span class="smallcaps smallerCapital">d</span>-amicetose, a sugar not present in <b>1</b>, and that of <span class="smallcaps smallerCapital">d</span>-olivose, which is altered in the mutant strain. Analysis of the resultant strain <i>S. argillaceus</i> M7C1-pFL845 by HPLC and HPLC–MS revealed the production of several mithramycin-like compounds (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). The major one corresponded to the previously identified demycarosylmithramycin,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> a compound with structure identical to that of <b>1</b> but lacking <span class="smallcaps smallerCapital">d</span>-mycarose, the biosynthesis of which is blocked in this mutant. Compounds from the other peaks showed retention times and masses that did not fit with those of previously identified mithramycin analogues and most probably corresponded to novel mithramycin derivatives, which were later identified as dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldemycarosyl-2-<i>O</i>-β-<span class="smallcaps smallerCapital">d</span>-oliosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-olivosylmithramycin (<b>5</b>), dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldemycarosylmithramycin (<b>6</b>), deoliosyldemycarosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-amicetosylmithramycin (<b>7</b>), and dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldeoliosyldemycarosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-amicetosylmithramycin (<b>8</b>).</div><div class="NLM_p">A second type of mithramycin analogue was generated, aiming at compounds with modifications in the glycosylation pattern and the 3-carbon side chain. We have previously shown that by inactivating the <i>mtmW</i> gene (encoding for a ketoreductase), several mithramycins were generated with modifications in the 3-carbon side chain that showed improved antitumor activities.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> On the other hand, we have also obtained several mithramycins with antitumor activity with modifications in the glycosylation pattern, among which the most active one was demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin (compound <b>2</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A).<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> On the basis of this information, we set out to generate mithramycin derivatives containing both types of structural features in the molecule and expecting to improve the antitumor properties in relation to the parental compound. To achieve this, we provided to the <i>S. argillaceus</i> mutant M3W1<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (which produces mithramycins with modifications at the carbon side chain), with the capability to synthesize <span class="smallcaps smallerCapital">d</span>-digitoxose (i) by expressing plasmid pMP3*BII<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and (ii) by expressing plasmid pKOL.</div><div class="NLM_p">Plasmid pMP3*BII encodes the biosynthesis of NDP-<span class="smallcaps smallerCapital">d</span>-digitoxose. Analysis by HPLC and HPLC–MS of ethyl acetate extracts of cultures of the resultant strain <i>S. argillaceus</i> M3W1-pMP3*BII revealed the production of four compounds, in addition to mithramycin SK (compound <b>3</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) and mithramycin SDK (compound <b>4</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B), originally produced by mutant M3W1 (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). One of these compounds corresponded to the previously identified demycarosylmithramycin SK,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> while retention times and masses from the other three indicated most probably novel compounds and were subsequently identified as demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SK (<b>9</b>), demycarosylmithramycin SDK (<b>10</b>), and demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SDK (<b>11</b>).</div><div class="NLM_p">From the attempts to generate new <b>1</b> analogues through heterologous expression of “deoxy sugar plasmids” that encode NDP-activated deoxyhexose pathways in wild type <i>Streptomyces argillaceus</i>, overexpression of plasmid pLNBIV was most successful. This plasmid encodes the biosynthesis of both NDP-<span class="smallcaps smallerCapital">d</span>- and NDP-<span class="smallcaps smallerCapital">l</span>-digitoxose (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), and its expression resulted in the accumulation of new mithramycin compounds containing digitoxose. One of the mithramycins accumulated, demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin (compound <b>2</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) featured a <span class="smallcaps smallerCapital">d</span>-digitoxose substituting the <span class="smallcaps smallerCapital">d</span>-mycarose normally found in the E-position of the trisaccharide chain.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Plasmid pKOL is a derivative of pLN2 and encodes predominantly the biosynthesis of NDP-4-keto-<span class="smallcaps smallerCapital">d</span>-olivose. It resembles plasmid pLBIV, the plasmid previously used for the generation of demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin (<b>2</b>),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> but lacks ketoreductase EryBIV, thereby avoiding the formation of NDP-<span class="smallcaps smallerCapital">l</span>-digitoxose, which led to the production of several undesirable analogues (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We reasoned that pKOL’s main product, NDP-4-keto-<span class="smallcaps smallerCapital">d</span>-olivose, would be reduced selectively by keto reductase MtmTIII into <span class="smallcaps smallerCapital">d</span>-digitoxose, either prior or after its incorporation into the E-position (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). MtmTIII had been identified as being responsible for the 4-keto reduction of the <span class="smallcaps smallerCapital">d</span>-mycarose building block, generating simultaneously an equatorial OH group in 4-position and an axial OH group in 3-position of the sugar during <b>1 </b>biosynthesis. However, it remained unclear whether MtmTIII acts prior to or after the incorporation of the sugar in E-position.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Furthermore, we expected that pKOL’s second product, NDP-4-keto-<span class="smallcaps smallerCapital">l</span>-olivose, would partly inhibit the <i>C</i>-methyltransferase activity of MtmC, thereby reducing the <span class="smallcaps smallerCapital">d</span>-mycarose production (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Indeed, expressing pKOL resulted in a significantly increased accumulation of demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin (<b>2</b>) in fermentations of <i>Streptomyces argillaceus</i> (pKOL) and in the production of two new compounds, subsequently identified as compounds <b>9</b> and <b>11</b> in fermentations of <i>Streptomyces argillaceus</i> M3W1-pKOL (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Depictions of Deoxysugar Biosynthesis Pathways Encoded by pLNBIV (NDP-<span class="smallcaps smallerCapital">l</span>-digitoxose, Gray, Solid Arrows) and pKOL (NDP-4-keto-<span class="smallcaps smallerCapital">d</span>-olivose, Black, Dotted Arrows) and Observed Outcomes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Purification and Structural Elucidation of New Mithramycin Analogues</h3><div class="NLM_p">Four new compounds were purified from <i>S. argillaceus</i> M7C1-pFL845 (compounds <b>5</b>–<b>8</b>). Purification was carried out by preparative HPLC, and the novel compounds were initially identified by HPLC–MS analyses by comparing the retention time, UV absortion spectrum, and the mass of the molecular ion with those of already known mithramycin analogues. A preliminary analysis based on the mass spectra showed that the four compounds isolated from <i>S. argillaceus</i> M7C1-pFL845 presented the typical fragment ascribed to the aglycone moiety of <b>1</b> (<i>m</i>/<i>z</i> 420). Likewise, the mass of the molecular ions revealed the absence of one or two sugar residues with respect to <b>1</b>. Final elucidation of the compounds was carried out by NMR experiments; spin systems of each single sugar moiety were analyzed by means of H,H-COSY and TOCSY experiments, and both sugar–aglycone and intersugar connections were established through HMBC experiments. Further <sup>1</sup>H homodecoupling experiments allowed the unambiguous identification of each sugar. Regarding compound <b>7</b>, its <sup>1</sup>H spectrum revealed not only the absence of the sugar E but also a different profile for the sugar D, typically occupied by a <span class="smallcaps smallerCapital">d</span>-oliose residue in mithramycin derivatives. Thus, analysis of the 2D COSY/TOCSY experiments revealed a spin system stretching from 1-H to 6-H, with two protons attached to the 3D position (δ H<sub>ax</sub> 1.60 ppm and δ H<sub>eq</sub> 2.05 ppm). Because of the overlapping and complexity of the signals of 2D-H<sub>ax</sub>, 2D-H<sub>eq</sub>, 3D-H<sub>ax</sub>, 3D-H<sub>eq</sub>, 4D-H, and 5D, <sup>1</sup>H homodecoupling experiments were required to establish the sugar D as a <span class="smallcaps smallerCapital">d</span>-amicetose unit, concluding the identity of <b>7</b> as deoliosyldemycarosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-amicetosylmithramycin (compound <b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). The mass spectra of <b>5</b>, <b>6</b>, and <b>8</b> were consistent with mithramycin analogues harboring only three sugar residues. For example, compound <b>8</b> lacked the sugars B and E (confirmed by comparison with previously described compounds and also due to the absence of intersugar connections for 3A and 3D in the HMBC spectra). Moreover, both sugars A and D were identified as <span class="smallcaps smallerCapital">d</span>-amicetoses as above detailed for <b>7</b>, allowing us to confirm the structure of <b>8</b> as dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldeoliosyldemycarosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-amicetosylmithramycin (compound <b>8</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Regarding <b>6</b> and <b>5</b>, they showed identical molecular ion peaks and fragmentations in the mass spectra. The <sup>1</sup>H and <sup>13</sup>C spectra showed the absence of the sugar B and a pattern typical of β-<span class="smallcaps smallerCapital">d</span>-amicetose for the A sugar in both cases. The other two remaining sugars (C and D) were identified as β-<span class="smallcaps smallerCapital">d</span>-olivose and β-<span class="smallcaps smallerCapital">d</span>-oliose units. In the case of <b>6</b>, as revealed by the HMBC long-range couplings, the β-<span class="smallcaps smallerCapital">d</span>-olivosyl residue was directly attached to the aglycone moiety. Thus, cross-peaks were observed between H-1C (δ 5.14) and C-2 (δ 76.6) as well as between C-3C (δ 81.3) and H-1D (δ 4.70), allowing us to establish <b>6</b> as dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldemycarosylmithramycin (compound <b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). On the contrary, <b>5</b> was connected to the aglycone moiety toward the β-<span class="smallcaps smallerCapital">d</span>-oliosyl residue (according to HMBC analysis) and turned out to be dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldemycarosyl-2-<i>O</i>-β-<span class="smallcaps smallerCapital">d</span>-oliosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-olivosylmithramycin (compound <b>5</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of new mithramycin analogues generated by combinatorial biosynthesis. (A) Compounds with modified glycosylation patterns produced by <i>S. argillaceus</i> M7C1-pFL845: dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldemycarosyl-2-<i>O</i>-β-<span class="smallcaps smallerCapital">d</span>-oliosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-olivosylmithramycin (<b>5</b>), dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldemycarosylmithramycin (<b>6</b>), deoliosyldemycarosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-amicetosylmithramycin (<b>7</b>), and dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldeoliosyldemycarosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-amicetosylmithramycin (<b>8</b>). (B) Compounds with modified glycosylation pattern and different structure of the 3-carbon side chain produced by <i>S. argillaceus</i> M3W1-pMP3*BII: demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SK (<b>9</b>), demicarosylmithramycin SDK (<b>10</b>), and demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SDK (<b>11</b>). Differences from <b>1</b> are highlighted in bold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As anticipated, since the biosynthesis of <span class="smallcaps smallerCapital">d</span>-mycarose is blocked in mutant M7C1, compounds <b>5</b>–<b>8</b> all lacked the <span class="smallcaps smallerCapital">d</span>-mycarose residue. However, none of them incorporated another sugar at the same position of the trisaccharide chain. This suggests that the glycosyltransferase responsible for transferring sugar E shows limited sugar donor substrate flexibility. Actually, in all mithramycin derivatives generated so far by combinatorial biosynthesis, the third position of the trisaccharide chain is mostly occupied by <span class="smallcaps smallerCapital">d</span>-mycarose (the natural sugar) or with less frequency by <span class="smallcaps smallerCapital">d</span>-digitoxose and in a single case by 4-keto-<span class="smallcaps smallerCapital">d</span>-mycarose.<a onclick="showRef(event, 'ref30 ref31 ref38'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref38">(30, 31, 38)</a> On the other hand, all compounds contain <span class="smallcaps smallerCapital">d</span>-olivose residues, indicating that the biosynthesis of <span class="smallcaps smallerCapital">d</span>-olivose was restored in the mutant strain by pFL845. Moreover, in agreement with the sugar biosynthetic pathways encoded by pFL845, all new analogues incorporated one or two <span class="smallcaps smallerCapital">d</span>-amicetose residues: at the first position of the disaccharide chain (compounds <b>5</b>, <b>6</b>, and <b>8</b>) or the second position of the trisaccharide chain (compounds <b>7</b> and <b>8</b>). Noticeably, <b>5</b> contains the same first two sugar residues at the trisaccharide chain as <b>1</b>, but in the other way around. As far as we know, <b>5</b> represents the first mithramycin analogue with a different sugar than <span class="smallcaps smallerCapital">d</span>-olivose at the first position of the trisaccharide chain.</div><div class="NLM_p"><i>S. argillaceus</i> M3W1-pMP3*BII produces three new compounds (compounds <b>9</b>–<b>11</b>). These were initially identified by HPLC–MS, taking advantage of the mass of the molecular ions and the information extracted from the characteristic fragmentation pattern of the mithramycin-type compounds. In the case of <b>10</b>, a molecular formula of C<sub>44</sub>H<sub>60</sub>O<sub>20</sub> (<i>m</i>/<i>z</i> 908) was deduced, and the analysis of fragments revealed the typical aglycone moiety of compound <b>4</b> (<i>m</i>/<i>z</i> 388) and the disaccharide side chain (sugars A and B). Moreover, considering the absence of the trisaccharide side chain fragment (sugars C, D, and E) as well as the molecular mass of 144 amu smaller than that of compound <b>4</b>, <b>10</b> was tentatively established as demycarosylmithramycin SDK, lacking the sugar E of the parental compound. Regarding <b>9</b> and <b>11</b>, they showed molecular formulas of C<sub>50</sub>H<sub>72</sub>O<sub>23</sub> (<i>m</i>/<i>z</i> 1040) and C<sub>50</sub>H<sub>70</sub>O<sub>23</sub> (<i>m</i>/<i>z</i> 1038) and fragments ascribed to the aglycone moieties of compound <b>3</b> (<i>m</i>/<i>z</i> 390) and compound <b>4</b> (<i>m</i>/<i>z</i> 388), respectively. In both cases, the fragment associated with the disaccharide chain remained unaltered. Meanwhile the fragment typical of the trisaccharide chain exhibited 14 amu less than that of the parental compounds, suggesting a non-<i>C</i>-methylated dideoxy sugar for the sugar E. Compounds <b>9</b>–<b>11</b> were unambiguously elucidated by mono- and bidimensional NMR experiments, including <sup>1</sup>H NMR, <sup>13</sup>C NMR, COSY, TOCSY, HSQC, HMBC, and NOESY, and by comparing the corresponding spectra with those previously described for the parental <b>3</b> and <b>4</b>. In the case of <b>10</b>, NMR spectra were identical to those of <b>4</b> but lacking all the signals attached to the sugar E, the molecule being confirmed as demycarosylmithramycin SDK (compound <b>10</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). Regarding <b>9</b> and <b>11</b>, the signals of the aglycone moiety, the disaccharide side chain (sugars A and B), and sugar units C and D of the trisaccharide chain in the <sup>1</sup>H NMR spectra showed an analogous profile to the corresponding moieties of <b>3</b> and <b>4</b>, respectively, while the difference was found in sugar E. Analysis of 2D COSY contour plots in conjunction with 1D spectra revealed a coupling of both 2E-H<sub>ax</sub> and 2E-H<sub>eq</sub> protons with a proton in 3E, indicating that the 3E-CH<sub>3</sub> is missing (according to our previous findings in HPLC–MS). Moreover, the appearance of this 3E-H as a broad signal (singlet in <b>9</b> or doublet in <b>11</b>, with small coupling constants) was indicative of an equatorial position. The <sup>13</sup>C NMR data confirmed the disappearance of the 3E-CH<sub>3</sub> signal as well as the exchange of the previous 3E-C quaternary center of <b>3</b> and <b>4</b> by a novel tertiary carbon (δ 67.8 ppm). Overall, careful analysis of the 2D COSY correlations between 2E-H<sub>eq</sub>, 2E-H<sub>ax</sub>, 4E-H, and 3E-H and their coupling constants allowed us to establish the <span class="smallcaps smallerCapital">d</span>-digitoxose stereochemistry (correlating well with the digitoxose signals of the known compound <b>2</b>), <b>9</b> and <b>11</b> being identified as demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SK and demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SDK, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). In conclusion and as anticipated, strain <i>S. argillaceus</i> M3W1-pMP3*BII produced new compounds combining modifications at the 3-carbon side chain and in the glycosylation profile (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B): compound <b>9</b>, a 2-hydroxy-1-methoxy-3-oxobutyl side chain (compound <b>3</b>-like),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and <b>10</b> and <b>11</b>, a 1-methoxy-2,3-dioxobutyl side chain (compound <b>4</b>-like).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In addition, in compounds <b>9</b> and <b>11</b> the <span class="smallcaps smallerCapital">d</span>-mycarose residue was replaced by <span class="smallcaps smallerCapital">d</span>-digitoxose, and in <b>10</b> the third sugar in the trisaccharide chain was absent.</div><div class="NLM_p last">The expression of plasmid pKOL in mutant strain <i>S. argillaceus</i> M3W1, resulting in recombinant strain <i>S. argillaceus</i> M3W1-pKOL, produced several mithramycin-type compounds, including the known metabolites <b>3</b> and <b>4</b> and demycarosylmithramycin SK.<a onclick="showRef(event, 'ref5 ref29'); return false;" href="javascript:void(0);" class="ref ref5 ref29">(5, 29)</a> The two new compounds, not present in extracts of <i>S. argillaceus</i> M7W1, showed mithramycin-type UV absorptions and slightly faster retention times (Δ<i>R</i><sub>t</sub> = 0.6 min<sup>–1</sup>) compared to <b>3</b> and <b>4</b>, with masses of 14 amu less than their <b>3</b> and <b>4</b> counterparts, indicating the substitution of an unmethylated 2,6-dideoxysugar at E-position (1039 amu [M – H] for the peak at <i>R</i><sub>rel</sub> = 16.6 min<sup>–1</sup> and 1037 amu [M – H] for the peak at <i>R</i><sub>rel</sub><i>= </i> 18.6 min<sup>–1</sup>, (−) APCI-MS). A 10 L fermentation of <i>S. argillaceus</i> M3W1-pKOL yielded sufficient amounts of the new compounds, which were identified through HR-ESI mass spectrometry and 1D- and 2D-NMR spectroscopy as compounds <b>9</b> and <b>11</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Antitumor Activity of New Mithramycin Analogues</h3><div class="NLM_p">Antitumor activity of selected new mithramycin analogues was initially tested against a panel of three tumor cell lines. Only compounds <b>9</b>–<b>11</b>, which combine modifications in both the sugar moiety and C3 side chain in their structures, showed high antitumor activity, with average GI<sub>50</sub> (50% of growth inhibition) between 0.3 and 1.3 μM. The anticancer activity of compounds <b>9</b>–<b>11</b> were tested in the National Cancer Institute’s cell viability screen using 60 cancer cell lines derived from different solid and liquid tumors.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> As a reference, compound <b>2</b>, with only modifications in the glycosylation pattern, was also tested. Data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. All three new compounds showed high antitumor activity against all human tumor cell lines tested, with GI<sub>50</sub> values between 10 nM and 1 μM except in ovarian tumor cell line NCI/ADR-RES where GI<sub>50</sub> values for compounds <b>9</b> and <b>10</b> are higher than 10 μM. Compounds <b>9</b> and <b>11</b> showed the highest antitumor activity, being on average about 5-fold more active than <b>10</b>. A comparison of the GI<sub>50</sub> values of compounds <b>9</b> and <b>11</b> with those of compound <b>2</b>, which only differs from them in the structure of the 3-carbon side chain, revealed an increase of activity (between 2- and 7-fold) for <b>9</b> and <b>11</b> for a number of cell lines (see numbers shadowed in gray in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compared with <b>1</b> which has average GI<sub>50</sub> of 18 nM (according to historical data at the NCI), <b>9</b> and <b>11</b> were slight less potent (average GI<sub>50</sub> at 30 and 28 nM, respectively), while <b>10</b> is significantly less potent, with average GI<sub>50</sub> at 158 nM. However, <b>9</b> and <b>11</b> are more potent than <b>1</b> in a couple of cell lines spreading in different tumor types, particularly in ovarian tumor IGROV1 and breast tumor MDA-MB-231 cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antitumor Analysis and Comparison of Compounds <b>9</b> and <b>11</b> with Compound <b>2</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0008.gif" alt="" id="GRAPHIC-d3800e1519-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The activity improvement factor is obtained from 10<sup>Δ2–<i>x</i></sup>, where <i>x</i> is the identifying value for compound <b>9</b> or <b>11</b>. An activity improvement factor of 1.0 means no difference in activity.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Non-small-cell lung.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Central nervous system. Numbers in different shades of gray mean an increase of antitumor activity (from light to dark gray) for the corresponding compound in relation to compound <b>2</b> and the tumor cell line tested.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. GI<sub>50</sub> in Selective Cancer Cell Lines for Compounds <b>9</b> and <b>11</b> in Comparison to Compound <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center" char=".">average GI<sub>50</sub> (nM) in selective cell lines</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CNS</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">ovarian</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">NSCL<br /></br>A549</th><th class="colsep0 rowsep0" align="center" char=".">colon<br /></br>COLO205</th><th class="colsep0 rowsep0" align="center" char=".">SF-295</th><th class="colsep0 rowsep0" align="center" char=".">U251</th><th class="colsep0 rowsep0" align="center" char=".">melanoma<br /></br>SK-MEL-5</th><th class="colsep0 rowsep0" align="center" char=".">IGROV 1</th><th class="colsep0 rowsep0" align="center" char=".">OVCAR-8</th><th class="colsep0 rowsep0" align="center" char=".">breast<br /></br>MDA-MB-231</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">158</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">63</td></tr></tbody></table></div></div><div class="NLM_p last">In the NCI hollow fiber assay, which measures the preliminary growth inhibition efficacy on a selected panel of 12 tumor cell lines implanted in mice, <b>9</b> appeared to be more potent than <b>1</b> and <b>11</b>, with highest total score of 66/96 (compared to 58/96 for <b>1</b>) and specifically an intraperitoneal score of 36/48 (34/48 for <b>1</b>) and a subcutaneous score of 30/48 (24/48 for <b>1</b>). In contrast, compound <b>11</b> shows a total score of 48/96. On the basis of these data, we decided to evaluate further the toxicity of compounds <b>9</b> and <b>11</b>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vivo Toxicity of Compounds <b>9</b> and <b>11</b></h3><div class="NLM_p">Compound <b>1</b> side effects are a major limitation for its use in antitumor therapy. Therefore, we determined experimentally the doses at which compounds <b>9</b> and <b>11</b> could be safely dosed to mice upon both acute and chronic schedules and using intravenous and intraperitoneal administration routes. As can be seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the single maximum tolerated dose of <b>9</b> is the highest of the mithramycin analogues tested, with maximum tolerated dose (MTD) of 64 mg/kg for single intravenous injection and 200 mg/kg for single intraperitoneal injection, yet <b>11</b> had similar toxicity as <b>1</b> (4 and 6.25 mg/kg, respectively). When testing repeated doses via intravenous administration every 2 or 3 days for 8 cycles (q2d×8 or q3d×8), the MTD for <b>1</b> is 0.6 mg/kg (according to literature data) or 1.5 mg/kg, respectively, while for compound <b>9</b> is 12 or 24 mg/kg, respectively. Thus, it is clearly established that higher doses of compound <b>9</b> could be safely administered to mice compared to <b>1</b>, especially in a repeated dose schedule using intravenous injection. This is the preferred mode of administration, since humans will be dosed intravenously; thus, these data can be used as the starting point for a comprehensive toxicology evaluation program.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Maximun Tolerated Doses of Mithramycin Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"> single dose,<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>mg/kg</th><th class="rowsep1 colsep0" colspan="2" align="center">iv repeated dose,<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>mg/kg</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">iv</th><th class="colsep0 rowsep0" align="center">ip</th><th class="colsep0 rowsep0" align="center">q2d×8</th><th class="colsep0 rowsep0" align="center">q3d×8</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">6.25</td><td class="colsep0 rowsep0" align="left">0.6<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">6.25</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">CD-1 mice received intraperitoneal (ip) or intravenous (iv) single injections or repeated injections of the compound every 2 days (q2d×8) or 3 days (q3d×8) for 8 days. ND, not determined.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Literature data.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmacokinetic Studies of Compounds <b>1</b> and <b>9</b></h3><div class="NLM_p">Plasma levels of compounds <b>1</b> and <b>9</b> were quantified after intravenous injections at doses of 1 and 18 mg/kg, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The concentration of both compounds in the bloodstream declined exponentially over time, following similar kinetics. Plasma levels of compound <b>9</b> were between 5- and 20-fold higher than compound <b>1</b>, reflecting the different doses injected initially. After 5 min plasma levels of compounds <b>1</b> and <b>9</b> were approximately 2.7 and 28 μM, respectively. After 30 min, the level of compound <b>1</b> was approximately 0.2 μM and that of compound <b>9</b> was 1.7 μM. After 120 min, levels of both compounds were below 0.1 μM. According to these data, blood clearance does not seem responsible for the differences in toxicity detected for both compounds.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacokinetics profile of compounds <b>1</b> and <b>9</b>. Mice (<i>n</i> = 3 per group) were injected intravenously with a single dose of 1 mg/kg in the case of compound <b>1</b> (A) or 18 mg/kg of compound <b>9</b> (B). Each time point represents the mean ± SD of three mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Inhibition of Growth of Subcutaneous Colon and Melanoma Xenografts by Compound <b>9</b></h3><div class="NLM_p">Since compound <b>9</b> showed the highest antitumor activity in vivo and the lowest toxicity, we decided to examine its antitumor activity in more detail using subcutaneous tumor xenografs of COLO-205 colon cancer cells and SK-MEL-2 melanoma cells, since these are well established tumor models and their GI<sub>50</sub> are close to the average value for the NCI-60 screen. On the basis of the data obtained for the MTD on intravenous repeated dose, mice received intravenous injections q2d×10 at dose 10 mg/kg, and q3d×10 at dose 20 mg/kg of compound <b>9</b>. Total cumulative doses were 100 and 200 mg/kg. Cis-platin and doxorubicin were used as positive controls. The experiments were terminated long after treatment finished in order to observe post-treatment effects, with the exception of mice in control groups that had to be sacrificed because of excessive tumor burden according to ethical guidelines. Treatment with compound <b>9</b> notably reduced both colon and melanoma tumors growth at all doses tested (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A,B). Administration of compound <b>9</b> was well tolerated, and no signs of toxicity or deaths with any of the schedules of treatment were observed. Body weights were not different between mice treated with sterile saline solution or drug even at the highest doses (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C,D). In the case of COLO-205 colon xenografts, the tumor growth was inhibited by compound <b>9</b> at about the same rate using both schedules (every 2 or every 3 days), being in both cases more effective than cis-platin. Growth of SK-MEL-2 human melanoma xenografts was markedly delayed by treatment with compound <b>9</b> at both dosages tested and by doxorubicin. Doxorubicin and compound <b>9</b> at a dosage of 20 mg/kg/injection were comparatively more effective than compound <b>9</b> at a dosage of 10 mg/kg per injection. The effect of the drug during treatment does not cause the tumor to come back aggressively, in the worst case at the same rate as before treatment. It is also of note that efficacy is not compromised by the rapid clearance from bloodstream indicated by pharmacokinetic data. This, together with the better response at higher and more spaced doses, can be interpreted as efficacy being dependent not on half-life but on maximum plasma concentration, which in intravenous administration is obtained just after injection and therefore is linked to the MTD. Indeed, we measured apoptosis at 48 h by flow cytometry in wash-out experiments with drug mice plasma concentrations exposed for the time indicated in the pharmacokinetic curve (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). Short exposures at high concentrations (7 μM for 15 min) showed significantly higher levels of apoptosis compared to lower concentrations for longer time (0.2 μM for 2 h, within the limits of the pharmacokinetic curve). Taken collectively, these data demonstrate that treatment using a spaced schedule (allowing a higher amount of drug) is not worse (but even better) than every other day. The use of a higher amount of drug could translate into a better safety profile while opening the door to an effective but safe treatment.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antitumor activity of compound <b>9</b> in subcutaneous colon and melanoma tumor xenografts. Mice (eight per group) with subcutaneous colon (A) or melanoma (B) tumors were treated with sterile saline solution (control, closed circles) or the indicated doses of compound <b>9</b> given by intravenous injections every 2 days (q2d×10, closed triangles) or 3 days (q3d×10; closed squares). Additionally, mice (eight per group) with subcutaneous colon or melanoma tumors were also intraperitoneally injected with 8 mg/kg cis-platin (A) or doxorubicin (B) every 4 days (q4d×3, open rhombs). Part A represents the tumor volumes over time with colon cancer COLO-205 cell line. Part C represents evolution of the mice weights with COLO-205 cell line. Part B represents the tumor volumes over time with melanoma SK-MEL-2 cell line. Part D represents evolution of the mice weights with SK-MEL-2 cell line. Each point represents the mean ± SD of eight mice. q2d and q3d indicate end of the treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have demonstrated the potential of combinatorial biosynthesis to expand the chemical space of an antitumor compound like mithramycin, resulting in the generation of new analogues not possible to prepare by current synthetic chemistry technology. A set of these compounds (compounds <b>5</b>–<b>8</b>) differed from <b>1</b> in the glycosylation pattern and showed lower antitumor activity in vitro. This result was in accordance to what had been previously reported for other glycosylated analogues of <b>1</b>, which also lacked one or two deoxy sugars and showed a decrease in its antitumor activity.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Some exceptions to this rule were compounds that lacking one deoxysugar still contained a <span class="smallcaps smallerCapital">d</span>-mycarose residue.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Since compounds <b>5</b>–<b>8</b> were generated in a mutant defective in <span class="smallcaps smallerCapital">d</span>-mycarose biosynthesis, they do not contain this saccharide residue, which fits with their anticipated lower activity. A second set of compounds (compounds <b>9</b>–<b>11</b>) combined modifications in the glycosylation pattern and in the 3-side chain and showed high antitumor activity, compounds <b>9</b> and <b>11</b> being on average about 5-fold more active than <b>10</b>. Compounds <b>9</b> and <b>11</b> showed similar antitumor activity in vitro and were also more potent than <b>1</b> for some tumor cell lines, although on average they were slightly less potent. These two compounds combined two structural features that had been previously found to improve mithramycin pharmacological behavior: a <span class="smallcaps smallerCapital">d</span>-digitoxose residue instead of <span class="smallcaps smallerCapital">d</span>-mycarose at the E-position of the trisaccharide chain, and a modified 3-carbon side chain.<a onclick="showRef(event, 'ref5 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref5 ref29 ref30 ref31">(5, 29-31)</a> It has been reported that the oligosaccharide moieties participate in the binding of this family of compounds to DNA, the sugar E of the trisaccharide sugar chain being one of the main interaction points.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19 ref20 ref21">(15-21)</a> Also, modifications at the 3-side chain have been revealed to influence the strength of binding to DNA, the capability of inhibiting Sp1 binding to DNA, and the cellular uptake of mithramycins.<a onclick="showRef(event, 'ref5 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref5 ref17 ref18 ref19">(5, 17-19)</a> Since compounds <b>9</b> and <b>11</b> are modified exactly at the sugar E and at the 3-side chain, it would be expected to show different properties, as it is the case. In addition, compound <b>9</b> showed better behavior in vivo than <b>1</b> and <b>11</b> in hollow fiber assays, on both intraperitoneal and subcutaneous implants. Currently, the reason for this is unclear. A better bioavailability and/or differences in DNA specificity, and consequently differences on inhibition of gene transcription mediated by Sp1 and/or other transcription factors, could account for this better behavior. In this sense, compounds <b>3</b> and <b>4</b>, which only differ from <b>1</b> at the 3-side chain, also showed a better activity in vivo in ovarian and prostate tumor xenografs.<a onclick="showRef(event, 'ref6 ref42'); return false;" href="javascript:void(0);" class="ref ref6 ref42">(6, 42)</a> On the other hand, pharmacokinetics of compound <b>9</b> does not seem the reason for its better behavior in vivo in comparison to the parental compound <b>1</b>, since studies in mice revealed similar pharmacokinetics for both compounds. In addition, although compound <b>9</b> is cleared rapidly from the bloodstream, it is efficacious in melanoma and colon xenografs, especially at higher, more spaced doses, indicating that maximum concentration, not half-life, is the key for efficacy.</div><div class="NLM_p last">Moreover, compound <b>9</b> shows about 32- and between 20- and 16- fold (depending of the pattern of administration) less toxicity than the parental compound <b>1</b> for single and repeated treatment in vivo, respectively; therefore, it has a better safety profile than the parent natural product, while being in the same range of bioactivity, which hints of the possibility of opening the therapeutic window of compounds historically too toxic to provide enough margin of safety to be used in humans. It is known in natural product chemistry that minor structural differences could cause major biological effects. For example doxorubicin and epirubicin show differences in cardiac toxicity, despite the structural differences being just one epimerization in the monosaccharide of the compounds.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In the case of mithramycins, the 3-side chain seems to have an important role in toxicity. Thus, it has been reported that mithramycin compounds only differing at the 3-side chain show different degrees of toxicity: compound <b>1</b> and <b>4</b> are less tolerated than compound <b>3</b>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> These data are consistent with the fact that compound <b>9</b> showed lower toxicity, since it shares the same 3-side chain with compound <b>3</b>. However, compound <b>9</b> was about 2-fold less toxic than compound <b>3</b>, which suggests that combining a 3-side chain compound <b>3</b>-like with the presence of <span class="smallcaps smallerCapital">d</span>-digitoxe at the E position of the trisaccharide chain has a synergic effect on decreasing its toxicity. It is not clear at this point the reason for this lower toxicity. A possible interpretation is that DNA binding to GC regions by compound <b>9</b> shows different specificity and can result in interfering transcription of a different set of genes in healthy and tumor cells. In this sense, it has been reported that there are subtle differences in the GC-rich sequences specifically recognized by different analogues of the aureolic acid antibiotics, which either differed in the 3-side chain, the saccharide profile, or both.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Also, in vivo studies on the closely related compounds <b>3</b> and <b>4</b> have shown that the more toxic analogue compound <b>4</b> causes higher down-regulation in a larger number of genes and recovery takes longer than in the less toxic analogue <b>3</b> in prostate cancer cells.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Recent evidence shows better potency and improved selectivity of compound <b>9</b> over <b>1</b> in sarcoma cell lines overexpressing the EWS-FLI1 transcription factor. Compound <b>9</b> compared to <b>1</b> inhibits more effectively luciferase activity driven by NRB01 (a downstream target of EWS-FLI1) as opposed to a nonspecific promoter.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> These observations may change depending on the histology under study. Ongoing research to clarify the reasons for the lower toxicity will be published in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Strains, Culture Conditions, and DNA Manipulation</h3><div class="NLM_p last"><i>Streptomyces argillaceus</i> M7C1<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and <i>S. argillaceus</i> M3W1<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> were used as hosts for plasmid expression and production. For sporulation they were grown for 7 days at 30 °C on agar plates containing medium A<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> supplemented with 25 μg/mL thiostrepton. For protoplasts regeneration, the organisms were grown on R5 solid medium plates.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Liquid and solid media for production and isolation of mithramycin derivatives were modified R5 medium (R5A).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> DNA manipulations were performed according to standard techniques for <i>E. coli</i><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and <i>Streptomyces</i>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Generation of Mithramycin Derivatives</h3><div class="NLM_p last">Three sugar plasmids were used: pFL845, pMP3*BII, and pKOL. pFL845 directs the biosynthesis of <span class="smallcaps smallerCapital">d</span>-amicetose and <span class="smallcaps smallerCapital">d</span>-olivose.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> pMP3*BII codes for the biosynthesis of <span class="smallcaps smallerCapital">d</span>-digitoxose.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Plasmid pKOL was constructed from plasmid pLN2<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> by digesting out the <i>oleU</i> 4-ketoreductase gene using <i>Nhe</i>I and <i>Spe</i>I restriction enzymes and religation of the compatible ends to generate pKOL (see also Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). All the genes in the plasmids are under control of one or two strong <i>ermEp</i>* promoters. Plasmids pFL845, and pMP3*BII and pKOL were introduced into <i>Streptomyces argillaceus</i> M7C1 and <i>S. argillaceus</i> M3W1, respectively, by protoplast transformation according to standard procedures for <i>Streptomyces.</i><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Transformants were selected with thiostrepton (50 μg/mL final concentration). A thiostrepton-resistant colony from each was selected for further characterization (strains <i>S. argillaceus</i> M7C1-pFL845, <i>S. argillaceus</i> M3W1-pMP3*BII, and <i>S. argillaceus</i> M3W1-pKOL, respectively). HPLC analyses were performed as previously described.<a onclick="showRef(event, 'ref32 ref49'); return false;" href="javascript:void(0);" class="ref ref32 ref49">(32, 49)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Purification of New Compounds</h3><div class="NLM_p">For purification of compounds produced by strain <i>S. argillaceus</i> M7C1-pFL845, 100 plates of R5A medium supplemented with thiostrepton were uniformly inoculated and incubated at 30 °C during 7 days. Agar cultures were removed from the plates and were extracted three times with ethyl acetate.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The organic extracts were evaporated under vacuum and finally dissolved in 5 mL of a mixture of DMSO and methanol (50:50). The first purification step was done by chromatography in an XTerra PrepRP18 column (19 mm × 300 mm, Waters) with acetonitrile and 0.05% trifluoroacetic acid (TFA) in water as solvents. A linear gradient from 30% to 100% acetonitrile in 7 min followed by a 3 min isocratic hold with 100% acetonitrile was used at a flow rate of 15 mL/min. The 1 min fractions were taken and analyzed by HPLC. Those containing the desired compounds were evaporated and dissolved in a small volume of the mixture of DMSO and methanol. Further purifications were performed in isocratic conditions with a Symmetry C18 column (7.8 mm × 300 mm, Waters), using mixtures of acetonitrile and 0.05% TFA in water optimized for each peak, at a flow rate of 7 mL/min. Peaks of interest were collected on 0.1 M phosphate buffer, pH 7.0. The solutions obtained were partially evaporated under vacuum to reduce the organic solvent concentration and then applied to a solid phase extraction cartridge (Sep-Pak C18, Waters), washed with water to remove salts, and eluted with methanol. The isolated compounds were finally dissolved in <i>tert</i>-butanol and lyophilized.</div><div class="NLM_p">An alternative method was carried out for purification of the novel derivatives produced by strain <i>S. argillaceus</i> M3W1-pMP3*BII. Then 150 agar plates of R5A medium supplemented with thiostrepton were uniformly inoculated, and after 10 days of incubation at 30 °C, cultures were extracted six times with ethyl acetate and extracts were evaporated under vacuum. The dry extract was dissolved in 50 mL of distilled water and solid-phase-extracted (SepPak Vac C18, Waters). A linear gradient of methanol and water (0–100% methanol during 60 min at 10 mL min<sup>–1</sup>) was applied for elution of the retained material. Fractions obtained were analyzed by HPLC, and those containing the desired compounds were mixed and dried under vacuum. This dry extract, previously dissolved in 10 mL of methanol, was chromatographed in a XBridge Prep C18 column (5 μm, 30 mm × 150 mm, Waters) using a mixture of MeCN and 0.1% TFA in water (35:65) as mobile phase, at flow of 20 mL min<sup>–1</sup>. All compounds collected were repurified using the same column and mixture of solvents. Fractions obtained were collected on 0.1 M phosphate buffer (pH 7.0), and after purification, samples were diluted 4-fold with water, desalted, concentrated by solid-phase extraction, and finally lyophilized. Their purity (≥95%) was checked by HPLC.</div><div class="NLM_p last">The isolated amounts for the different compounds were as follows: 2.5 mg of <b>5</b>; 22.2 mg of <b>6</b>; 3.9 mg of <b>7</b>; 3.8 mg of <b>8</b>; 52.1 mg of <b>9</b>; 18.8 mg of <b>10</b>; 38.0 mg of <b>11</b>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemical Characterization of New Mithramycin Derivatives</h3><div class="NLM_p last">The structures of the new mithramycin analogues were elucidated by NMR spectroscopy, employing 1D <sup>1</sup>H, <sup>13</sup>C, 2D homonuclear <sup>1</sup>H COSY/TOCSY/NOESY, and heteronuclear <sup>1</sup>H–<sup>13</sup>C HSQC/HMBC experiments. NMR data were recorded in acetone-<i>d</i><sub>6</sub> at 298 K using a Bruker Avance Ultrashield Plus 600 spectrometer (600 MHz for <sup>1</sup>H experiments, 150 MHz for <sup>13</sup>C experiments). Typical parameters for 2D experiments were as follows: COSY/TOCSY, 256 and 2048 points in F1 and F2, respectively, 48 transients each; HSQC, 256 and 2048 points in F1 and F2, respectively, 64 transients each; HMBC, 512 and 2048 points in F1 and F2, respectively, 64 transients each. NMR results were processed using the program Topspin 1.3 (Bruker GmbH, Karlsruhe, Germany).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Antitumor Assays. In Vitro Cell Growth Inhibition Assay</h3><div class="NLM_p last">The antitumor activity of the mithramycin derivatives was preliminarily tested against a panel of three tumor cell lines: COLO-205 (colon), A549 (non-small-cell lung), and BXCP3 (pancreas). Cell viability was determined using the MTT colorimetric assay.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Cells were plated in 96-well plates and incubated with vehicle or compounds for 72 h. Each treatment was performed in triplicate, and experiments were repeated at least three times.</div></div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> NCI-60 Anticancer Drug Screen and Hollow Fiber Assay</h3><div class="NLM_p">The methodologies have been described in detail elsewhere (<a href="http://www.dtp.nci.nih.gov/branches/btb/ivclsp.html" class="extLink">http://www.dtp.nci.nih.gov/branches/btb/ivclsp.html</a>, <a href="http://dtp.nci.nih.gov/branches/btb/acute_tox.html" class="extLink">http://dtp.nci.nih.gov/branches/btb/acute_tox.html</a>, <a href="http://dtp.nci.nih.gov/branches/btb/hfa.html" class="extLink">http://dtp.nci.nih.gov/branches/btb/hfa.html</a>). NCI-60 screening experiments were conducted using five concentrations between 10<sup>–9</sup> to 10<sup>–5</sup> M of each compound. To compare the antiproliferative activities between <b>1</b> and <b>9</b>–<b>11</b>, averaged GI<sub>50</sub> across different cell lines were calculated from duplicated screening experiments performed for <b>9</b>–<b>11</b> in the present study and two historically experiments for <b>1</b>.</div><div class="NLM_p last">Preliminary in vivo efficacy was determined in hollow fiber assay using 12 tumor cell lines: COLO205, SW-620 (colon), LOX IMV1, UACC-62, and MDA-MB-435 (melanoma), MDA-MB-231 (breast), NCI-H23 and NCI-H522 (non-small-cell lung), OVCAR-3 and OVCAR-5 (ovarian), and SF-295 and U251 (CNS). Mice bearing different cell lines were treated with each compound administered daily by intraperitoneal injection at dose levels calculated based on MTD for 4 days.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Assays of Toxicity</h3><div class="NLM_p last">Healthy CD-1 mice (<i>n</i> = 4) provided by the University of Oviedo Specific Pathogen Free Animal Facility, Spain, were treated with single tail intravenous injections of compounds <b>9</b>, <b>11</b>, and <b>1</b>, using saline solution as vehicle for solubilization of the compounds. Body weight, deaths, changes in behavior, motility, eating and drinking habits, and any other sign of local or systemic toxicity were recorded daily. Maximum tolerated dose (MTD) is the maximum dose that did not cause apparent symptoms or significant mortality (one mice per group allowed) in the 15 days following administration. Compound <b>1</b> tolerated dose is 2 mg/kg, and dose escalation for the other derivatives started at 4 mg/kg and doubling dose using groups of four mice (two males and two females) in order to determine the MTD. Alternatively, acute toxicity was determined by measuring MTD in a single intraperitoneal injection of each compound at different concentrations using NCI protocols. Repeated dose MTD was determined only for intravenous administration of different dose levels (10 and 20 mg/kg) at different schedules (each 2 days and each 3 days, respectively). Mice were monitored during the course of the treatment and 7 days afterward.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Pharmacokinetics Studies</h3><div class="NLM_p last">Plasma pharmacokinetics of compounds <b>1</b> and <b>9</b> was evaluated in healthy female CD-1 mice following single-dose intravenous administration of 1 and 18 mg/kg, respectively. Plasma samples were collected at 5, 15, 30, 60, and 120 min after injection using three animals per time point. Samples were 5-fold diluted with methanol and centrifuged to eliminate any insoluble precipitate. Concentration of compounds <b>1</b> and <b>9</b> in the supernatant was determine by LC–MS analysis as described elsewhere.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> In Vivo Evaluation of Antitumor Activity</h3><div class="NLM_p last">To assess tumor growth inhibition, groups of athymic nu/nu mice (n = 8) provided by Harlan were implanted subcutaneous tumors and were treated with compounds or vehicle. Drugs were prepared in sterile saline solution and given by intravenous injections q3d×10 and q2d×10. Tumor size was measured with a caliper twice a week. Mice weight and other toxicity symptoms were recorded twice weekly. Animals were sacrificed if needed according to ethical regulations; otherwise, the experiment was terminated 2 months since the implantation in order to observe post-treatment effects.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25"><a href="/doi/suppl/10.1021/jm300234t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44631" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44631" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">HPLC chromatograms of <i>S. argillaceus</i> compared to <i>S. argillaceus</i> (pKOL), <i>S. argillaceus</i> M3W1 compared to <i>S. argillaceus</i> M3W1-pKOL, <i>S. argillaceus</i> M3C1-pFL845, and <i>S. argillaceus</i> M3W1-pMP3*BII; NMR data and spectra of novel compounds; apoptosis data for wash-out experiments; listing of abbreviations used. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300234t/suppl_file/jm300234t_si_001.pdf">jm300234t_si_001.pdf (5.35 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300234t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jürgen Rohr</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, Kentucky 40508, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe948c91968cccbe9b939f9792d08b9587d09b9a8bde9d939b909a9b8498be8b9097918897d09b8d"><span class="__cf_email__" data-cfemail="1a7068757268285a7f777b7376346f7163347f7e6f">[email protected]</span> <span class="__cf_email__" data-cfemail="1f7c727a717b7a65795f6a7176706976317a6c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Méndez</span> - <span class="hlFld-Affiliation affiliation">Departamento de Biología
Funcional e Instituto Universitario de Oncología del Principado
de Asturias (I.U.O.P.A), Universidad de Oviedo, 33006 Oviedo, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f298809d9a80c0b2979f939b9edc87998bdc979687d2919f979c96978894b2879c9b9d849bdc9781"><span class="__cf_email__" data-cfemail="38524a57504a0a785d55595154164d5341165d5c4d">[email protected]</span> <span class="__cf_email__" data-cfemail="f2919f979c96978894b2879c9b9d849bdc9781">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luz E. Núñez</span> - <span class="hlFld-Affiliation affiliation">EntreChem, S.L., Edificio Científico Tecnológico, Campus El Cristo,
Oviedo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen E. Nybo</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, Kentucky 40508, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javier González-Sabín</span> - <span class="hlFld-Affiliation affiliation">EntreChem, S.L., Edificio Científico Tecnológico, Campus El Cristo,
Oviedo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Pérez</span> - <span class="hlFld-Affiliation affiliation">Departamento de Biología
Funcional e Instituto Universitario de Oncología del Principado
de Asturias (I.U.O.P.A), Universidad de Oviedo, 33006 Oviedo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nuria Menéndez</span> - <span class="hlFld-Affiliation affiliation">EntreChem, S.L., Edificio Científico Tecnológico, Campus El Cristo,
Oviedo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alfredo F. Braña</span> - <span class="hlFld-Affiliation affiliation">Departamento de Biología
Funcional e Instituto Universitario de Oncología del Principado
de Asturias (I.U.O.P.A), Universidad de Oviedo, 33006 Oviedo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khaled A. Shaaban</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, Kentucky 40508, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min He</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Program,
Division of Cancer Treatment and Diagnosis, National
Cancer Institute, National Institutes of Health, Rockville,
Maryland, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Morís</span> - <span class="hlFld-Affiliation affiliation">EntreChem, S.L., Edificio Científico Tecnológico, Campus El Cristo,
Oviedo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José A. Salas</span> - <span class="hlFld-Affiliation affiliation">Departamento de Biología
Funcional e Instituto Universitario de Oncología del Principado
de Asturias (I.U.O.P.A), Universidad de Oviedo, 33006 Oviedo, Spain</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): F.M., J.A.S., and C.M. report stock ownership in Entrechem S.L.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3800e2453-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the National Institutes of Health (Grant CA091901 to J.R.) and the Spanish Ministry of Science and Innovation (Grants BIO2005-04115 and BIO2008-00269 to C.M. and Grant PET2005-0401 to C.M. and F.M.). M.P. was the recipient of a predoctoral fellowship from the Spanish Ministry of Science and Innovation. L.E.N. was the recipient of Torres-Quevedo Program Funding (Grant PTQ04-3-0487) from the Spanish Ministry of Science and Innovation. S.E.N. was partially supported by a graduate fellowship from the University of Kentucky graduate school.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> Abbreviations Used</h2><tr><td class="NLM_term">cox2</td><td class="NLM_def"><p class="first last">cyclooxygenase-2</p></td></tr><tr><td class="NLM_term">ESFTs</td><td class="NLM_def"><p class="first last">Ewing sarcoma family of tumors</p></td></tr><tr><td class="NLM_term">EWS-FLI1</td><td class="NLM_def"><p class="first last">Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">50% growth inhibition</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">MDR-1</td><td class="NLM_def"><p class="first last">multidrug resistant gene 1</p></td></tr><tr><td class="NLM_term">NDP</td><td class="NLM_def"><p class="first last">nucleoside diphosphate</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κ light-chain enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">p21cip1/waf1</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase inhibitor 1</p></td></tr><tr><td class="NLM_term">p53</td><td class="NLM_def"><p class="first last">protein 53</p></td></tr><tr><td class="NLM_term">q2d×10</td><td class="NLM_def"><p class="first last">a single dose every 2 days times 10</p></td></tr><tr><td class="NLM_term">q3d×10</td><td class="NLM_def"><p class="first last">a single dose every 3 days times 10</p></td></tr><tr><td class="NLM_term">R5A</td><td class="NLM_def"><p class="first last">modified R5 medium</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">Sp1</td><td class="NLM_def"><p class="first last">specificity protein 1</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">TF</td><td class="NLM_def"><p class="first last">transcription factor</p></td></tr><tr><td class="NLM_term">TGF-β</td><td class="NLM_def"><p class="first last">transforming growth factor β</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Darnell, J. E.,  Jr.</span><span> </span><span class="NLM_article-title">Transcription factors as targets for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">740</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1038%2Fnrc906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=12360277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=740-749&author=J.+E.+Darnell&title=Transcription+factors+as+targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription factors as targets for cancer therapy</span></div><div class="casAuthors">Darnell, James E., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">740-749</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A limited list of transcription factors are overactive in most human cancer cells, which makes them targets for the development of anticancer drugs.  That they are the most direct and hopeful targets for treating cancer is proposed, and this is supported by the fact that there are many more human oncogenes in signaling pathways than there are oncogenic transcription factors.  But how could specific transcription-factor activity be inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJxyqucgv0aLVg90H21EOLACvtfcHk0lh1Udc_GWdfIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbo%253D&md5=239132f634b138965e3a11c63f7cab76</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc906%26sid%3Dliteratum%253Aachs%26aulast%3DDarnell%26aufirst%3DJ.%2BE.%26atitle%3DTranscription%2520factors%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D740%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Germain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D. A.</span><span> </span><span class="NLM_article-title">Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5665</span><span class="NLM_x">–</span> <span class="NLM_lpage">5669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1158%2F1078-0432.CCR-06-2491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=17908954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSntLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=5665-5669&author=D.+Germainauthor=D.+A.+Frank&title=Targeting+the+cytoplasmic+and+nuclear+functions+of+signal+transducers+and+activators+of+transcription+3+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Cytoplasmic and Nuclear Functions of Signal Transducers and Activators of Transcription 3 for Cancer Therapy</span></div><div class="casAuthors">Germain, Doris; Frank, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5665-5669</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Signal transducers and activators of transcription (STAT) are a highly conserved family of transcription factors that are activated by phosphorylation in the cytoplasm, after which they translocate to the nucleus to regulate gene expression.  Among the seven STATs, STAT3 is of particular interest due to its constitutive phosphorylation in a large proportion of human cancers and its ability to induce neoplastic transformation.  Inhibition of STAT3 can reverse tumor growth in exptl. systems while having few effects in normal cells.  These findings have implicated STAT3 as a potentially important target for therapeutic intervention.  In addn. to its well-described role as a transcription factor, STAT3 has been found recently to have important effects in the cytoplasm.  Collectively, these functions of STAT3 directly contribute to tumorigenesis, invasion, and metastasis.  Given the potential importance of STAT3 as a target for cancer therapy, mols. have been developed that can block STAT3 function at a variety of steps.  These drugs show promise as anticancer agents in model systems of a variety of common human cancers.  Thus, elucidating the functions of STAT3 and developing agents to inhibit this protein remain important scientific and clin. challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM6w8Sek_eY7Vg90H21EOLACvtfcHk0lh1Udc_GWdfIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSntLzK&md5=7c06b8b398fa29f41b1e2049abbb04ea</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2491%26sid%3Dliteratum%253Aachs%26aulast%3DGermain%26aufirst%3DD.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26atitle%3DTargeting%2520the%2520cytoplasmic%2520and%2520nuclear%2520functions%2520of%2520signal%2520transducers%2520and%2520activators%2520of%2520transcription%25203%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D5665%26epage%3D5669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Page, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Signal transducer and activator of transcription 3 inhibitors: a patent review</span> <span class="citation_source-journal">Expert. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1517%2F13543776.2011.539205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21114420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFyktrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=65-83&author=B.+D.+Pageauthor=D.+P.+Ballauthor=P.+T.+Gunning&title=Signal+transducer+and+activator+of+transcription+3+inhibitors%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transducer and activator of transcription 3 inhibitors: a patent review</span></div><div class="casAuthors">Page, Brent D. G.; Ball, Daniel P.; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-83</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Aberrant activation of signal transducer and activator of transcription (Stat) 3, a member of the STAT family of proteins, is prevalent in numerous human cancers and is now widely recognized as a crit. mol. abnormality and a master regulator of tumor processes.  Thus, the identification of potent and selective Stat3 inhibitors will have a high com. potential as anticancer drugs, given the many tumors in which Stat3 is implicated.  Areas covered in this review: This review covers the structures and activities of direct inhibitors of Stat3 protein activity described in the patent literature since the research field's inception in 2001.  The patents reviewed include peptide and peptidomimetic compds., small mols., oligonucleotides and platinum-based Stat3 inhibitors.  What the reader will gain: Readers will gain an understanding of how Stat3 protein function has been inhibited by a wide variety of structurally diverse therapeutic compds.  Readers will learn about which classes of patented Stat3 inhibitors are most advanced toward clin. trials, and will be exposed to the proposed mechanisms of inhibition and scope of their application in treating human cancers.  Take home message: Numerous groups have shown that in vivo administration of inhibitors of activated Stat3 induce human tumor regression in xenograft models.  Indeed, the growing no. of preclin. studies in numerous cancer types, as well as the first Phase 0 clin. trial of a Stat3 inhibitor, suggest that Stat3 is a valid and exciting therapeutic target for mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogO9J3Yw_G5bVg90H21EOLACvtfcHk0ljUl87K4ERd-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFyktrvJ&md5=338065a442a0de9993a90b1c25a5e084</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.539205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.539205%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DBall%26aufirst%3DD.%2BP.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DSignal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D65%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wilczynski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duechler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czyz, M.</span><span> </span><span class="NLM_article-title">Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I</span> <span class="citation_source-journal">Arch. Immunol. Ther. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1007%2Fs00005-011-0131-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21625848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1ShtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=289-299&author=J.+Wilczynskiauthor=M.+Duechlerauthor=M.+Czyz&title=Targeting+NF-%CE%BAB+and+HIF-1+pathways+for+the+treatment+of+cancer%3A+part+I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting NF-κB and HIF-1 Pathways for the Treatment of Cancer: Part I</span></div><div class="casAuthors">Wilczynski, Jacek; Duechler, Markus; Czyz, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">Archivum Immunologiae et Therapiae Experimentalis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-299</span>CODEN:
                <span class="NLM_cas:coden">AITEAT</span>;
        ISSN:<span class="NLM_cas:issn">0004-069X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  The process of chronic inflammation is a common link which connects different kinds of environmental pollutants and infections with tumorigenesis.  Transcription factor NF-κB is a common final target for many inflammatory and cell proliferation pathways, independent of the source of stimuli (e.g., cytokines, growth factors, environmental carcinogens, radiation, hypoxia, bacteria, and viruses).  Over-activation of NF-κB has been confirmed in many tumors, resulting in worse prognosis for patient survival.  Therefore, inhibition of cellular pathways for NF-κB activation is nowadays considered as a promising anti-cancer therapy and is extensively studied in clin. trials, or even has been adopted as an approved therapy in some kinds of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowOK9I_rALSrVg90H21EOLACvtfcHk0ljUl87K4ERd-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1ShtLo%253D&md5=9b93524a3cfd41b8bed5a8a0ac799c61</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00005-011-0131-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00005-011-0131-4%26sid%3Dliteratum%253Aachs%26aulast%3DWilczynski%26aufirst%3DJ.%26aulast%3DDuechler%26aufirst%3DM.%26aulast%3DCzyz%26aufirst%3DM.%26atitle%3DTargeting%2520NF-%25CE%25BAB%2520and%2520HIF-1%2520pathways%2520for%2520the%2520treatment%2520of%2520cancer%253A%2520part%2520I%26jtitle%3DArch.%2520Immunol.%2520Ther.%2520Exp.%26date%3D2011%26volume%3D59%26spage%3D289%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Albertini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napoli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinaldi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nur-e-Alam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catapano, C. V.</span><span> </span><span class="NLM_article-title">Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer <i>Streptomyces argillaceus</i> exhibits improved transcriptional repressor activity: implications for cancer therapy</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1721-1734&author=V.+Albertiniauthor=A.+Jainauthor=S.+Vignatiauthor=S.+Napoliauthor=A.+Rinaldiauthor=I.+Kweeauthor=M.+Nur-e-Alamauthor=J.+Bergantauthor=F.+Bertoniauthor=G.+Carboneauthor=J.+Rohrauthor=C.+V.+Catapano&title=Novel+GC-rich+DNA-binding+compound+produced+by+a+genetically+engineered+mutant+of+the+mithramycin+producer+Streptomyces+argillaceus+exhibits+improved+transcriptional+repressor+activity%3A+implications+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlbertini%26aufirst%3DV.%26aulast%3DJain%26aufirst%3DA.%26aulast%3DVignati%26aufirst%3DS.%26aulast%3DNapoli%26aufirst%3DS.%26aulast%3DRinaldi%26aufirst%3DA.%26aulast%3DKwee%26aufirst%3DI.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DBergant%26aufirst%3DJ.%26aulast%3DBertoni%26aufirst%3DF.%26aulast%3DCarbone%26aufirst%3DG.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26atitle%3DNovel%2520GC-rich%2520DNA-binding%2520compound%2520produced%2520by%2520a%2520genetically%2520engineered%2520mutant%2520of%2520the%2520mithramycin%2520producer%2520Streptomyces%2520argillaceus%2520exhibits%2520improved%2520transcriptional%2520repressor%2520activity%253A%2520implications%2520for%2520cancer%2520therapy%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3D1721%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Previdi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broggini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catapano, C. V.</span><span> </span><span class="NLM_article-title">Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1016%2Fj.ygyno.2010.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=20452660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=182-188&author=S.+Previdiauthor=A.+Malekauthor=V.+Albertiniauthor=C.+Rivaauthor=C.+Capellaauthor=M.+Brogginiauthor=G.+M.+Carboneauthor=J.+Rohrauthor=C.+V.+Catapano&title=Inhibition+of+Sp1-dependent+transcription+and+antitumor+activity+of+the+new+aureolic+acid+analogues+mithramycin+SDK+and+SK+in+human+ovarian+cancer+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts</span></div><div class="casAuthors">Previdi, Sara; Malek, Anastasia; Albertini, Veronica; Riva, Cristina; Capella, Carlo; Broggini, Massimo; Carbone, Giuseppina M.; Rohr, Jurgen; Catapano, Carlo V.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-188</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Objective: Increased activity of Sp family of transcription factors is a frequent and crit. event in cancer development and progression.  Genes governing tumor growth, invasion and angiogenesis are regulated by Sp factors, like Sp1, Sp3 or Sp4, and are frequently over-expressed in tumors.  Targeting Sp factors has been explored as a therapeutic approach.  Mithramycin (MTM) is a natural antibiotic that binds DNA and inhibit Sp1-dependent transcription.  New analogs, named MTM-SDK and MTM-SK, were recently obtained by genetic engineering of the MTM biosynthetic pathway and have demonstrated improved transcriptional and antiproliferative activity in ovarian cancer cell lines in vitro.  In the present study we evaluated the activity of the new compds. in human ovarian cancer xenografts.  Methods: Expression of Sp1 and target proteins in ovarian cancer specimens and tumor xenografts was assessed by immunohistochem.  Drug-induced silencing of Sp1-regulated genes in cells and tumor xenograft samples was assessed by quant. RT-PCR.  Toxicity and antitumor activity of the compds. were investigated in healthy and tumor-bearing immunocompromised mice, resp.  Results: Expression of Sp1 was frequently increased in human epithelial ovarian cancers.  MTM-SDK and MTM-SK acted as potent inhibitors of Sp1-dependent transcription both in vitro and in tumor xenografts.  Both compds. were well tolerated even after prolonged administration and delayed growth of ovarian tumor xenografts.  MTM-SDK was particularly effective against orthotopic tumors leading to a significant increase of survival and delay of tumor progression.  Conclusions: MTM-SDK and MTM-SK show relevant activity in vivo and represent interesting candidates for treatment of ovarian cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeJTYgFUbvNrVg90H21EOLACvtfcHk0liBCNxgOEq7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGgsrg%253D&md5=598990226414169b2fce6e735fc48801</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2010.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2010.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DPrevidi%26aufirst%3DS.%26aulast%3DMalek%26aufirst%3DA.%26aulast%3DAlbertini%26aufirst%3DV.%26aulast%3DRiva%26aufirst%3DC.%26aulast%3DCapella%26aufirst%3DC.%26aulast%3DBroggini%26aufirst%3DM.%26aulast%3DCarbone%26aufirst%3DG.%2BM.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26atitle%3DInhibition%2520of%2520Sp1-dependent%2520transcription%2520and%2520antitumor%2520activity%2520of%2520the%2520new%2520aureolic%2520acid%2520analogues%2520mithramycin%2520SDK%2520and%2520SK%2520in%2520human%2520ovarian%2520cancer%2520xenografts%26jtitle%3DGynecol.%2520Oncol.%26date%3D2010%26volume%3D118%26spage%3D182%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Safe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelrahim, M.</span><span> </span><span class="NLM_article-title">Sp transcription factor family and its role in cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2438</span><span class="NLM_x">–</span> <span class="NLM_lpage">2448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=2438-2448&author=S.+Safeauthor=M.+Abdelrahim&title=Sp+transcription+factor+family+and+its+role+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DAbdelrahim%26aufirst%3DM.%26atitle%3DSp%2520transcription%2520factor%2520family%2520and%2520its%2520role%2520in%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D2438%26epage%3D2448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Newman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, G. M.</span><span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the last 25 years</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/doi/10.1021/np068054v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=461-477&author=J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+last+25+years"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Last 25 Years</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-477</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review is an updated and expanded version of two prior reviews that were published in this journal in 1997 and 2003.  In the case of all approved agents the time frame has been extended to include the 251/2 years from 01/1981 to 06/2006 for all diseases worldwide and from 1950 (earliest so far identified) to 06/2006 for all approved antitumor drugs worldwide.  We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions.  From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well.  Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 155 small mols., 73% are other than "S" (synthetic), with 47% actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the antiinfective area being dependent on natural products and their structures.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have, in fact, been used in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compd. approved as a drug in this 25 plus year time frame.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpih5kusSUibVg90H21EOLACvtfcHk0liBCNxgOEq7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D&md5=9fc0909750367ccd3b97589aaf087cdf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fnp068054v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp068054v%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%2520last%252025%2520years%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D461%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conforto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratan, R. R.</span><span> </span><span class="NLM_article-title">Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1002%2Fana.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=11261509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVyqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=345-354&author=S.+Chatterjeeauthor=K.+Zamanauthor=H.+Ryuauthor=A.+Confortoauthor=R.+R.+Ratan&title=Sequence-selective+DNA+binding+drugs+mithramycin+A+and+chromomycin+A3+are+potent+inhibitors+of+neuronal+apoptosis+induced+by+oxidative+stress+and+DNA+damage+in+cortical+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons</span></div><div class="casAuthors">Chatterjee, Sukalyan; Zaman, Khalequz; Ryu, Hoon; Conforto, Adriana; Ratan, Rajiv R.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-354</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Global inhibitors of RNA or protein synthesis such as actinomycin D or cycloheximide abrogate neuronal apoptosis induced by numerous pathol. stimuli in vitro and in vivo.  The clin. application of actinomycin D or cycloheximide to human neurol. disease has been limited by the toxicities of these agents.  To overcome these toxicities, strategies must be developed to inhibit selectively the expression of deleterious proapoptotic proteins, while leaving the expression of antiapoptotic, proregeneration, and other crit. homeostatic proteins unperturbed.  Mithramycin A (trade name Plicamycin) is an aureolic acid antibiotic that has been used in humans to treat hypercalcemia and several types of cancers.  This class of agents is believed to act, in part, by selectively inhibiting gene expression by displacing transcriptional activators that bind to G-C-rich regions of promoters.  Here we demonstrate that mithramycin A and its structural analog chromomycin A3 are potent inhibitors of neuronal apoptosis induced by glutathione depletion-induced oxidative stress or the DNA-damaging agent camptothecin.  We correlate the protective effects of mithramycin A with its ability to inhibit enhanced DNA binding of the transcription factors Sp1 and Sp3 to their cognate "G-C" box induced by oxidative stress or DNA damage.  The protective effects of mithramycin A cannot be attributed to global inhibition of protein synthesis.  Together, these results suggest that mithramycin A and its structural analogs may be effective agents for the treatment of neurol. diseases assocd. with aberrant activation of apoptosis and highlight the potential use of sequence-selective DNA-binding drugs as neurol. therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyQUSlsOrb0LVg90H21EOLACvtfcHk0liBCNxgOEq7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVyqtLY%253D&md5=96739b4c3a2230b62589e4eefda4d5f9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fana.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.71%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DZaman%26aufirst%3DK.%26aulast%3DRyu%26aufirst%3DH.%26aulast%3DConforto%26aufirst%3DA.%26aulast%3DRatan%26aufirst%3DR.%2BR.%26atitle%3DSequence-selective%2520DNA%2520binding%2520drugs%2520mithramycin%2520A%2520and%2520chromomycin%2520A3%2520are%2520potent%2520inhibitors%2520of%2520neuronal%2520apoptosis%2520induced%2520by%2520oxidative%2520stress%2520and%2520DNA%2520damage%2520in%2520cortical%2520neurons%26jtitle%3DAnn.%2520Neurol.%26date%3D2001%26volume%3D49%26spage%3D345%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span> </span><span class="NLM_article-title">Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4878</span><span class="NLM_x">–</span> <span class="NLM_lpage">4885</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4878-4885&author=Z.+Jiaauthor=J.+Zhangauthor=D.+Weiauthor=L.+Wangauthor=P.+Yuanauthor=X.+Leauthor=Q.+Liauthor=J.+Yaoauthor=K.+Xie&title=Molecular+basis+of+the+synergistic+antiangiogenic+activity+of+bevacizumab+and+mithramycin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DLe%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DK.%26atitle%3DMolecular%2520basis%2520of%2520the%2520synergistic%2520antiangiogenic%2520activity%2520of%2520bevacizumab%2520and%2520mithramycin%2520A%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4878%26epage%3D4885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Jia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span> </span><span class="NLM_article-title">Treatment with combination of mithramycin A and tolfenamic acid promotes degradation of Sp1 protein and synergistic antitumor activity in pancreatic cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1111-1119&author=Z.+Jiaauthor=Y.+Gaoauthor=L.+Wangauthor=Q+Liauthor=J.+Zhangauthor=X.+Leauthor=D.+Weiauthor=J.+C.+Yaoauthor=D.+Z.+Changauthor=S.+Huangauthor=K.+Xie&title=Treatment+with+combination+of+mithramycin+A+and+tolfenamic+acid+promotes+degradation+of+Sp1+protein+and+synergistic+antitumor+activity+in+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DJ.%2BC.%26aulast%3DChang%26aufirst%3DD.%2BZ.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DK.%26atitle%3DTreatment%2520with%2520combination%2520of%2520mithramycin%2520A%2520and%2520tolfenamic%2520acid%2520promotes%2520degradation%2520of%2520Sp1%2520protein%2520and%2520synergistic%2520antitumor%2520activity%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1111%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Fajardo, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parapuram, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leask, A.</span><span> </span><span class="NLM_article-title">Mithramycin reduces expression of fibro-proliferative mRNAs in human gingival fibroblasts</span> <span class="citation_source-journal">Cell Proliferation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=166-173&author=O.+A.+Fajardoauthor=+Thompsonauthor=S.+K.+Parapuramauthor=S.+Liuauthor=A.+Leask&title=Mithramycin+reduces+expression+of+fibro-proliferative+mRNAs+in+human+gingival+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFajardo%26aufirst%3DO.%2BA.%26aulast%3DThompson%26aulast%3DParapuram%26aufirst%3DS.%2BK.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLeask%26aufirst%3DA.%26atitle%3DMithramycin%2520reduces%2520expression%2520of%2520fibro-proliferative%2520mRNAs%2520in%2520human%2520gingival%2520fibroblasts%26jtitle%3DCell%2520Proliferation%26date%3D2011%26volume%3D44%26spage%3D166%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Seznec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silkenstedt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naumann, U.</span><span> </span><span class="NLM_article-title">Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma</span> <span class="citation_source-journal">J. Neuro-Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1007%2Fs11060-010-0266-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=20556479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFCntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2011&pages=365-377&author=J.+Seznecauthor=B.+Silkenstedtauthor=U.+Naumann&title=Therapeutic+effects+of+the+Sp1+inhibitor+mithramycin+A+in+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma</span></div><div class="casAuthors">Seznec, Janina; Silkenstedt, Bjoern; Naumann, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mithramycin A (MitA) is a chemotherapeutic compd. which has been used in the therapy of several types of cancer.  For exptl. cancer it has been shown that MitA mediates the expression of genes involved in tumor progression such as genes involved in immunosurveillance, cell motility or cell death.  MitA works synergistically with Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and with antiangiogenic agents.  We were therefore interested in analyzing whether MitA might be a suitable agent for glioma therapy.  We demonstrate herein that the cell death sensitizing effects of MitA are cell line specific, independent of the endogenous status of the tumor suppressor p53 as well as of the endogenous expression of X-linked inhibitor of apoptosis (XIAP) or basal sensitivity towards death ligand-induced cell death.  In glioma cells, MitA reduced the secretion and activity of the migration-involved matrix metalloproteinases (MMP), diminished vascular endothelial growth factor (VEGF), and increased recepteur d'origine nantais (RON) kinase mRNA, paralleled by a significant redn. of glioma cell migration.  In contrast to other cancer types, in glioma cells MitA did not alter the expression of the immunorelevant genes major histocompatibility complex I class related (MIC)-A, MIC-B or UL16 binding proteins (ULBP).  We conclude that, whereas MitA-mediated redn. of XIAP expression and sensitization to Apo2L/TRAIL are cell line specific, its antimigratory effects are more general and might be the result of altered expression of MMP, VEGF, and/or RON kinase.  Therefore, MitA might be a potential agent to reduce glioma cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppIXp425RWvbVg90H21EOLACvtfcHk0lhRBVRLU0193A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFCntg%253D%253D&md5=e36bc57e6d5e79a2e989290ed0eb1197</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs11060-010-0266-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-010-0266-x%26sid%3Dliteratum%253Aachs%26aulast%3DSeznec%26aufirst%3DJ.%26aulast%3DSilkenstedt%26aufirst%3DB.%26aulast%3DNaumann%26aufirst%3DU.%26atitle%3DTherapeutic%2520effects%2520of%2520the%2520Sp1%2520inhibitor%2520mithramycin%2520A%2520in%2520glioblastoma%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2011%26volume%3D101%26spage%3D365%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Grohar, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldemichael, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currier, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helman, L. J.</span><span> </span><span class="NLM_article-title">Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">962</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1093%2Fjnci%2Fdjr156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21653923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2011&pages=962-978&author=P.+J.+Groharauthor=G.+M.+Woldemichaelauthor=L.+B.+Griffinauthor=A.+Mendozaauthor=Q.-R.+Chenauthor=C.+Yeungauthor=D.+G.+Currierauthor=S.+Davisauthor=C.+Khannaauthor=J.+Khanauthor=J.+B.+McMahonauthor=L.+J.+Helman&title=Identification+of+an+inhibitor+of+the+EWS-FLI1+oncogenic+transcription+factor+by+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening</span></div><div class="casAuthors">Grohar, Patrick J.; Woldemichael, Girma M.; Griffin, Laurie B.; Mendoza, Arnulfo; Chen, Qing-Rong; Yeung, Choh; Currier, Duane G.; Davis, Sean; Khanna, Chand; Khan, Javed; McMahon, James B.; Helman, Lee J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">962-978</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Chromosomal translocations generating oncogenic transcription factors are the hallmark of a variety of tumors, including many sarcomas.  Ewing sarcoma family of tumors (ESFTs) are characterized by the t(11;22)(q24;q12) translocation that generates the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) fusion transcription factor responsible for the highly malignant phenotype of this tumor.  Although continued expression of EWS-FLI1 is believed to be crit. for ESFT cell survival, a clin. effective small-mol. inhibitor remains elusive likely because EWS-FLI1 is a transcription factor and therefore widely felt to be "undruggable.  " Methods We developed a high-throughput screen to evaluate more than 50 000 compds. for inhibition of EWS-FLI1 activity in TC32 ESFT cells.  We used a TC32 cell-based luciferase reporter screen using the EWS-FLI1 downstream target NR0B1 promoter and a gene signature secondary screen to sort and prioritize the compds.  We characterized the lead compd., mithramycin, based on its ability to inhibit EWS-FLI1 activity in vitro using microarray expression profiling, quant. reverse transcription-polymerase chain reaction, and immunoblot anal., and in vivo using immunohistochem.  We studied the impact of this inhibition on cell viability in vitro and on tumor growth in ESFT xenograft models in vivo (n = 15-20 mice per group).  All statistical tests were two-sided.  Results Mithramycin inhibited expression of EWS-FLI1 downstream targets at the mRNA and protein levels and decreased the growth of ESFT cells at half maximal inhibitory concns. between 10 (95% confidence interval [CI] = 8 to 13 nM) and 15 nM (95% CI = 13 to 19 nM).  Mithramycin suppressed the growth of two different ESFT xenograft tumors and prolonged the survival of ESFT xenograft-bearing mice by causing a decrease in mean tumor vol.  For example, in the TC32 xenograft model, on day 15 of treatment, the mean tumor vol. for the mithramycin-treated mice was approx. 3% of the tumor vol. obsd. in the control mice (mithramycin vs control: 69 vs 2388 mm3, difference = 2319 mm3, 95% CI = 1766 to 2872 mm3, P < .001).  Conclusion Mithramycin inhibits EWS-FLI1 activity and demonstrates ESFT antitumor activity both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-zpZMmMy4bLVg90H21EOLACvtfcHk0lgBBB5qonLmKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cltro%253D&md5=814cc95d2b54de9b275cc1df8a1b19ee</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjr156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjr156%26sid%3Dliteratum%253Aachs%26aulast%3DGrohar%26aufirst%3DP.%2BJ.%26aulast%3DWoldemichael%26aufirst%3DG.%2BM.%26aulast%3DGriffin%26aufirst%3DL.%2BB.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DQ.-R.%26aulast%3DYeung%26aufirst%3DC.%26aulast%3DCurrier%26aufirst%3DD.%2BG.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DKhanna%26aufirst%3DC.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26atitle%3DIdentification%2520of%2520an%2520inhibitor%2520of%2520the%2520EWS-FLI1%2520oncogenic%2520transcription%2520factor%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2011%26volume%3D103%26spage%3D962%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sastry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. J.</span><span> </span><span class="NLM_article-title">Solution structure of the mithramycin dimer–DNA complex</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">6588</span><span class="NLM_x">–</span> <span class="NLM_lpage">6604</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00077a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=6588-6604&author=M.+Sastryauthor=D.+J.+Patel&title=Solution+structure+of+the+mithramycin+dimer%E2%80%93DNA+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbi00077a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00077a012%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26atitle%3DSolution%2520structure%2520of%2520the%2520mithramycin%2520dimer%25E2%2580%2593DNA%2520complex%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D6588%26epage%3D6604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sastry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. J.</span><span> </span><span class="NLM_article-title">Solution structure of mithramycin dimers bound to partially overlapping sites on DNA</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">689</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1995&pages=674-689&author=M.+Sastryauthor=R.+Fialaauthor=D.+J.+Patel&title=Solution+structure+of+mithramycin+dimers+bound+to+partially+overlapping+sites+on+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DM.%26aulast%3DFiala%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26atitle%3DSolution%2520structure%2520of%2520mithramycin%2520dimers%2520bound%2520to%2520partially%2520overlapping%2520sites%2520on%2520DNA%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D251%26spage%3D674%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Barcelo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Lombardía, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portugal, J.</span><span> </span><span class="NLM_article-title">Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2215</span><span class="NLM_x">–</span> <span class="NLM_lpage">2226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=2215-2226&author=F.+Barceloauthor=C.+Scottaauthor=M.+Ortiz-Lombard%C3%ADaauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Portugal&title=Entropically-driven+binding+of+mithramycin+in+the+minor+groove+of+C%2FG-rich+DNA+sequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarcelo%26aufirst%3DF.%26aulast%3DScotta%26aufirst%3DC.%26aulast%3DOrtiz-Lombard%25C3%25ADa%26aufirst%3DM.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DPortugal%26aufirst%3DJ.%26atitle%3DEntropically-driven%2520binding%2520of%2520mithramycin%2520in%2520the%2520minor%2520groove%2520of%2520C%252FG-rich%2520DNA%2520sequences%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3D2215%26epage%3D2226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Barcelo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Lombardia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martorell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portugal, J.</span><span> </span><span class="NLM_article-title">DNA binding characteristics of mithramycin and chromomycin analogues obtained by combinatorial biosynthesis</span> <span class="citation_source-journal">Biochemistry.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">10543</span><span class="NLM_x">–</span> <span class="NLM_lpage">1055</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi101398s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=10543-1055&author=F.+Barceloauthor=M.+Ortiz-Lombardiaauthor=M.+Martorellauthor=M.+Oliverauthor=C.+Mendezauthor=J.+A.+Salasauthor=J.+Portugal&title=DNA+binding+characteristics+of+mithramycin+and+chromomycin+analogues+obtained+by+combinatorial+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi101398s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi101398s%26sid%3Dliteratum%253Aachs%26aulast%3DBarcelo%26aufirst%3DF.%26aulast%3DOrtiz-Lombardia%26aufirst%3DM.%26aulast%3DMartorell%26aufirst%3DM.%26aulast%3DOliver%26aufirst%3DM.%26aulast%3DMendez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DPortugal%26aufirst%3DJ.%26atitle%3DDNA%2520binding%2520characteristics%2520of%2520mithramycin%2520and%2520chromomycin%2520analogues%2520obtained%2520by%2520combinatorial%2520biosynthesis%26jtitle%3DBiochemistry.%26date%3D2010%26volume%3D49%26spage%3D10543%26epage%3D1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mansilla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ferrer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portugal, J.</span><span> </span><span class="NLM_article-title">Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure–activity relationships</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1418</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1418-1427&author=S.+Mansillaauthor=I.+Garcia-Ferrerauthor=C.+Mendezauthor=J.+A.+Salasauthor=J.+Portugal&title=Differential+inhibition+of+restriction+enzyme+cleavage+by+chromophore-modified+analogues+of+the+antitumour+antibiotics+mithramycin+and+chromomycin+reveals+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMansilla%26aufirst%3DS.%26aulast%3DGarcia-Ferrer%26aufirst%3DI.%26aulast%3DMendez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DPortugal%26aufirst%3DJ.%26atitle%3DDifferential%2520inhibition%2520of%2520restriction%2520enzyme%2520cleavage%2520by%2520chromophore-modified%2520analogues%2520of%2520the%2520antitumour%2520antibiotics%2520mithramycin%2520and%2520chromomycin%2520reveals%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1418%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Yuan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span> </span><span class="NLM_article-title">Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin A correlates directly with potent antiangiogenic effects on human pancreatic cancer</span> <span class="citation_source-journal">Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2007&pages=2682-2690&author=P.+Yuanauthor=L.+Wangauthor=D.+Weiauthor=J.+Zhangauthor=Z.+Jiaauthor=Q.+Liauthor=X.+Leauthor=H.+Wangauthor=J.+Yaoauthor=K.+Xie&title=Therapeutic+inhibition+of+Sp1+expression+in+growing+tumors+by+mithramycin+A+correlates+directly+with+potent+antiangiogenic+effects+on+human+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLe%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DK.%26atitle%3DTherapeutic%2520inhibition%2520of%2520Sp1%2520expression%2520in%2520growing%2520tumors%2520by%2520mithramycin%2520A%2520correlates%2520directly%2520with%2520potent%2520antiangiogenic%2520effects%2520on%2520human%2520pancreatic%2520cancer%26jtitle%3DCancer.%26date%3D2007%26volume%3D110%26spage%3D2682%26epage%3D2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Campbell, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Patterson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayfield, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramoto, R. A.</span><span> </span><span class="NLM_article-title">The G-C specific DNA binding drug, mithramycin, selectively inhibits transcription of the c-myc and c-ha-ras genes in regenerating liver</span> <span class="citation_source-journal">Am. J. Med. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=1994&pages=167-172&author=V.+W.+Campbellauthor=D.+Davinauthor=S.+Thomasauthor=D.+Jonesauthor=J.+Roeselauthor=R.+Tran-Pattersonauthor=C.+A.+Mayfieldauthor=B.+Roduauthor=D.+M.+Millerauthor=R.+A.+Hiramoto&title=The+G-C+specific+DNA+binding+drug%2C+mithramycin%2C+selectively+inhibits+transcription+of+the+c-myc+and+c-ha-ras+genes+in+regenerating+liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DV.%2BW.%26aulast%3DDavin%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DTran-Patterson%26aufirst%3DR.%26aulast%3DMayfield%26aufirst%3DC.%2BA.%26aulast%3DRodu%26aufirst%3DB.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DHiramoto%26aufirst%3DR.%2BA.%26atitle%3DThe%2520G-C%2520specific%2520DNA%2520binding%2520drug%252C%2520mithramycin%252C%2520selectively%2520inhibits%2520transcription%2520of%2520the%2520c-myc%2520and%2520c-ha-ras%2520genes%2520in%2520regenerating%2520liver%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D1994%26volume%3D307%26spage%3D167%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lee, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, T. K.</span><span> </span><span class="NLM_article-title">Mithramycin a sensitizes cancer cells to trail-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2737</span><span class="NLM_x">–</span> <span class="NLM_lpage">2746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1158%2F1535-7163.MCT-06-0426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=17121920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2737-2746&author=T.+J.+Leeauthor=E.+M.+Jungauthor=J.+T.+Leeauthor=S.+Kimauthor=J.+W.+Parkauthor=K.+S.+Choiauthor=T.+K.+Kwon&title=Mithramycin+a+sensitizes+cancer+cells+to+trail-mediated+apoptosis+by+down-regulation+of+XIAP+gene+promoter+through+Sp1+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites</span></div><div class="casAuthors">Lee, Tae-Jin; Jung, Eun Mi; Lee, Jung Tae; Kim, Shin; Park, Jong-Wook; Choi, Kyeong Sook; Kwon, Taeg Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2737-2746</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mithramycin A is a DNA-binding antitumor agent, which has been clin. used in the therapies of several types of cancer and Paget's disease.  In this study, we investigated the combined effect of mithramycin A and tumor necrosis factor-α-related apoptosis-inducing ligand (TRAIL) on apoptosis of cancer cells.  In Caki renal cancer cells, which are resistant to TRAIL, cotreatment with subtoxic doses of mithramycin A and TRAIL resulted in a marked increase in apoptosis.  This combined treatment was also cytotoxic to Caki cells overexpressing Bcl-2 but not to normal mesengial cells.  Moreover, apoptosis by the combined treatment with mithramycin A and TRAIL was dramatically induced in various cancer cell types, thus offering an attractive strategy for safely treating malignant tumors.  Mithramycin A-stimulated TRAIL-induced apoptosis was blocked by pretreatment with the broad caspase inhibitor zVAD-fmk or Crm-A overexpression, showing its dependence on caspases.  We found that mithramycin A selectively down-regulated XIAP protein levels in various cancer cells.  Luciferase reporter assay and the chromatin immunopptn. assay using the XIAP promoter constructs show that mithramycin A down-regulates the transcription of XIAP gene through inhibition of Sp1 binding to its promoter.  Although XIAP overexpression significantly attenuated apoptosis induced by mithramycin A plus TRAIL, suppression of XIAP expression by transfection with its small interfering RNA prominently enhanced TRAIL-induced apoptosis.  We present here for the first time that mithramycin A-induced suppression of XIAP transcription plays a crit. role in the recovery of TRAIL sensitivity in various cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK5M6doV-akLVg90H21EOLACvtfcHk0lgu_sAkoK5Bvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7nF&md5=34085e84a62a4d48f5e119646ff0130e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0426%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%2BJ.%26aulast%3DJung%26aufirst%3DE.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DChoi%26aufirst%3DK.%2BS.%26aulast%3DKwon%26aufirst%3DT.%2BK.%26atitle%3DMithramycin%2520a%2520sensitizes%2520cancer%2520cells%2520to%2520trail-mediated%2520apoptosis%2520by%2520down-regulation%2520of%2520XIAP%2520gene%2520promoter%2520through%2520Sp1%2520sites%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2737%26epage%3D2746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Koutsodontis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardassis, D.</span><span> </span><span class="NLM_article-title">Inhibition of p53-mediated transcriptional responses by mithramycin A</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">9190</span><span class="NLM_x">–</span> <span class="NLM_lpage">9200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=9190-9200&author=G.+Koutsodontisauthor=D.+Kardassis&title=Inhibition+of+p53-mediated+transcriptional+responses+by+mithramycin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoutsodontis%26aufirst%3DG.%26aulast%3DKardassis%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520p53-mediated%2520transcriptional%2520responses%2520by%2520mithramycin%2520A%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D9190%26epage%3D9200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tagashira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isonishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, Y.</span><span> </span><span class="NLM_article-title">Mithramycin represses MDR1 gene expression in vitro, modulating multidrug resistance</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1248%2Fbpb.23.926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=10963297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFams74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=926-929&author=M.+Tagashiraauthor=T.+Kitagawaauthor=S.+Isonishiauthor=A.+Okamotoauthor=K.+Ochiaiauthor=Y.+Ohtake&title=Mithramycin+represses+MDR1+gene+expression+in+vitro%2C+modulating+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin represses MDR1 gene expression in vitro, modulating multidrug resistance</span></div><div class="casAuthors">Tagashira, Motoyuki; Kitagawa, Takanori; Isonishi, Seiji; Okamoto, Aikou; Ochiai, Kazunori; Ohtake, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">926-929</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">The effect of an aureolic acid, mithramycin (MTM) on multidrug resistance (MDR) was investigated.  At a concn. of 0.02-0.1 mg/mL (about 20-90 μM), MTM repressed MDR1 gene transcription of SBC-3/ADM, a MDR-phenotype subline derived from human small cell lung tumor.  Under the same conditions, another aureolic acid, chromomycin A3, showed potent cytotoxicity.  FACS anal. revealed that 5 μM MTM depleted the P-glycoprotein (Pgp) and lowered the efflux activity of SBC-3/ADM cells.  Furthermore, MTM sensitized the cells against adriamycin.  These results suggest that MTM would be a useful modulator of MDR induced by Pgp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUEzU6wPRQzLVg90H21EOLACvtfcHk0lgu_sAkoK5Bvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFams74%253D&md5=08874e766fa2354c9b77f18dadf93c1e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1248%2Fbpb.23.926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.23.926%26sid%3Dliteratum%253Aachs%26aulast%3DTagashira%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DT.%26aulast%3DIsonishi%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DOhtake%26aufirst%3DY.%26atitle%3DMithramycin%2520represses%2520MDR1%2520gene%2520expression%2520in%2520vitro%252C%2520modulating%2520multidrug%2520resistance%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2000%26volume%3D23%26spage%3D926%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Sleiman, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payappilly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, J. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahishi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLellan, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratan, R. R.</span><span> </span><span class="NLM_article-title">Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">6858</span><span class="NLM_x">–</span> <span class="NLM_lpage">6870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1523%2FJNEUROSCI.0710-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21543616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFSjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=6858-6870&author=S.+F.+Sleimanauthor=B.+C.+Langleyauthor=M.+Bassoauthor=J.+Berlinauthor=L.+Xiaauthor=J.+B.+Payappillyauthor=M.+K.+Kharelauthor=H.+Guoauthor=J.+L+Marshauthor=L.+M.+Thompsonauthor=L.+Mahishiauthor=P.+Ahujaauthor=W.+R.+MacLellanauthor=D.+H.+Geschwindauthor=G.+Coppolaauthor=J.+Rohrauthor=R.+R.+Ratan&title=Mithramycin+is+a+gene-selective+Sp1+inhibitor+that+identifies+a+biological+intersection+between+cancer+and+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration</span></div><div class="casAuthors">Sleiman, Sama F.; Langley, Brett C.; Basso, Manuela; Berlin, Jill; Xia, Li; Payappilly, Jimmy B.; Kharel, Madan K.; Guo, Hengchang; Marsh, J. Lawrence; Thompson, Leslie Michels; Mahishi, Lata; Ahuja, Preeti; MacLellan, W. Robb; Geschwind, Daniel H.; Coppola, Giovanni; Rohr, Jurgen; Ratan, Rajiv R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6858-6870</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Oncogenic transformation of postmitotic neurons triggers cell death, but the identity of genes crit. for degeneration remain unclear.  The antitumor antibiotic mithramycin prolongs survival of mouse models of Huntington's disease in vivo and inhibits oxidative stress-induced death in cortical neurons in vitro.  We had correlated protection by mithramycin with its ability to bind to GC-rich DNA and globally displace Sp1 family transcription factors.  To understand how antitumor drugs prevent neurodegeneration, here we use structure-activity relationships of mithramycin analogs to discover that selective DNA-binding inhibition of the drug is necessary for its neuroprotective effect.  We identify several genes (Myc, c-Src, Hif1α, and p21waf1/cip1) involved in neoplastic transformation, whose altered expression correlates with protective doses of mithramycin or its analogs.  Most interestingly, inhibition of one these genes, Myc, is neuroprotective, whereas forced expression of Myc induces Rattus norvegicus neuronal cell death.  These results support a model in which cancer cell transformation shares key genetic components with neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4m3lCFV2e-7Vg90H21EOLACvtfcHk0lhblZ0I0tpBAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFSjtrw%253D&md5=6f9d0560b679b6b50b37a982e49cb59f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0710-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0710-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DSleiman%26aufirst%3DS.%2BF.%26aulast%3DLangley%26aufirst%3DB.%2BC.%26aulast%3DBasso%26aufirst%3DM.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DPayappilly%26aufirst%3DJ.%2BB.%26aulast%3DKharel%26aufirst%3DM.%2BK.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DMarsh%26aufirst%3DJ.%2BL%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DMahishi%26aufirst%3DL.%26aulast%3DAhuja%26aufirst%3DP.%26aulast%3DMacLellan%26aufirst%3DW.%2BR.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DCoppola%26aufirst%3DG.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DRatan%26aufirst%3DR.%2BR.%26atitle%3DMithramycin%2520is%2520a%2520gene-selective%2520Sp1%2520inhibitor%2520that%2520identifies%2520a%2520biological%2520intersection%2520between%2520cancer%2520and%2520neurodegeneration%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D6858%26epage%3D6870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wohlert, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machinek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">The structure of mithramycin reinvestigated</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/doi/10.1021/np980355k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=119-121&author=S.+E.+Wohlertauthor=E.+K%C3%BCnzelauthor=R.+Machinekauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=The+structure+of+mithramycin+reinvestigated"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fnp980355k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp980355k%26sid%3Dliteratum%253Aachs%26aulast%3DWohlert%26aufirst%3DS.%2BE.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DMachinek%26aufirst%3DR.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DThe%2520structure%2520of%2520mithramycin%2520reinvestigated%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1999%26volume%3D62%26spage%3D119%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menéndez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives</span> <span class="citation_source-journal">Appl. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2006&pages=1-14&author=F.+Lomb%C3%B3author=N.+Men%C3%A9ndezauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=The+aureolic+acid+family+of+antitumor+compounds%3A+structure%2C+mode+of+action%2C+biosynthesis%2C+and+novel+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DN.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DThe%2520aureolic%2520acid%2520family%2520of%2520antitumor%2520compounds%253A%2520structure%252C%2520mode%2520of%2520action%252C%2520biosynthesis%252C%2520and%2520novel%2520derivatives%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2006%26volume%3D73%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindseil, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frevert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">The novel hybrid antitumor compound premithramycinone H provides indirect evidence for a tricyclic intermediate of the biosynthesis of the aureolic acid antibiotic mithramycin</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">796</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=796-799&author=F.+Lomb%C3%B3author=E.+K%C3%BCnzelauthor=L.+Pradoauthor=A.+F.+Bra%C3%B1aauthor=K.+U.+Bindseilauthor=J.+Frevertauthor=D.+Beardenauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=The+novel+hybrid+antitumor+compound+premithramycinone+H+provides+indirect+evidence+for+a+tricyclic+intermediate+of+the+biosynthesis+of+the+aureolic+acid+antibiotic+mithramycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DPrado%26aufirst%3DL.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DBindseil%26aufirst%3DK.%2BU.%26aulast%3DFrevert%26aufirst%3DJ.%26aulast%3DBearden%26aufirst%3DD.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DThe%2520novel%2520hybrid%2520antitumor%2520compound%2520premithramycinone%2520H%2520provides%2520indirect%2520evidence%2520for%2520a%2520tricyclic%2520intermediate%2520of%2520the%2520biosynthesis%2520of%2520the%2520aureolic%2520acid%2520antibiotic%2520mithramycin%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2000%26volume%3D39%26spage%3D796%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Remsing, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nur-e-Alam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Lozano, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer <i>Streptomyces argillaceus</i> through combinatorial biosynthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">5745</span><span class="NLM_x">–</span> <span class="NLM_lpage">5753</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja034162h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=5745-5753&author=L.+L.+Remsingauthor=A.+M.+Gonz%C3%A1lezauthor=M.+Nur-e-Alamauthor=M.+J.+Fern%C3%A1ndez-Lozanoauthor=A.+F.+Bra%C3%B1aauthor=U.+Rixauthor=M.+A.+Oliveiraauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=Mithramycin+SK%2C+a+novel+antitumor+drug+with+improved+therapeutic+index%2C+mithramycin+SA%2C+and+demycarosyl-mithramycin+SK%3A+three+new+products+generated+in+the+mithramycin+producer+Streptomyces+argillaceus+through+combinatorial+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin SK, A Novel Antitumor Drug with Improved Therapeutic Index, Mithramycin SA, and Demycarosyl-mithramycin SK: Three New Products Generated in the Mithramycin Producer Streptomyces argillaceus through Combinatorial Biosynthesis</span></div><div class="casAuthors">Remsing, Lily L.; Gonzalez, Ana M.; Nur-e-Alam, Mohammad; Fernandez-Lozano, M. Jose; Brana, Alfredo F.; Rix, Uwe; Oliveira, Marcos A.; Mendez, Carmen; Salas, Jose A.; Rohr, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5745-5753</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To gain initial structure-activity relationships regarding the highly functionalized pentyl side chain attached at C-3 of mithramycin (MTM), we focused on a post-polyketide synthase (post-PKS) tailoring step of the MTM biosynthesis by Streptomyces argillaceus ATCC 12956, which was proposed to be catalyzed by ketoreductase (KR) MtmW.  In this last step of the MTM biosynthesis, a keto group of the pentyl side chain is reduced to a secondary alc., and we anticipated the generation of an MTM deriv. with an addnl. keto group in the 3-side chain.  Insertional inactivation of mtmW, a gene located ∼8 kb downstream of the mithramycin-PKS genes, yielded an S. argillaceus mutant, which accumulated three new mithramycin analogs, namely mithramycin SA, demycarosyl-mithramycin SK, and mithramycin SK (MTM-SK).  The structures of these three compds. confirmed indirectly the proposed role of MtmW in MTM biosynthesis.  However, the new mithramycin derivs. bear unexpectedly shorter 3-side chains (Et or butyl) than MTM, presumably caused by nonenzymic rearrangement or cleavage reactions of the initially formed pentyl side chain with a reactive β-dicarbonyl functional group.  The major product, MTM-SK, was tested in vitro against a variety of human cancer cell lines, as well as in an in vitro toxicity assay, and showed an improved therapeutic index, in comparison to the parent drug, MTM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNPA1wWdO_uLVg90H21EOLACvtfcHk0lhblZ0I0tpBAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFGnsr0%253D&md5=030ab7acf1d1e6315ae6273120193bc0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja034162h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja034162h%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DA.%2BM.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez-Lozano%26aufirst%3DM.%2BJ.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DOliveira%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DMithramycin%2520SK%252C%2520a%2520novel%2520antitumor%2520drug%2520with%2520improved%2520therapeutic%2520index%252C%2520mithramycin%2520SA%252C%2520and%2520demycarosyl-mithramycin%2520SK%253A%2520three%2520new%2520products%2520generated%2520in%2520the%2520mithramycin%2520producer%2520Streptomyces%2520argillaceus%2520through%2520combinatorial%2520biosynthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D5745%26epage%3D5753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Baig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomathinayagam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damodaran, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/doi/10.1021/np0705763" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=199-207&author=I.+Baigauthor=M.+Perezauthor=A.+F.+Bra%C3%B1aauthor=R.+Gomathinayagamauthor=C.+Damodaranauthor=J.+A.+Salasauthor=C.+M%C3%A9ndezauthor=J.+Rohr&title=Mithramycin+analogues+generated+by+combinatorial+biosynthesis+show+improved+bioactivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fnp0705763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp0705763%26sid%3Dliteratum%253Aachs%26aulast%3DBaig%26aufirst%3DI.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DGomathinayagam%26aufirst%3DR.%26aulast%3DDamodaran%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DMithramycin%2520analogues%2520generated%2520by%2520combinatorial%2520biosynthesis%2520show%2520improved%2520bioactivity%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2008%26volume%3D71%26spage%3D199%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Pérez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2295</span><span class="NLM_x">–</span> <span class="NLM_lpage">2304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2295-2304&author=M.+P%C3%A9rezauthor=I.+Baigauthor=A.+F.+Bra%C3%B1aauthor=J.+A.+Salasauthor=J.+Rohrauthor=C.+M%C3%A9ndez&title=Generation+of+new+derivatives+of+the+antitumor+antibiotic+mithramycin+by+altering+the+glycosylation+pattern+through+combinatorial+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DBaig%26aufirst%3DI.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DGeneration%2520of%2520new%2520derivatives%2520of%2520the%2520antitumor%2520antibiotic%2520mithramycin%2520by%2520altering%2520the%2520glycosylation%2520pattern%2520through%2520combinatorial%2520biosynthesis%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D2295%26epage%3D2304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">García, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Sabín, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menéndez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morís, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">The chromomycin CmmA acetyltransferase: a membrane-bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin</span> <span class="citation_source-journal">Microb. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1111%2Fj.1751-7915.2010.00229.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21342468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1Wqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=226-238&author=B.+Garc%C3%ADaauthor=J.+Gonz%C3%A1lez-Sab%C3%ADnauthor=N.+Men%C3%A9ndezauthor=A.+F.+Bra%C3%B1aauthor=L.+E.+N%C3%BA%C3%B1ezauthor=F.+Mor%C3%ADsauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=The+chromomycin+CmmA+acetyltransferase%3A+a+membrane-bound+enzyme+as+a+tool+for+increasing+structural+diversity+of+the+antitumour+mithramycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The chromomycin CmmA acetyltransferase: a membrane-bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin</span></div><div class="casAuthors">Garcia, Beatriz; Gonzalez-Sabin, Javier; Menendez, Nuria; Brana, Alfredo F.; Nunez, Luz Elena; Moris, Francisco; Salas, Jose A.; Mendez, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Microbial Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-238</span>CODEN:
                <span class="NLM_cas:coden">MBIIB2</span>;
        ISSN:<span class="NLM_cas:issn">1751-7915</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mithramycin and chromomycin A3 are two structurally related antitumor compds., which differ in the glycosylation profiles and functional group substitutions of the sugars.  Chromomycin contains two acetyl groups, which are incorporated during the biosynthesis by the acetyltransferase CmmA in Streptomyces griseus ssp. griseus.  A bioconversion strategy using an engineered S. griseus strain generated seven novel acetylated mithramycins.  The newly formed compds. were purified and characterized by MS and NMR.  These new compds. differ from their parental compds. in the presence of one, two or three acetyl groups, attached at 3E, 4E and/or 4D positions.  All new mithramycin analogs showed antitumor activity at micromolar of lower concns.  Some of the compds. showed improved activities against glioblastoma or pancreas tumor cells.  The CmmA acetyltransferase was located in the cell membrane and was shown to accept several acylCoA substrates.  All these results highlight the potential of CmmA as a tool to create structural diversity in these antitumor compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohBEOoyC707LVg90H21EOLACvtfcHk0lgnDE9OIXENUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1Wqu78%253D&md5=9fc271fec554c4a1e51d9c344c66fdf8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-7915.2010.00229.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-7915.2010.00229.x%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%26aufirst%3DB.%26aulast%3DGonz%25C3%25A1lez-Sab%25C3%25ADn%26aufirst%3DJ.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DN.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DL.%2BE.%26aulast%3DMor%25C3%25ADs%26aufirst%3DF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DThe%2520chromomycin%2520CmmA%2520acetyltransferase%253A%2520a%2520membrane-bound%2520enzyme%2520as%2520a%2520tool%2520for%2520increasing%2520structural%2520diversity%2520of%2520the%2520antitumour%2520mithramycin%26jtitle%3DMicrob.%2520Biotechnol.%26date%3D2011%26volume%3D4%26spage%3D226%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Remsing, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahadori, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuffie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catapano, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">Inhibition of c-src transcription by mithramycin: structure–activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">8313</span><span class="NLM_x">–</span> <span class="NLM_lpage">8324</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi034091z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=8313-8324&author=L.+L.+Remsingauthor=H.+R.+Bahadoriauthor=G.+M.+Carboneauthor=E.+M.+McGuffieauthor=C.+V.+Catapanoauthor=J.+Rohr&title=Inhibition+of+c-src+transcription+by+mithramycin%3A+structure%E2%80%93activity+relationships+of+biosynthetically+produced+mithramycin+analogues+using+the+c-src+promoter+as+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi034091z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi034091z%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DBahadori%26aufirst%3DH.%2BR.%26aulast%3DCarbone%26aufirst%3DG.%2BM.%26aulast%3DMcGuffie%26aufirst%3DE.%2BM.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520c-src%2520transcription%2520by%2520mithramycin%253A%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520biosynthetically%2520produced%2520mithramycin%2520analogues%2520using%2520the%2520c-src%2520promoter%2520as%2520target%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D8313%26epage%3D8324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Mir, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, D.</span><span> </span><span class="NLM_article-title">Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2791</span><span class="NLM_x">–</span> <span class="NLM_lpage">2801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2791-2801&author=M.+A.+Mirauthor=S.+Majeeauthor=S.+Dasauthor=D.+Dasgupta&title=Association+of+chromatin+with+anticancer+antibiotics%2C+mithramycin+and+chromomycin+A3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMir%26aufirst%3DM.%2BA.%26aulast%3DMajee%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DDasgupta%26aufirst%3DD.%26atitle%3DAssociation%2520of%2520chromatin%2520with%2520anticancer%2520antibiotics%252C%2520mithramycin%2520and%2520chromomycin%2520A3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2791%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Majee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, D.</span><span> </span><span class="NLM_article-title">Differential interactions of the Mg<sup>2+</sup> complexes of chromomycin A3 and mithramycin with poly(dG-dC) × poly(dC-dG) and poly(dG) × poly(dC)</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2291</span><span class="NLM_x">–</span> <span class="NLM_lpage">2299</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi9613281" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=2291-2299&author=S.+Majeeauthor=R.+Senauthor=S.+Guhaauthor=D.+Bhattacharyyaauthor=D.+Dasgupta&title=Differential+interactions+of+the+Mg2%2B+complexes+of+chromomycin+A3+and+mithramycin+with+poly%28dG-dC%29+%C3%97+poly%28dC-dG%29+and+poly%28dG%29+%C3%97+poly%28dC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi9613281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9613281%26sid%3Dliteratum%253Aachs%26aulast%3DMajee%26aufirst%3DS.%26aulast%3DSen%26aufirst%3DR.%26aulast%3DGuha%26aufirst%3DS.%26aulast%3DBhattacharyya%26aufirst%3DD.%26aulast%3DDasgupta%26aufirst%3DD.%26atitle%3DDifferential%2520interactions%2520of%2520the%2520Mg2%252B%2520complexes%2520of%2520chromomycin%2520A3%2520and%2520mithramycin%2520with%2520poly%2528dG-dC%2529%2520%25C3%2597%2520poly%2528dC-dG%2529%2520and%2520poly%2528dG%2529%2520%25C3%2597%2520poly%2528dC%2529%26jtitle%3DBiochemistry%26date%3D1997%26volume%3D36%26spage%3D2291%26epage%3D2299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Sugar biosynthesis and modification</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=277-307&author=F.+Lomb%C3%B3author=C.+Olanoauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=Sugar+biosynthesis+and+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DOlano%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DSugar%2520biosynthesis%2520and%2520modification%26jtitle%3DMethods%2520Enzymol.%26date%3D2009%26volume%3D458%26spage%3D277%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">González, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remsing, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span> </span><span class="NLM_article-title">The <i>mtmVUC</i> genes of the mithramycin gene cluster in <i>Streptomyces argillaceus</i> are involved in the biosynthesis of the sugar moieties</span> <span class="citation_source-journal">Mol. Gen. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1007%2Fs004380000372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=11254130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslyntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=2001&pages=827-835&author=A.+Gonz%C3%A1lezauthor=L.+L.+Remsingauthor=F.+Lomb%C3%B3author=M.+J.+Fern%C3%A1ndezauthor=L.+Pradoauthor=A.+F.+Bra%C3%B1aauthor=E.+K%C3%BCnzelauthor=J.+Rohrauthor=C.+M%C3%A9ndezauthor=J.+A.+Salas&title=The+mtmVUC+genes+of+the+mithramycin+gene+cluster+in+Streptomyces+argillaceus+are+involved+in+the+biosynthesis+of+the+sugar+moieties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The mtmVUC genes of the mithramycin gene cluster in Streptomyces argillaceus are involved in the biosynthesis of the sugar moieties</span></div><div class="casAuthors">Gonzalez, A.; Remsing, L. L.; Lombo, F.; Fernandez, M. J.; Prado, L.; Brana, A. F.; Kunzel, E.; Rohr, J.; Mendez, C.; Salas, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and General Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">827-835</span>CODEN:
                <span class="NLM_cas:coden">MGGEAE</span>;
        ISSN:<span class="NLM_cas:issn">0026-8925</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Mithramycin is a glycosylated arom. polyketide produced by Streptomyces argillaceus, and is used as an antitumor drug.  Three genes (mtmV, mtmU and mtmC) from the mithramycin gene cluster have been cloned, and characterized by DNA sequencing and by anal. of the products that accumulate in nonproducing mutants, which were generated by insertional inactivation of these genes.  The mtmV gene codes for a 2,3-dehydratase that catalyzes early and common steps in the biosynthesis of the three sugars found in mithramycin (D-olivose, D-oliose and D-mycarose); its inactivation caused the accumulation of the nonglycosylated intermediate premithramycinone.  The mtmU gene codes for a 4-ketoreductase involved in D-oliose biosynthesis, and its inactivation resulted in the accumulation of premithramycinone and premithramycin A1, the first glycosylated intermediate which contains a D-olivose unit.  The third gene, mtmC, is involved in D-mycarose biosynthesis and codes for a C-methyltransferase.  Two mutants with lesions in the mtmC gene accumulated mithramycin intermediates lacking the D-mycarose moiety but contg. D-olivose units attached to C-12a in which the 4-keto group is unreduced.  This suggests that mtmC could code for a second enzyme activity, probably a D-olivose 4-ketoreductase, and that the glycosyltransferase responsible for the incorporation of D-olivose (MtmGIV) shows some degree of flexibility with respect to its sugar co-substrate, since the 4-ketoanalog is also transferred.  A pathway is proposed for the biosynthesis of the three sugar moieties in mithramycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp7T9VoSnesbVg90H21EOLACvtfcHk0lj6xk60aZKBXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslyntLw%253D&md5=a38f2669856f390138162fd21deb6ceb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs004380000372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004380000372%26sid%3Dliteratum%253Aachs%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DA.%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DM.%2BJ.%26aulast%3DPrado%26aufirst%3DL.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520mtmVUC%2520genes%2520of%2520the%2520mithramycin%2520gene%2520cluster%2520in%2520Streptomyces%2520argillaceus%2520are%2520involved%2520in%2520the%2520biosynthesis%2520of%2520the%2520sugar%2520moieties%26jtitle%3DMol.%2520Gen.%2520Genet.%26date%3D2001%26volume%3D264%26spage%3D827%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Remsing, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bernardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearden, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">Ketopremithramycins and ketomithramycins, four new aureolic acid-type compounds obtained upon inactivation of two genes involved in the biosynthesis of the deoxysugar moieties of the antitumor drug mithramycin by <i>Streptomyces argillaceus</i>, reveal novel insights into post-PKS tailoring steps of the mithramycin biosynthetic pathway</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1606</span><span class="NLM_x">–</span> <span class="NLM_lpage">1614</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0105156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=1606-1614&author=L.+L.+Remsingauthor=J.+Garcia-Bernardoauthor=A.+Gonzalezauthor=E.+K%C3%BCnzelauthor=U.+Rixauthor=A.+F.+Bra%C3%B1aauthor=D.+W.+Beardenauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=Ketopremithramycins+and+ketomithramycins%2C+four+new+aureolic+acid-type+compounds+obtained+upon+inactivation+of+two+genes+involved+in+the+biosynthesis+of+the+deoxysugar+moieties+of+the+antitumor+drug+mithramycin+by+Streptomyces+argillaceus%2C+reveal+novel+insights+into+post-PKS+tailoring+steps+of+the+mithramycin+biosynthetic+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja0105156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0105156%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DGarcia-Bernardo%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DBearden%26aufirst%3DD.%2BW.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DKetopremithramycins%2520and%2520ketomithramycins%252C%2520four%2520new%2520aureolic%2520acid-type%2520compounds%2520obtained%2520upon%2520inactivation%2520of%2520two%2520genes%2520involved%2520in%2520the%2520biosynthesis%2520of%2520the%2520deoxysugar%2520moieties%2520of%2520the%2520antitumor%2520drug%2520mithramycin%2520by%2520Streptomyces%2520argillaceus%252C%2520reveal%2520novel%2520insights%2520into%2520post-PKS%2520tailoring%2520steps%2520of%2520the%2520mithramycin%2520biosynthetic%2520pathway%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D1606%26epage%3D1614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Pérez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr., J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas., J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Combining sugar biosynthesis genes for the generation of <span class="smallcaps smallerCapital">l</span>- and <span class="smallcaps smallerCapital">d</span>-amicetose and formation of two novel antitumor tetracenomycins</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">1604</span><span class="NLM_x">–</span> <span class="NLM_lpage">1606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=1604-1606&author=M.+P%C3%A9rezauthor=F.+Lomb%C3%B3author=L.+Zhuauthor=M.+Gibsonauthor=A.+F.+Bra%C3%B1aauthor=J.+Rohr.author=J.+A.+Salas.author=C.+M%C3%A9ndez&title=Combining+sugar+biosynthesis+genes+for+the+generation+of+l-+and+d-amicetose+and+formation+of+two+novel+antitumor+tetracenomycins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DGibson%26aufirst%3DM.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRohr.%26aufirst%3DJ.%26aulast%3DSalas.%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DCombining%2520sugar%2520biosynthesis%2520genes%2520for%2520the%2520generation%2520of%2520l-%2520and%2520d-amicetose%2520and%2520formation%2520of%2520two%2520novel%2520antitumor%2520tetracenomycins%26jtitle%3DChem.%2520Commun.%26date%3D2005%26spage%3D1604%26epage%3D1606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Pérez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Combinatorial biosynthesis of antitumor deoxysugar pathways in <i>Streptomyces griseus</i>: reconstitution of “unnatural natural gene clusters” for the biosynthesis of four 2,6-<span class="smallcaps smallerCapital">d</span>-dideoxyhexoses</span> <span class="citation_source-journal">Appl. Environ. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">6644</span><span class="NLM_x">–</span> <span class="NLM_lpage">6652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=6644-6652&author=M.+P%C3%A9rezauthor=F.+Lomb%C3%B3author=I.+Baigauthor=A.+F.+Bra%C3%B1aauthor=J.+Rohrauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=Combinatorial+biosynthesis+of+antitumor+deoxysugar+pathways+in+Streptomyces+griseus%3A+reconstitution+of+%E2%80%9Cunnatural+natural+gene+clusters%E2%80%9D+for+the+biosynthesis+of+four+2%2C6-d-dideoxyhexoses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DBaig%26aufirst%3DI.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DCombinatorial%2520biosynthesis%2520of%2520antitumor%2520deoxysugar%2520pathways%2520in%2520Streptomyces%2520griseus%253A%2520reconstitution%2520of%2520%25E2%2580%259Cunnatural%2520natural%2520gene%2520clusters%25E2%2580%259D%2520for%2520the%2520biosynthesis%2520of%2520four%25202%252C6-d-dideoxyhexoses%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2006%26volume%3D72%26spage%3D6644%26epage%3D6652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span> </span><span class="NLM_article-title">Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=91-109&author=M.+R.+Boydauthor=K.+D.+Paull&title=Some+practical+considerations+and+applications+of+the+national+cancer+institute+in+vitro+anticancer+drug+discovery+screen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26atitle%3DSome%2520practical%2520considerations%2520and%2520applications%2520of%2520the%2520national%2520cancer%2520institute%2520in%2520vitro%2520anticancer%2520drug%2520discovery%2520screen%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D34%26spage%3D91%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Malek, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magistri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morís, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catapano, C. V.</span><span> </span><span class="NLM_article-title">Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cáncer</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_elocation-id">e35130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=A+Malekauthor=L.+E.+N%C3%BA%C3%B1ezauthor=M.+Magistriauthor=L.+Brambillaauthor=S.+Jovicauthor=G.+M.+Carboneauthor=F.+Mor%C3%ADsauthor=C.+V.+Catapano&title=Modulation+of+the+activity+of+Sp+transcription+factors+by+mithramycin+analogues+as+a+new+strategy+for+treatment+of+metastatic+prostate+c%C3%A1ncer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DA%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DL.%2BE.%26aulast%3DMagistri%26aufirst%3DM.%26aulast%3DBrambilla%26aufirst%3DL.%26aulast%3DJovic%26aufirst%3DS.%26aulast%3DCarbone%26aufirst%3DG.%2BM.%26aulast%3DMor%25C3%25ADs%26aufirst%3DF.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26atitle%3DModulation%2520of%2520the%2520activity%2520of%2520Sp%2520transcription%2520factors%2520by%2520mithramycin%2520analogues%2520as%2520a%2520new%2520strategy%2520for%2520treatment%2520of%2520metastatic%2520prostate%2520c%25C3%25A1ncer%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Torti, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aston, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, B. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannigan, J. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billingham, M. E.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3722</span><span class="NLM_x">–</span> <span class="NLM_lpage">3727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=3458531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A280%3ADyaL283hslyisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=3722-3727&author=F.+M.+Tortiauthor=M.+M.+Bristowauthor=B.+L.+Lumauthor=S.+K.+Carterauthor=A.+E.+Howesauthor=D.+A.+Astonauthor=B.+W.+Brownauthor=J.+F.+Hanniganauthor=F.+J.+Meyersauthor=E.+P.+Mitchellauthor=M.+E.+Billingham&title=Cardiotoxicity+of+epirubicin+and+doxorubicin%3A+assessment+by+endomyocardial+biopsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy</span></div><div class="casAuthors">Torti F M; Bristow M M; Lum B L; Carter S K; Howes A E; Aston D A; Brown B W Jr; Hannigan J F Jr; Meyers F J; Mitchell E P; et al</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3722-7</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Forty-two evaluable endomyocardial biopsies were obtained from 29 patients treated with epirubicin, the 4'-epimer of doxorubicin in cumulative doses ranging from 147 mg/m2 to 888 mg/m2.  In this study of the Northern California Oncology Group, myofibrillar loss and sarcoplasmic vacuolization were identified and shown to be identical to those previously described for doxorubicin.  However, when these biopsies were compared to 119 biopsies obtained from 98 patients treated with doxorubicin, milligram for milligram, epirubicin caused less endomyocardial injury than doxorubicin (P = 0.0013).  Age, sex, type of primary malignancy, prior cardiac disease, and hypertension did not influence the degree of histologically demonstrated anthracycline injury induced by epirubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGZOur-e2pIzDnmmyUf5qOfW6udTcc2eZAMBupypKwWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL283hslyisw%253D%253D&md5=4dbc6ca5846a328fc885cb3c0a0b429a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DBristow%26aufirst%3DM.%2BM.%26aulast%3DLum%26aufirst%3DB.%2BL.%26aulast%3DCarter%26aufirst%3DS.%2BK.%26aulast%3DHowes%26aufirst%3DA.%2BE.%26aulast%3DAston%26aufirst%3DD.%2BA.%26aulast%3DBrown%26aufirst%3DB.%2BW.%26aulast%3DHannigan%26aufirst%3DJ.%2BF.%26aulast%3DMeyers%26aufirst%3DF.%2BJ.%26aulast%3DMitchell%26aufirst%3DE.%2BP.%26aulast%3DBillingham%26aufirst%3DM.%2BE.%26atitle%3DCardiotoxicity%2520of%2520epirubicin%2520and%2520doxorubicin%253A%2520assessment%2520by%2520endomyocardial%2520biopsy%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D3722%26epage%3D3727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Gebregiorgis, M.; Woldemichael, G.; He, M.; Kang, M. H.; Núñez, L. E.; Morís, F.; Smith, M. A.; Helman, L. J.; Grohar, P. J.</span><span> </span><span class="NLM_article-title">Identification of Mithramycin Analogues with Increased Potency and More Selective Inhibition of EWS-FLI1 for the Treatment of Ewing Sarcoma</span>. Presented at the AACR Annual Meeting, March 31–April 4,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>Chicago, IL; Poster.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Gebregiorgis&author=G.+Woldemichael&author=M.+He&author=M.+H.+Kang&author=L.+E.+N%C3%BA%C3%B1ez&author=F.+Mor%C3%ADs&author=M.+A.+Smith&author=L.+J.+Helman&author=P.+J.+Grohar&title=Identification+of+Mithramycin+Analogues+with+Increased+Potency+and+More+Selective+Inhibition+of+EWS-FLI1+for+the+Treatment+of+Ewing+Sarcoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGebregiorgis%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Mithramycin%2520Analogues%2520with%2520Increased%2520Potency%2520and%2520More%2520Selective%2520Inhibition%2520of%2520EWS-FLI1%2520for%2520the%2520Treatment%2520of%2520Ewing%2520Sarcoma%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Fernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weibbach, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez Reillo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span> </span><span class="NLM_article-title">Identification of two genes from <i>Streptomyces argillaceus</i> encoding two glycosyltransferases involved in the transfer of a disaccharide during the biosynthesis of the antitumor drug mithramycin</span> <span class="citation_source-journal">J. Bacteriol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">4929</span><span class="NLM_x">–</span> <span class="NLM_lpage">4937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=9733697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADyaK1cXmt1Sns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=1998&pages=4929-4937&author=E.+Fern%C3%A1ndezauthor=U.+Weibbachauthor=C.+S%C3%A1nchez+Reilloauthor=A.+F.+Bra%C3%B1aauthor=C.+M%C3%A9ndezauthor=J.+Rohrauthor=J.+A.+Salas&title=Identification+of+two+genes+from+Streptomyces+argillaceus+encoding+two+glycosyltransferases+involved+in+the+transfer+of+a+disaccharide+during+the+biosynthesis+of+the+antitumor+drug+mithramycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two genes from Streptomyces argillaceus encoding glycosyltransferases involved in transfer of a disaccharide during biosynthesis of the antitumor drug mithramycin</span></div><div class="casAuthors">Fernandez, Ernestina; Weissbach, Ulrike; Reillo, Cesar Sanchez; Brana, Alfredo F.; Mendez, Carmen; Rohr, Jurgen; Salas, Jose A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4929-4937</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mithramycin is an antitumor polyketide drug produced by Streptomyces argillaceus that contains two deoxysugar chains, a disaccharide consisting of two d-olivoses and a trisaccharide consisting of a d-olivose, a d-oliose, and a d-mycarose.  From a cosmid clone (cosAR3) which confers resistance to mithramycin in streptomycetes, a 3-kb PstI-XhoI fragment was sequenced, and two divergent genes (mtmGI and mtmGII) were identified.  Comparison of the deduced products of both genes with proteins in databases showed similarities with glycosyltransferases and glucuronosyltransferases from different sources, including several glycosyltransferases involved in sugar transfer during antibiotic biosynthesis.  Both genes were independently inactivated by gene replacement, and the mutants generated (M3G1 and M3G2) did not produce mithramycin.  High-performance liq. chromatog. anal. of Et acetate exts. of culture supernatants of both mutants showed the presence of several peaks with the characteristic spectra of mithramycin biosynthetic intermediates.  Four compds. were isolated from both mutants by preparative high-performance liq. chromatog., and their structures were elucidated by physicochem. methods.  The structures of these compds. were identical in both mutants, and the compds. are suggested to be glycosylated intermediates of mithramycin biosynthesis with different nos. of sugar moieties attached to C-12a-O of a tetracyclic mithramycin precursor and to C-2-O of mithramycinone: three tetracyclic intermediates contg. one sugar (premithramycin A1), two sugars (premithramycin A2), or three sugars (premithramycin A3) and one tricyclic intermediate contg. a trisaccharide chain (premithramycin A4).  It is proposed that the glycosyltransferases encoded by mtmGI and mtmGII are responsible for forming and transferring the disaccharide during mithramycin biosynthesis.  From the structures of the new metabolites, a new biosynthetic sequence regarding late steps of mithramycin biosynthesis can be suggested, a sequence which includes glycosyl transfer steps prior to the final shaping of the aglycon moiety of mithramycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrNmPNrzf1vLVg90H21EOLACvtfcHk0lh5VrOZsB1lGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmt1Sns7Y%253D&md5=38358e0a6e09a181b69cb3c73ddfbb1f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DWeibbach%26aufirst%3DU.%26aulast%3DS%25C3%25A1nchez%2BReillo%26aufirst%3DC.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520two%2520genes%2520from%2520Streptomyces%2520argillaceus%2520encoding%2520two%2520glycosyltransferases%2520involved%2520in%2520the%2520transfer%2520of%2520a%2520disaccharide%2520during%2520the%2520biosynthesis%2520of%2520the%2520antitumor%2520drug%2520mithramycin%26jtitle%3DJ.%2520Bacteriol.%26date%3D1998%26volume%3D180%26spage%3D4929%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kieser, T.; Bibb, M. J.; Buttner, M. J.; Chater, K. F.; Hopwood, D. A.</span> <span class="citation_source-book">Practical Streptomyces Genetics</span>; <span class="NLM_publisher-name">The John Innes Foundation</span>: <span class="NLM_publisher-loc">Norwich, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=T.+Kieser&author=M.+J.+Bibb&author=M.+J.+Buttner&author=K.+F.+Chater&author=D.+A.+Hopwood&title=Practical+Streptomyces+Genetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKieser%26aufirst%3DT.%26btitle%3DPractical%2520Streptomyces%2520Genetics%26pub%3DThe%2520John%2520Innes%2520Foundation%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Sambrook, J.; Russell, D. W.</span> <span class="citation_source-book">Molecular Cloning: A Laboratory Manual</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Cold Spring Harbor Laboratory</span>: <span class="NLM_publisher-loc">Cold Spring Harbor, NY, U.S.</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+Sambrook&author=D.+W.+Russell&title=Molecular+Cloning%3A+A+Laboratory+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSambrook%26aufirst%3DJ.%26btitle%3DMolecular%2520Cloning%253A%2520A%2520Laboratory%2520Manual%26pub%3DCold%2520Spring%2520Harbor%2520Laboratory%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Rodríguez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirrezabalaga, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span> </span><span class="NLM_article-title">Engineering deoxysugar biosynthetic pathways from antibiotic-producing microorganisms. A tool to produce novel glycosylated bioactive compounds</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1016%2FS1074-5521%2802%2900154-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=12079784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFOisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=721-729&author=L.+Rodr%C3%ADguezauthor=I.+Aguirrezabalagaauthor=N.+Allendeauthor=A.+F.+Bra%C3%B1aauthor=C.+M%C3%A9ndezauthor=J.+A.+Salas&title=Engineering+deoxysugar+biosynthetic+pathways+from+antibiotic-producing+microorganisms.+A+tool+to+produce+novel+glycosylated+bioactive+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering Deoxysugar Biosynthetic Pathways from Antibiotic-Producing Microorganisms. A Tool to Produce Novel Glycosylated Bioactive Compounds</span></div><div class="casAuthors">Rodriguez, Leticia; Aguirrezabalaga, Ignacio; Allende, Nerea; Brana, Alfredo F.; Mendez, Carmen; Salas, Jose A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">721-729</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A plasmid (pLN2) was generated in which genes involved in the biosynthesis of L-oleandrose in the oleandomycin producer Streptomyces antibioticus ATCC 11891 were cloned.  Plasmid pLN2 was used to direct the biosynthesis of different deoxysugars by exchanging and/or adding genes from other antibiotic biosynthetic clusters.  Transfer of the synthesized deoxysugars to the tetracenomycin C aglycon, 8-demethyl-tetracenomycin C, through the use of the "sugar flexible" glycosyltransferase ElmGT, validated the system.  Several pLN2 derivs. were constructed by replacement of the oleU 4-ketoreductase gene by different 4-ketoreductase genes.  Some of them, such as EryBIV and UrdR, reduced the keto group of the 4-keto intermediates, generating L-olivosyl and D-olivosyl derivs., resp.  The system was also used to generate an L-rhamnosyl deriv. (through a two-gene deletion) and an L-rhodinosyl deriv. (through a combination of a gene replacement and a gene addn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NBOjQjMK8rVg90H21EOLACvtfcHk0lh5VrOZsB1lGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFOisLk%253D&md5=17068efca43f7df131eb896165fb1b37</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900154-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900154-0%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DL.%26aulast%3DAguirrezabalaga%26aufirst%3DI.%26aulast%3DAllende%26aufirst%3DN.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DEngineering%2520deoxysugar%2520biosynthetic%2520pathways%2520from%2520antibiotic-producing%2520microorganisms.%2520A%2520tool%2520to%2520produce%2520novel%2520glycosylated%2520bioactive%2520compounds%26jtitle%3DChem.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D721%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelfattah, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Elucidation of oxygenation steps during oviedomycin biosynthesis and generation of derivatives with increased antitumor activity</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=296-303&author=F.+Lomb%C3%B3author=M.+S.+Abdelfattahauthor=A.+F.+Bra%C3%B1aauthor=J.+A.+Salasauthor=J.+Rohrauthor=C.+M%C3%A9ndez&title=Elucidation+of+oxygenation+steps+during+oviedomycin+biosynthesis+and+generation+of+derivatives+with+increased+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DAbdelfattah%26aufirst%3DM.%2BS.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DElucidation%2520of%2520oxygenation%2520steps%2520during%2520oviedomycin%2520biosynthesis%2520and%2520generation%2520of%2520derivatives%2520with%2520increased%2520antitumor%2520activity%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D296%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Menéndez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Biosynthesis of the antitumor chromomycin A<sub>3</sub> in <i>Streptomyces griseus</i>: analysis of the gene cluster and rational design of novel chromomycin analogues</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=15112992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXps1yntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=21-32&author=N.+Men%C3%A9ndezauthor=N.+Mohammadauthor=A.+F.+Bra%C3%B1aauthor=J.+Rohrauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=Biosynthesis+of+the+antitumor+chromomycin+A3+in+Streptomyces+griseus%3A+analysis+of+the+gene+cluster+and+rational+design+of+novel+chromomycin+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of the antitumor chromomycin A3 in Streptomyces griseus. analysis of the gene cluster and rational design of novel chromomycin analogs</span></div><div class="casAuthors">Menendez, Nuria; Nur-e-Alam, Mohammad; Brana, Alfredo F.; Rohr, Jurgen; Salas, Jose A.; Mendez, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-32</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The biosynthetic gene cluster of the aureolic acid type antitumor drug chromomycin A3 from S. griseus subsp. griseus has been identified and characterized.  It spans 43 kb and contains 36 genes involved in polyketide biosynthesis and modification, deoxysugar biosynthesis and sugar transfer, pathway regulation and resistance.  The organization of the cluster clearly differs from that of the closely related mithramycin.  Involvement of the cluster in chromomycin A3 biosynthesis was demonstrated by disrupting the cmmWI gene encoding a polyketide reductase involved in side chain redn.  Three novel chromomycin derivs. were obtained, named chromomycin SK, chromomycin SA, and chromomycin SDK, which show antitumor activity and differ with respect to their 3-side chains.  A pathway for the biosynthesis of chromomycin A3 and its deoxysugars is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE-1NGDbwV_7Vg90H21EOLACvtfcHk0lhVbMXqHVfJTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXps1yntA%253D%253D&md5=f08961a261e3557c7520ede71f9c52e8</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DN.%26aulast%3DMohammad%26aufirst%3DN.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DBiosynthesis%2520of%2520the%2520antitumor%2520chromomycin%2520A3%2520in%2520Streptomyces%2520griseus%253A%2520analysis%2520of%2520the%2520gene%2520cluster%2520and%2520rational%2520design%2520of%2520novel%2520chromomycin%2520analogues%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D21%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Mosmann, T.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1016%2F0022-1759%2883%2990303-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=6606682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1983&pages=55-63&author=T.+Mosmann&title=Rapid+colorimetric+assay+for+cellular+growth+and+survival%3A+application+to+proliferation+and+cytotoxicity+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span></div><div class="casAuthors">Mosmann T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation.  The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells.  This method can therefore be used to measure cytotoxicity, proliferation or activation.  The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision.  No washing steps are used in the assay.  The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope.  We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbRLMWf0dI3thwrmtH4OBfW6udTcc2eb5Kg2UE8BTOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D&md5=c1116f4ca7a7d2b79fab2a0bd2c2d439</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2883%2990303-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252883%252990303-4%26sid%3Dliteratum%253Aachs%26aulast%3DMosmann%26aufirst%3DT.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cellular%2520growth%2520and%2520survival%253A%2520application%2520to%2520proliferation%2520and%2520cytotoxicity%2520assay%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1983%26volume%3D65%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Katelyn V. Brown, Benjamin Nji Wandi, Mikko Metsä-Ketelä, <span class="NLM_string-name hlFld-ContribAuthor">S. Eric Nybo</span>. </span><span class="cited-content_cbyCitation_article-title">Pathway Engineering of Anthracyclines: Blazing Trails in Natural Product Glycodiversification. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (19)
                                     , 12012-12023. <a href="https://doi.org/10.1021/acs.joc.0c01863" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01863%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPathway%252BEngineering%252Bof%252BAnthracyclines%25253A%252BBlazing%252BTrails%252Bin%252BNatural%252BProduct%252BGlycodiversification%26aulast%3DBrown%26aufirst%3DKatelyn%2BV.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03082020%26date%3D22092020%26date%3D16092020%26volume%3D85%26issue%3D19%26spage%3D12012%26epage%3D12023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu Hu, Zhuan Zhang, Yue Yin, <span class="NLM_string-name hlFld-ContribAuthor">Gong-Li Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Directed Biosynthesis of Iso-aclacinomycins with Improved Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (1)
                                     , 150-154. <a href="https://doi.org/10.1021/acs.orglett.9b04069" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b04069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b04069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b04069%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDirected%252BBiosynthesis%252Bof%252BIso-aclacinomycins%252Bwith%252BImproved%252BAnticancer%252BActivity%26aulast%3DHu%26aufirst%3DYu%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D13112019%26date%3D12122019%26volume%3D22%26issue%3D1%26spage%3D150%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary A.  Bosserman</span>, <span class="hlFld-ContribAuthor ">Theresa  Downey</span>, <span class="hlFld-ContribAuthor ">Nicholas  Noinaj</span>, <span class="hlFld-ContribAuthor ">Susan K.  Buchanan</span>, and <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>  . </span><span class="cited-content_cbyCitation_article-title">Molecular Insight into Substrate Recognition and Catalysis of Baeyer–Villiger Monooxygenase MtmOIV, the Key Frame-Modifying Enzyme in the Biosynthesis of Anticancer Agent Mithramycin. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (11)
                                     , 2466-2477. <a href="https://doi.org/10.1021/cb400399b" title="DOI URL">https://doi.org/10.1021/cb400399b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb400399b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb400399b%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DMolecular%252BInsight%252Binto%252BSubstrate%252BRecognition%252Band%252BCatalysis%252Bof%252BBaeyer%2525E2%252580%252593Villiger%252BMonooxygenase%252BMtmOIV%25252C%252Bthe%252BKey%252BFrame-Modifying%252BEnzyme%252Bin%252Bthe%252BBiosynthesis%252Bof%252BAnticancer%252BAgent%252BMithramycin%26aulast%3DBosserman%26aufirst%3DMary%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D05062013%26date%3D30082013%26date%3D13092013%26date%3D15112013%26date%3D30082013%26volume%3D8%26issue%3D11%26spage%3D2466%26epage%3D2477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Bisignano</span>, <span class="hlFld-ContribAuthor ">Chiara  Lambruschini</span>, <span class="hlFld-ContribAuthor ">Manuele  Bicego</span>, <span class="hlFld-ContribAuthor ">Vittorio  Murino</span>, <span class="hlFld-ContribAuthor ">Angelo D.  Favia</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">In Silico Deconstruction of ATP-Competitive Inhibitors of Glycogen Synthase Kinase-3β. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (12)
                                     , 3233-3244. <a href="https://doi.org/10.1021/ci300355p" title="DOI URL">https://doi.org/10.1021/ci300355p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci300355p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci300355p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIn%252BSilico%252BDeconstruction%252Bof%252BATP-Competitive%252BInhibitors%252Bof%252BGlycogen%252BSynthase%252BKinase-3%2525CE%2525B2%26aulast%3DBisignano%26aufirst%3DPaola%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D28072012%26date%3D12122012%26date%3D21122012%26date%3D30112012%26volume%3D52%26issue%3D12%26spage%3D3233%26epage%3D3244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parichehr  Hassanzadeh</span>, <span class="hlFld-ContribAuthor ">Elham  Arbabi</span>, <span class="hlFld-ContribAuthor ">Fatemeh  Rostami</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a novel nanoformulation against the colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2021,</strong> <em>281 </em>, 119772. <a href="https://doi.org/10.1016/j.lfs.2021.119772" title="DOI URL">https://doi.org/10.1016/j.lfs.2021.119772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2021.119772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2021.119772%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DDevelopment%252Bof%252Ba%252Bnovel%252Bnanoformulation%252Bagainst%252Bthe%252Bcolorectal%252Bcancer%26aulast%3DHassanzadeh%26aufirst%3DParichehr%26date%3D2021%26volume%3D281%26spage%3D119772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chakrabhavi Dhananjaya  Mohan</span>, <span class="hlFld-ContribAuthor ">Shobith  Rangappa</span>, <span class="hlFld-ContribAuthor ">S. Chandra  Nayak</span>, <span class="hlFld-ContribAuthor ">Ragi  Jadimurthy</span>, <span class="hlFld-ContribAuthor ">Lingzhi  Wang</span>, <span class="hlFld-ContribAuthor ">Gautam  Sethi</span>, <span class="hlFld-ContribAuthor ">Manoj  Garg</span>, <span class="hlFld-ContribAuthor ">Kanchugarakoppal S.  Rangappa</span>. </span><span class="cited-content_cbyCitation_article-title">Bacteria as a treasure house of secondary metabolites with anticancer potential. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2021,</strong> <em>69 </em><a href="https://doi.org/10.1016/j.semcancer.2021.05.006" title="DOI URL">https://doi.org/10.1016/j.semcancer.2021.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2021.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2021.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DBacteria%252Bas%252Ba%252Btreasure%252Bhouse%252Bof%252Bsecondary%252Bmetabolites%252Bwith%252Banticancer%252Bpotential%26aulast%3DMohan%26aufirst%3DChakrabhavi%2BDhananjaya%26date%3D2021%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke J.  Stevenson</span>, <span class="hlFld-ContribAuthor ">Joe  Bracegirdle</span>, <span class="hlFld-ContribAuthor ">Liwei  Liu</span>, <span class="hlFld-ContribAuthor ">Abigail V.  Sharrock</span>, <span class="hlFld-ContribAuthor ">David F.  Ackerley</span>, <span class="hlFld-ContribAuthor ">Robert A.  Keyzers</span>, <span class="hlFld-ContribAuthor ">Jeremy G.  Owen</span>. </span><span class="cited-content_cbyCitation_article-title">Metathramycin, a new bioactive aureolic acid discovered by heterologous expression of a metagenome derived biosynthetic pathway. </span><span class="cited-content_cbyCitation_journal-name">RSC Chemical Biology</span><span> <strong>2021,</strong> <em>2 </em>
                                    (2)
                                     , 556-567. <a href="https://doi.org/10.1039/D0CB00228C" title="DOI URL">https://doi.org/10.1039/D0CB00228C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CB00228C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CB00228C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Chemical%2520Biology%26atitle%3DMetathramycin%25252C%252Ba%252Bnew%252Bbioactive%252Baureolic%252Bacid%252Bdiscovered%252Bby%252Bheterologous%252Bexpression%252Bof%252Ba%252Bmetagenome%252Bderived%252Bbiosynthetic%252Bpathway%26aulast%3DStevenson%26aufirst%3DLuke%2BJ.%26date%3D2021%26date%3D2021%26volume%3D2%26issue%3D2%26spage%3D556%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José  Portugal</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into DNA‐drug interactions in the era of omics. </span><span class="cited-content_cbyCitation_journal-name">Biopolymers</span><span> <strong>2021,</strong> <em>112 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/bip.23385" title="DOI URL">https://doi.org/10.1002/bip.23385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bip.23385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbip.23385%26sid%3Dliteratum%253Aachs%26jtitle%3DBiopolymers%26atitle%3DInsights%252Binto%252BDNA%2525E2%252580%252590drug%252Binteractions%252Bin%252Bthe%252Bera%252Bof%252Bomics%26aulast%3DPortugal%26aufirst%3DJos%25C3%25A9%26date%3D2021%26date%3D2020%26volume%3D112%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Schweer</span>, <span class="hlFld-ContribAuthor ">J. Robert  McCorkle</span>, <span class="hlFld-ContribAuthor ">Jurgen  Rohr</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Tsodikov</span>, <span class="hlFld-ContribAuthor ">Frederick  Ueland</span>, <span class="hlFld-ContribAuthor ">Jill  Kolesar</span>. </span><span class="cited-content_cbyCitation_article-title">Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     , 70. <a href="https://doi.org/10.3390/biomedicines9010070" title="DOI URL">https://doi.org/10.3390/biomedicines9010070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9010070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9010070%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DMithramycin%252Band%252BAnalogs%252Bfor%252BOvercoming%252BCisplatin%252BResistance%252Bin%252BOvarian%252BCancer%26aulast%3DSchweer%26aufirst%3DDavid%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D1%26spage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Zabala</span>, <span class="hlFld-ContribAuthor ">Lijiang  Song</span>, <span class="hlFld-ContribAuthor ">Yousef  Dashti</span>, <span class="hlFld-ContribAuthor ">Gregory L.  Challis</span>, <span class="hlFld-ContribAuthor ">José A.  Salas</span>, <span class="hlFld-ContribAuthor ">Carmen  Méndez</span>. </span><span class="cited-content_cbyCitation_article-title">Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycin. </span><span class="cited-content_cbyCitation_journal-name">Microbial Cell Factories</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12934-020-01368-3" title="DOI URL">https://doi.org/10.1186/s12934-020-01368-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12934-020-01368-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12934-020-01368-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobial%2520Cell%2520Factories%26atitle%3DHeterologous%252Breconstitution%252Bof%252Bthe%252Bbiosynthesis%252Bpathway%252Bfor%252B4-demethyl-premithramycinone%25252C%252Bthe%252Baglycon%252Bof%252Bantitumor%252Bpolyketide%252Bmithramycin%26aulast%3DZabala%26aufirst%3DDaniel%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Ruihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Xinxiao  Sun</span>, <span class="hlFld-ContribAuthor ">Yajun  Yan</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Shen</span>, <span class="hlFld-ContribAuthor ">Qipeng  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Biosynthesis of aromatic polyketides in microorganisms using type II polyketide synthases. </span><span class="cited-content_cbyCitation_journal-name">Microbial Cell Factories</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12934-020-01367-4" title="DOI URL">https://doi.org/10.1186/s12934-020-01367-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12934-020-01367-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12934-020-01367-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobial%2520Cell%2520Factories%26atitle%3DBiosynthesis%252Bof%252Baromatic%252Bpolyketides%252Bin%252Bmicroorganisms%252Busing%252Btype%252BII%252Bpolyketide%252Bsynthases%26aulast%3DWang%26aufirst%3DJia%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Kormanec</span>, <span class="hlFld-ContribAuthor ">Renata  Novakova</span>, <span class="hlFld-ContribAuthor ">Dominika  Csolleiova</span>, <span class="hlFld-ContribAuthor ">Lubomira  Feckova</span>, <span class="hlFld-ContribAuthor ">Bronislava  Rezuchova</span>, <span class="hlFld-ContribAuthor ">Beatrica  Sevcikova</span>, <span class="hlFld-ContribAuthor ">Dagmar  Homerova</span>. </span><span class="cited-content_cbyCitation_article-title">The antitumor antibiotic mithramycin: new advanced approaches in modification and production. </span><span class="cited-content_cbyCitation_journal-name">Applied Microbiology and Biotechnology</span><span> <strong>2020,</strong> <em>104 </em>
                                    (18)
                                     , 7701-7721. <a href="https://doi.org/10.1007/s00253-020-10782-x" title="DOI URL">https://doi.org/10.1007/s00253-020-10782-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00253-020-10782-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00253-020-10782-x%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Microbiology%2520and%2520Biotechnology%26atitle%3DThe%252Bantitumor%252Bantibiotic%252Bmithramycin%25253A%252Bnew%252Badvanced%252Bapproaches%252Bin%252Bmodification%252Band%252Bproduction%26aulast%3DKormanec%26aufirst%3DJan%26date%3D2020%26date%3D2020%26volume%3D104%26issue%3D18%26spage%3D7701%26epage%3D7721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip  Dao Trong</span>, <span class="hlFld-ContribAuthor ">Gerhard  Jungwirth</span>, <span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Stefan  Pusch</span>, <span class="hlFld-ContribAuthor ">Andreas  Unterberg</span>, <span class="hlFld-ContribAuthor ">Christel  Herold-Mende</span>, <span class="hlFld-ContribAuthor ">Rolf  Warta</span>. </span><span class="cited-content_cbyCitation_article-title">Large-Scale Drug Screening in Patient-Derived IDHmut Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (6)
                                     , 1389. <a href="https://doi.org/10.3390/cells9061389" title="DOI URL">https://doi.org/10.3390/cells9061389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9061389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9061389%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DLarge-Scale%252BDrug%252BScreening%252Bin%252BPatient-Derived%252BIDHmut%252BGlioma%252BStem%252BCells%252BIdentifies%252BSeveral%252BEfficient%252BDrugs%252Bamong%252BFDA-Approved%252BAntineoplastic%252BAgents%26aulast%3DDao%2BTrong%26aufirst%3DPhilip%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D6%26spage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia T.  Menendez</span>, <span class="hlFld-ContribAuthor ">Veronica  Rey</span>, <span class="hlFld-ContribAuthor ">Lucia  Martinez-Cruzado</span>, <span class="hlFld-ContribAuthor ">M. Victoria  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Alvaro  Morales-Molina</span>, <span class="hlFld-ContribAuthor ">Laura  Santos</span>, <span class="hlFld-ContribAuthor ">Verónica  Blanco</span>, <span class="hlFld-ContribAuthor ">Carlos  Alvarez</span>, <span class="hlFld-ContribAuthor ">Oscar  Estupiñan</span>, <span class="hlFld-ContribAuthor ">Eva  Allonca</span>, <span class="hlFld-ContribAuthor ">Juan Pablo  Rodrigo</span>, <span class="hlFld-ContribAuthor ">Javier  García-Castro</span>, <span class="hlFld-ContribAuthor ">Juana Maria  Garcia-Pedrero</span>, <span class="hlFld-ContribAuthor ">Rene  Rodriguez</span>. </span><span class="cited-content_cbyCitation_article-title">SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , 964. <a href="https://doi.org/10.3390/cancers12040964" title="DOI URL">https://doi.org/10.3390/cancers12040964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12040964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12040964%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DSOX2%252BExpression%252Band%252BTranscriptional%252BActivity%252BIdentifies%252Ba%252BSubpopulation%252Bof%252BCancer%252BStem%252BCells%252Bin%252BSarcoma%252Bwith%252BPrognostic%252BImplications%26aulast%3DMenendez%26aufirst%3DSofia%2BT.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3D964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Hu</span>, <span class="hlFld-ContribAuthor ">Qiu-Yue  Nie</span>, <span class="hlFld-ContribAuthor ">Hai-Xue  Pan</span>, <span class="hlFld-ContribAuthor ">Gong-Li  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Bacterial Type II Polyketide Synthases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 198-249. <a href="https://doi.org/10.1016/B978-0-12-409547-2.14626-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14626-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14626-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14626-8%26sid%3Dliteratum%253Aachs%26atitle%3DBacterial%252BType%252BII%252BPolyketide%252BSynthases%26aulast%3DHu%26aufirst%3DYu%26date%3D2020%26spage%3D198%26epage%3D249%26pub%3DElsevier%26atitle%3DComprehensive%252BNatural%252BProducts%252BIII%26date%3D2020%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohsen  Gozari</span>, <span class="hlFld-ContribAuthor ">Nima  Bahador</span>, <span class="hlFld-ContribAuthor ">Mohammad Seddiq  Mortazavi</span>, <span class="hlFld-ContribAuthor ">Ebrahim  Eftekhar</span>, <span class="hlFld-ContribAuthor ">Amir Reza  Jassbi</span>. </span><span class="cited-content_cbyCitation_article-title">An “olivomycin A” derivative from a sponge-associated Streptomyces sp. strain SP 85. </span><span class="cited-content_cbyCitation_journal-name">3 Biotech</span><span> <strong>2019,</strong> <em>9 </em>
                                    (12)
                                     <a href="https://doi.org/10.1007/s13205-019-1964-5" title="DOI URL">https://doi.org/10.1007/s13205-019-1964-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13205-019-1964-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13205-019-1964-5%26sid%3Dliteratum%253Aachs%26jtitle%3D3%2520Biotech%26atitle%3DAn%252B%2525E2%252580%25259Colivomycin%252BA%2525E2%252580%25259D%252Bderivative%252Bfrom%252Ba%252Bsponge-associated%252BStreptomyces%252Bsp.%252Bstrain%252BSP%252B85%26aulast%3DGozari%26aufirst%3DMohsen%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria  García-Morales</span>, <span class="hlFld-ContribAuthor ">Guillermo  Rodríguez-Bey</span>, <span class="hlFld-ContribAuthor ">Laura  Gómez-Pérez</span>, <span class="hlFld-ContribAuthor ">Germán  Domínguez-Vías</span>, <span class="hlFld-ContribAuthor ">David  González-Forero</span>, <span class="hlFld-ContribAuthor ">Federico  Portillo</span>, <span class="hlFld-ContribAuthor ">Antonio  Campos-Caro</span>, <span class="hlFld-ContribAuthor ">Ángela  Gento-Caro</span>, <span class="hlFld-ContribAuthor ">Noura  Issaoui</span>, <span class="hlFld-ContribAuthor ">Rosa M.  Soler</span>, <span class="hlFld-ContribAuthor ">Ana  Garcera</span>, <span class="hlFld-ContribAuthor ">Bernardo  Moreno-López</span>. </span><span class="cited-content_cbyCitation_article-title">Sp1-regulated expression of p11 contributes to motor neuron degeneration by membrane insertion of TASK1. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-11637-4" title="DOI URL">https://doi.org/10.1038/s41467-019-11637-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-11637-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-11637-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DSp1-regulated%252Bexpression%252Bof%252Bp11%252Bcontributes%252Bto%252Bmotor%252Bneuron%252Bdegeneration%252Bby%252Bmembrane%252Binsertion%252Bof%252BTASK1%26aulast%3DGarc%25C3%25ADa-Morales%26aufirst%3DVictoria%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangui  Mei</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Lan</span>, <span class="hlFld-ContribAuthor ">Guodong  Cui</span>, <span class="hlFld-ContribAuthor ">Hongwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Weiming  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Caerulomycins from
              Actinoalloteichus cyanogriseus
              WH1-2216-6: isolation, identification and cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (20)
                                     , 3566-3574. <a href="https://doi.org/10.1039/C9QO00685K" title="DOI URL">https://doi.org/10.1039/C9QO00685K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO00685K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO00685K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DCaerulomycins%252Bfrom%252BActinoalloteichus%252Bcyanogriseus%252BWH1-2216-6%25253A%252Bisolation%25252C%252Bidentification%252Band%252Bcytotoxicity%26aulast%3DMei%26aufirst%3DXiangui%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D20%26spage%3D3566%26epage%3D3574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga N.  Sekurova</span>, <span class="hlFld-ContribAuthor ">Olha  Schneider</span>, <span class="hlFld-ContribAuthor ">Sergey B.  Zotchev</span>. </span><span class="cited-content_cbyCitation_article-title">Novel bioactive natural products from bacteria via bioprospecting, genome mining and metabolic engineering. </span><span class="cited-content_cbyCitation_journal-name">Microbial Biotechnology</span><span> <strong>2019,</strong> <em>12 </em>
                                    (5)
                                     , 828-844. <a href="https://doi.org/10.1111/1751-7915.13398" title="DOI URL">https://doi.org/10.1111/1751-7915.13398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1751-7915.13398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1751-7915.13398%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobial%2520Biotechnology%26atitle%3DNovel%252Bbioactive%252Bnatural%252Bproducts%252Bfrom%252Bbacteria%252Bvia%252Bbioprospecting%25252C%252Bgenome%252Bmining%252Band%252Bmetabolic%252Bengineering%26aulast%3DSekurova%26aufirst%3DOlga%2BN.%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D5%26spage%3D828%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francisco  Hermida-Prado</span>, <span class="hlFld-ContribAuthor ">M. Ángeles  Villaronga</span>, <span class="hlFld-ContribAuthor ">Rocío  Granda-Díaz</span>, <span class="hlFld-ContribAuthor ">Nagore  del-Río-Ibisate</span>, <span class="hlFld-ContribAuthor ">Laura  Santos</span>, <span class="hlFld-ContribAuthor ">Maria Ana  Hermosilla</span>, <span class="hlFld-ContribAuthor ">Patricia  Oro</span>, <span class="hlFld-ContribAuthor ">Eva  Allonca</span>, <span class="hlFld-ContribAuthor ">Jackeline  Agorreta</span>, <span class="hlFld-ContribAuthor ">Irati  Garmendia</span>, <span class="hlFld-ContribAuthor ">Juan  Tornín</span>, <span class="hlFld-ContribAuthor ">Jhudit  Perez-Escuredo</span>, <span class="hlFld-ContribAuthor ">Rocío  Fuente</span>, <span class="hlFld-ContribAuthor ">Luis M.  Montuenga</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">Juan P.  Rodrigo</span>, <span class="hlFld-ContribAuthor ">René  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Juana M.  García-Pedrero</span>. </span><span class="cited-content_cbyCitation_article-title">The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2019,</strong> <em>8 </em>
                                    (8)
                                     , 1157. <a href="https://doi.org/10.3390/jcm8081157" title="DOI URL">https://doi.org/10.3390/jcm8081157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm8081157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm8081157%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DThe%252BSRC%252BInhibitor%252BDasatinib%252BInduces%252BStem%252BCell-Like%252BProperties%252Bin%252BHead%252Band%252BNeck%252BCancer%252BCells%252Bthat%252Bare%252BEffectively%252BCounteracted%252Bby%252Bthe%252BMithralog%252BEC-8042%26aulast%3DHermida-Prado%26aufirst%3DFrancisco%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D8%26spage%3D1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph M.  Eckenrode</span>, <span class="hlFld-ContribAuthor ">Prithiba  Mitra</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>, <span class="hlFld-ContribAuthor ">Markos  Leggas</span>. </span><span class="cited-content_cbyCitation_article-title">Bioanalytical method for quantitative determination of mithramycin analogs in mouse plasma by HPLC–QTOF. </span><span class="cited-content_cbyCitation_journal-name">Biomedical Chromatography</span><span> <strong>2019,</strong> <em>33 </em>
                                    (8)
                                     <a href="https://doi.org/10.1002/bmc.4544" title="DOI URL">https://doi.org/10.1002/bmc.4544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bmc.4544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbmc.4544%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Chromatography%26atitle%3DBioanalytical%252Bmethod%252Bfor%252Bquantitative%252Bdetermination%252Bof%252Bmithramycin%252Banalogs%252Bin%252Bmouse%252Bplasma%252Bby%252BHPLC%2525E2%252580%252593QTOF%26aulast%3DEckenrode%26aufirst%3DJoseph%2BM.%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dheeraj  Shinde</span>, <span class="hlFld-ContribAuthor ">Domenico  Albino</span>, <span class="hlFld-ContribAuthor ">Marita  Zoma</span>, <span class="hlFld-ContribAuthor ">Azzurra  Mutti</span>, <span class="hlFld-ContribAuthor ">Sarah N.  Mapelli</span>, <span class="hlFld-ContribAuthor ">Gianluca  Civenni</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Kokanovic</span>, <span class="hlFld-ContribAuthor ">Jessica  Merulla</span>, <span class="hlFld-ContribAuthor ">Jhudit  Perez-Escuredo</span>, <span class="hlFld-ContribAuthor ">Paula  Costales</span>, <span class="hlFld-ContribAuthor ">Francisco  Morìs</span>, <span class="hlFld-ContribAuthor ">Carlo V.  Catapano</span>, <span class="hlFld-ContribAuthor ">Giuseppina M.  Carbone</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">European Urology Oncology</span><span> <strong>2019,</strong> <em>2 </em>
                                    (4)
                                     , 415-424. <a href="https://doi.org/10.1016/j.euo.2018.08.024" title="DOI URL">https://doi.org/10.1016/j.euo.2018.08.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.euo.2018.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.euo.2018.08.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Urology%2520Oncology%26atitle%3DTranscriptional%252BReprogramming%252Band%252BInhibition%252Bof%252BTumor-propagating%252BStem-like%252BCells%252Bby%252BEC-8042%252Bin%252BERG-positive%252BProstate%252BCancer%26aulast%3DShinde%26aufirst%3DDheeraj%26date%3D2019%26volume%3D2%26issue%3D4%26spage%3D415%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd Sajjad Ahmad  Khan</span>, <span class="hlFld-ContribAuthor ">Mohd Musheer  Altaf</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Bioactive Products and Combinatorion Biosynthesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 131-139. <a href="https://doi.org/10.1016/B978-0-444-63504-4.00010-4" title="DOI URL">https://doi.org/10.1016/B978-0-444-63504-4.00010-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63504-4.00010-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63504-4.00010-4%26sid%3Dliteratum%253Aachs%26atitle%3DHybrid%252BBioactive%252BProducts%252Band%252BCombinatorion%252BBiosynthesis%26aulast%3DKhan%26aufirst%3DMohd%2BSajjad%2BAhmad%26date%3D2019%26spage%3D131%26epage%3D139%26pub%3DElsevier%26atitle%3DNew%252Band%252BFuture%252BDevelopments%252Bin%252BMicrobial%252BBiotechnology%252Band%252BBioengineering%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Arnaud J.  Legrand</span>, <span class="hlFld-ContribAuthor ">Siobhan  Cunniffe</span>, <span class="hlFld-ContribAuthor ">Samuel  Hume</span>, <span class="hlFld-ContribAuthor ">Mattia  Poletto</span>, <span class="hlFld-ContribAuthor ">Bruno  Vaz</span>, <span class="hlFld-ContribAuthor ">Kristijan  Ramadan</span>, <span class="hlFld-ContribAuthor ">Dengfu  Yao</span>, <span class="hlFld-ContribAuthor ">Grigory L.  Dianov</span>. </span><span class="cited-content_cbyCitation_article-title">Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients. </span><span class="cited-content_cbyCitation_journal-name">Cellular Oncology</span><span> <strong>2018,</strong> <em>41 </em>
                                    (5)
                                     , 527-539. <a href="https://doi.org/10.1007/s13402-018-0390-8" title="DOI URL">https://doi.org/10.1007/s13402-018-0390-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13402-018-0390-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13402-018-0390-8%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Oncology%26atitle%3DInterplay%252Bbetween%252Bbase%252Bexcision%252Brepair%252Bprotein%252BXRCC1%252Band%252BALDH2%252Bpredicts%252Boverall%252Bsurvival%252Bin%252Blung%252Band%252Bliver%252Bcancer%252Bpatients%26aulast%3DChen%26aufirst%3DXin%26date%3D2018%26date%3D2018%26volume%3D41%26issue%3D5%26spage%3D527%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoe  Tatematsu</span>, <span class="hlFld-ContribAuthor ">Yuko  Waguri-Nagaya</span>, <span class="hlFld-ContribAuthor ">Yohei  Kawaguchi</span>, <span class="hlFld-ContribAuthor ">Yusuke  Oguri</span>, <span class="hlFld-ContribAuthor ">Kenji  Ikuta</span>, <span class="hlFld-ContribAuthor ">Masaaki  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Masahiro  Nozaki</span>, <span class="hlFld-ContribAuthor ">Kiyofumi  Asai</span>, <span class="hlFld-ContribAuthor ">Mineyoshi  Aoyama</span>, <span class="hlFld-ContribAuthor ">Takanobu  Otsuka</span>. </span><span class="cited-content_cbyCitation_article-title">Mithramycin has inhibitory effects on gliostatin and matrix metalloproteinase expression induced by gliostatin in rheumatoid fibroblast-like synoviocytes. </span><span class="cited-content_cbyCitation_journal-name">Modern Rheumatology</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 495-505. <a href="https://doi.org/10.1080/14397595.2017.1350332" title="DOI URL">https://doi.org/10.1080/14397595.2017.1350332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14397595.2017.1350332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14397595.2017.1350332%26sid%3Dliteratum%253Aachs%26jtitle%3DModern%2520Rheumatology%26atitle%3DMithramycin%252Bhas%252Binhibitory%252Beffects%252Bon%252Bgliostatin%252Band%252Bmatrix%252Bmetalloproteinase%252Bexpression%252Binduced%252Bby%252Bgliostatin%252Bin%252Brheumatoid%252Bfibroblast-like%252Bsynoviocytes%26aulast%3DTatematsu%26aufirst%3DNaoe%26date%3D2018%26date%3D2017%26volume%3D28%26issue%3D3%26spage%3D495%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bradley T.  Scroggins</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Burkeen</span>, <span class="hlFld-ContribAuthor ">Ayla O.  White</span>, <span class="hlFld-ContribAuthor ">Eun Joo  Chung</span>, <span class="hlFld-ContribAuthor ">Darmood  Wei</span>, <span class="hlFld-ContribAuthor ">Su I.  Chung</span>, <span class="hlFld-ContribAuthor ">Luca F.  Valle</span>, <span class="hlFld-ContribAuthor ">Shilpa S.  Patil</span>, <span class="hlFld-ContribAuthor ">Grace  McKay-Corkum</span>, <span class="hlFld-ContribAuthor ">Kathryn E.  Hudak</span>, <span class="hlFld-ContribAuthor ">W. Marston  Linehan</span>, <span class="hlFld-ContribAuthor ">Deborah E.  Citrin</span>. </span><span class="cited-content_cbyCitation_article-title">Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Radiation Oncology*Biology*Physics</span><span> <strong>2018,</strong> <em>100 </em>
                                    (2)
                                     , 344-352. <a href="https://doi.org/10.1016/j.ijrobp.2017.09.049" title="DOI URL">https://doi.org/10.1016/j.ijrobp.2017.09.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijrobp.2017.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijrobp.2017.09.049%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Radiation%2520Oncology%252ABiology%252APhysics%26atitle%3DMithramycin%252BA%252BEnhances%252BTumor%252BSensitivity%252Bto%252BMitotic%252BCatastrophe%252BResulting%252BFrom%252BDNA%252BDamage%26aulast%3DScroggins%26aufirst%3DBradley%2BT.%26date%3D2018%26volume%3D100%26issue%3D2%26spage%3D344%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donna M.  Lee</span>, <span class="hlFld-ContribAuthor ">Anette  Duensing</span>. </span><span class="cited-content_cbyCitation_article-title">What's the FOX Got to Do with the KITten? Regulating the Lineage-Specific Transcriptional Landscape in GIST. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2018,</strong> <em>8 </em>
                                    (2)
                                     , 146-149. <a href="https://doi.org/10.1158/2159-8290.CD-17-1370" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-17-1370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-17-1370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-17-1370%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DWhat%252527s%252Bthe%252BFOX%252BGot%252Bto%252BDo%252Bwith%252Bthe%252BKITten%25253F%252BRegulating%252Bthe%252BLineage-Specific%252BTranscriptional%252BLandscape%252Bin%252BGIST%26aulast%3DLee%26aufirst%3DDonna%2BM.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D2%26spage%3D146%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renata  Novakova</span>, <span class="hlFld-ContribAuthor ">Luz Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Dagmar  Homerova</span>, <span class="hlFld-ContribAuthor ">Renata  Knirschova</span>, <span class="hlFld-ContribAuthor ">Lubomira  Feckova</span>, <span class="hlFld-ContribAuthor ">Bronislava  Rezuchova</span>, <span class="hlFld-ContribAuthor ">Beatrica  Sevcikova</span>, <span class="hlFld-ContribAuthor ">Nuria  Menéndez</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">Jesús  Cortés</span>, <span class="hlFld-ContribAuthor ">Jan  Kormanec</span>. </span><span class="cited-content_cbyCitation_article-title">Increased heterologous production of the antitumoral polyketide mithramycin A by engineered Streptomyces lividans TK24 strains. </span><span class="cited-content_cbyCitation_journal-name">Applied Microbiology and Biotechnology</span><span> <strong>2018,</strong> <em>102 </em>
                                    (2)
                                     , 857-869. <a href="https://doi.org/10.1007/s00253-017-8642-5" title="DOI URL">https://doi.org/10.1007/s00253-017-8642-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00253-017-8642-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00253-017-8642-5%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Microbiology%2520and%2520Biotechnology%26atitle%3DIncreased%252Bheterologous%252Bproduction%252Bof%252Bthe%252Bantitumoral%252Bpolyketide%252Bmithramycin%252BA%252Bby%252Bengineered%252BStreptomyces%252Blividans%252BTK24%252Bstrains%26aulast%3DNovakova%26aufirst%3DRenata%26date%3D2018%26date%3D2017%26volume%3D102%26issue%3D2%26spage%3D857%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Je Won  Park</span>, <span class="hlFld-ContribAuthor ">Sang-Jip  Nam</span>, <span class="hlFld-ContribAuthor ">Yeo Joon  Yoon</span>. </span><span class="cited-content_cbyCitation_article-title">Enabling techniques in the search for new antibiotics: Combinatorial biosynthesis of sugar-containing antibiotics. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2017,</strong> <em>134 </em>, 56-73. <a href="https://doi.org/10.1016/j.bcp.2016.10.009" title="DOI URL">https://doi.org/10.1016/j.bcp.2016.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2016.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2016.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DEnabling%252Btechniques%252Bin%252Bthe%252Bsearch%252Bfor%252Bnew%252Bantibiotics%25253A%252BCombinatorial%252Bbiosynthesis%252Bof%252Bsugar-containing%252Bantibiotics%26aulast%3DPark%26aufirst%3DJe%2BWon%26date%3D2017%26volume%3D134%26spage%3D56%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nataliya I.  Kalinovskaya</span>, <span class="hlFld-ContribAuthor ">Lyudmila A.  Romanenko</span>, <span class="hlFld-ContribAuthor ">Anatoly I.  Kalinovsky</span>, <span class="hlFld-ContribAuthor ">Svetlana P.  Ermakova</span>, <span class="hlFld-ContribAuthor ">Pavel S.  Dmitrenok</span>, <span class="hlFld-ContribAuthor ">Shamil Sh.  Afiyatullov</span>. </span><span class="cited-content_cbyCitation_article-title">The Antitumor Antibiotics Complex of Aureolic Acids from the Marine Sediment-associated Strain of
              Streptomyces
              sp. KMM 9048. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Communications</span><span> <strong>2017,</strong> <em>12 </em>
                                    (4)
                                     , 1934578X1701200. <a href="https://doi.org/10.1177/1934578X1701200427" title="DOI URL">https://doi.org/10.1177/1934578X1701200427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1934578X1701200427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1934578X1701200427%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Communications%26atitle%3DThe%252BAntitumor%252BAntibiotics%252BComplex%252Bof%252BAureolic%252BAcids%252Bfrom%252Bthe%252BMarine%252BSediment-associated%252BStrain%252Bof%252BStreptomyces%252Bsp.%252BKMM%252B9048%26aulast%3DKalinovskaya%26aufirst%3DNataliya%2BI.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D4%26spage%3D1934578X1701200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raúl García  Salcedo</span>, <span class="hlFld-ContribAuthor ">Carlos  Olano</span>, <span class="hlFld-ContribAuthor ">Rogelio  Fernández</span>, <span class="hlFld-ContribAuthor ">Alfredo F.  Braña</span>, <span class="hlFld-ContribAuthor ">Carmen  Méndez</span>, <span class="hlFld-ContribAuthor ">Fernando  de la Calle</span>, <span class="hlFld-ContribAuthor ">José A.  Salas</span>. </span><span class="cited-content_cbyCitation_article-title">Elucidation of the glycosylation steps during biosynthesis of antitumor macrolides PM100117 and PM100118 and engineering for novel derivatives. </span><span class="cited-content_cbyCitation_journal-name">Microbial Cell Factories</span><span> <strong>2016,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12934-016-0591-7" title="DOI URL">https://doi.org/10.1186/s12934-016-0591-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12934-016-0591-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12934-016-0591-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobial%2520Cell%2520Factories%26atitle%3DElucidation%252Bof%252Bthe%252Bglycosylation%252Bsteps%252Bduring%252Bbiosynthesis%252Bof%252Bantitumor%252Bmacrolides%252BPM100117%252Band%252BPM100118%252Band%252Bengineering%252Bfor%252Bnovel%252Bderivatives%26aulast%3DSalcedo%26aufirst%3DRa%25C3%25BAl%2BGarc%25C3%25ADa%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caixia  Hou</span>, <span class="hlFld-ContribAuthor ">Stevi  Weidenbach</span>, <span class="hlFld-ContribAuthor ">Kristin E.  Cano</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Wang</span>, <span class="hlFld-ContribAuthor ">Prithiba  Mitra</span>, <span class="hlFld-ContribAuthor ">Dmitri N.  Ivanov</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Tsodikov</span>. </span><span class="cited-content_cbyCitation_article-title">Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2016,</strong> <em>44 </em>
                                    (18)
                                     , 8990-9004. <a href="https://doi.org/10.1093/nar/gkw761" title="DOI URL">https://doi.org/10.1093/nar/gkw761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkw761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkw761%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DStructures%252Bof%252Bmithramycin%252Banalogues%252Bbound%252Bto%252BDNA%252Band%252Bimplications%252Bfor%252Btargeting%252Btranscription%252Bfactor%252BFLI1%26aulast%3DHou%26aufirst%3DCaixia%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D18%26spage%3D8990%26epage%3D9004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. N.  Tevyashova</span>. </span><span class="cited-content_cbyCitation_article-title">Olivomycin A – an Antitumor Antibiotic of the Aureolic Acid Group (Review). </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Chemistry Journal</span><span> <strong>2016,</strong> <em>50 </em>
                                    (7)
                                     , 425-430. <a href="https://doi.org/10.1007/s11094-016-1463-5" title="DOI URL">https://doi.org/10.1007/s11094-016-1463-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11094-016-1463-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11094-016-1463-5%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Chemistry%2520Journal%26atitle%3DOlivomycin%252BA%252B%2525E2%252580%252593%252Ban%252BAntitumor%252BAntibiotic%252Bof%252Bthe%252BAureolic%252BAcid%252BGroup%252B%252528Review%252529%26aulast%3DTevyashova%26aufirst%3DA.%2BN.%26date%3D2016%26date%3D2016%26volume%3D50%26issue%3D7%26spage%3D425%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christy L.  Osgood</span>, <span class="hlFld-ContribAuthor ">Nichole  Maloney</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Kidd</span>, <span class="hlFld-ContribAuthor ">Susan  Kitchen-Goosen</span>, <span class="hlFld-ContribAuthor ">Laura  Segars</span>, <span class="hlFld-ContribAuthor ">Meti  Gebregiorgis</span>, <span class="hlFld-ContribAuthor ">Girma M.  Woldemichael</span>, <span class="hlFld-ContribAuthor ">Min  He</span>, <span class="hlFld-ContribAuthor ">Savita  Sankar</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Lessnick</span>, <span class="hlFld-ContribAuthor ">Min  Kang</span>, <span class="hlFld-ContribAuthor ">Malcolm  Smith</span>, <span class="hlFld-ContribAuthor ">Lisa  Turner</span>, <span class="hlFld-ContribAuthor ">Zachary B.  Madaj</span>, <span class="hlFld-ContribAuthor ">Mary E.  Winn</span>, <span class="hlFld-ContribAuthor ">Luz-Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Javier  González-Sabín</span>, <span class="hlFld-ContribAuthor ">Lee J.  Helman</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Grohar</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2016,</strong> <em>22 </em>
                                    (16)
                                     , 4105-4118. <a href="https://doi.org/10.1158/1078-0432.CCR-15-2624" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-15-2624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-15-2624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-15-2624%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DIdentification%252Bof%252BMithramycin%252BAnalogues%252Bwith%252BImproved%252BTargeting%252Bof%252Bthe%252BEWS-FLI1%252BTranscription%252BFactor%26aulast%3DOsgood%26aufirst%3DChristy%2BL.%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D16%26spage%3D4105%26epage%3D4118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Tornin</span>, <span class="hlFld-ContribAuthor ">Lucia  Martinez-Cruzado</span>, <span class="hlFld-ContribAuthor ">Laura  Santos</span>, <span class="hlFld-ContribAuthor ">Aida  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Luz-Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Patricia  Oro</span>, <span class="hlFld-ContribAuthor ">Maria Ana  Hermosilla</span>, <span class="hlFld-ContribAuthor ">Eva  Allonca</span>, <span class="hlFld-ContribAuthor ">Maria Teresa  Fernández-García</span>, <span class="hlFld-ContribAuthor ">Aurora  Astudillo</span>, <span class="hlFld-ContribAuthor ">Carlos  Suarez</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">Rene  Rodriguez</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (21)
                                     , 30935-30950. <a href="https://doi.org/10.18632/oncotarget.8817" title="DOI URL">https://doi.org/10.18632/oncotarget.8817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.8817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.8817%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibition%252Bof%252BSP1%252Bby%252Bthe%252Bmithramycin%252Banalog%252BEC-8042%252Befficiently%252Btargets%252Btumor%252Binitiating%252Bcells%252Bin%252Bsarcoma%26aulast%3DTornin%26aufirst%3DJuan%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D21%26spage%3D30935%26epage%3D30950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azahara  Fernández-Guizán</span>, <span class="hlFld-ContribAuthor ">Alejandro  López-Soto</span>, <span class="hlFld-ContribAuthor ">Andrea  Acebes-Huerta</span>, <span class="hlFld-ContribAuthor ">Leticia  Huergo-Zapico</span>, <span class="hlFld-ContribAuthor ">Mónica  Villa-Álvarez</span>, <span class="hlFld-ContribAuthor ">Luz-Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">Segundo  Gonzalez</span>, . </span><span class="cited-content_cbyCitation_article-title">Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042). </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , e0140786. <a href="https://doi.org/10.1371/journal.pone.0140786" title="DOI URL">https://doi.org/10.1371/journal.pone.0140786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0140786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0140786%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DPleiotropic%252BAnti-Angiogenic%252Band%252BAnti-Oncogenic%252BActivities%252Bof%252Bthe%252BNovel%252BMithralog%252BDemycarosyl-3D-%2525C3%25259F-D-Digitoxosyl-Mithramycin%252BSK%252B%252528EC-8042%252529%26aulast%3DFern%25C3%25A1ndez-Guiz%25C3%25A1n%26aufirst%3DAzahara%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3De0140786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atanasio  Pandiella</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">Alberto  Ocaña</span>, <span class="hlFld-ContribAuthor ">Luz-Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Juan C.  Montero</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (32)
                                     , 32856-32867. <a href="https://doi.org/10.18632/oncotarget.5942" title="DOI URL">https://doi.org/10.18632/oncotarget.5942</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.5942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.5942%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DAntitumoral%252Bactivity%252Bof%252Bthe%252Bmithralog%252BEC-8042%252Bin%252Btriple%252Bnegative%252Bbreast%252Bcancer%252Blinked%252Bto%252Bcell%252Bcycle%252Barrest%252Bin%252BG2%26aulast%3DPandiella%26aufirst%3DAtanasio%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D32%26spage%3D32856%26epage%3D32867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolina  Vizcaíno</span>, <span class="hlFld-ContribAuthor ">Maria A.  Rodríguez-Sánchez</span>, <span class="hlFld-ContribAuthor ">Luz-Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">José  Portugal</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic effects of mithramycin DIG-MSK can depend on the rise of autophagy. </span><span class="cited-content_cbyCitation_journal-name">Toxicology in Vitro</span><span> <strong>2015,</strong> <em>29 </em>
                                    (7)
                                     , 1537-1544. <a href="https://doi.org/10.1016/j.tiv.2015.06.008" title="DOI URL">https://doi.org/10.1016/j.tiv.2015.06.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tiv.2015.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tiv.2015.06.008%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520in%2520Vitro%26atitle%3DCytotoxic%252Beffects%252Bof%252Bmithramycin%252BDIG-MSK%252Bcan%252Bdepend%252Bon%252Bthe%252Brise%252Bof%252Bautophagy%26aulast%3DVizca%25C3%25ADno%26aufirst%3DCarolina%26date%3D2015%26volume%3D29%26issue%3D7%26spage%3D1537%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolina  Vizcaíno</span>, <span class="hlFld-ContribAuthor ">Sylvia  Mansilla</span>, <span class="hlFld-ContribAuthor ">José  Portugal</span>. </span><span class="cited-content_cbyCitation_article-title">Sp1 transcription factor: A long-standing target in cancer chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2015,</strong> <em>152 </em>, 111-124. <a href="https://doi.org/10.1016/j.pharmthera.2015.05.008" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2015.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2015.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DSp1%252Btranscription%252Bfactor%25253A%252BA%252Blong-standing%252Btarget%252Bin%252Bcancer%252Bchemotherapy%26aulast%3DVizca%25C3%25ADno%26aufirst%3DCarolina%26date%3D2015%26volume%3D152%26spage%3D111%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  González-Rubio</span>, <span class="hlFld-ContribAuthor ">Laura  López-Sánchez</span>, <span class="hlFld-ContribAuthor ">Juan  Muñoz-Castañeda</span>, <span class="hlFld-ContribAuthor ">Clara I.  Linares</span>, <span class="hlFld-ContribAuthor ">Patricia  Aguilar-Melero</span>, <span class="hlFld-ContribAuthor ">Manuel  Rodríguez-Perálvarez</span>, <span class="hlFld-ContribAuthor ">Rafael  Sánchez-Sánchez</span>, <span class="hlFld-ContribAuthor ">Ana  Fernández-Álvarez</span>, <span class="hlFld-ContribAuthor ">Marta  Casado</span>, <span class="hlFld-ContribAuthor ">Jose L.  Montero-Álvarez</span>, <span class="hlFld-ContribAuthor ">Antonio  Rodríguez-Ariza</span>, <span class="hlFld-ContribAuthor ">Jordi  Muntané</span>, <span class="hlFld-ContribAuthor ">Manuel  de la Mata</span>, <span class="hlFld-ContribAuthor ">Gustavo  Ferrín</span>. </span><span class="cited-content_cbyCitation_article-title">GCDCA down-regulates gene expression by increasing Sp1 binding to the NOS-3 promoter in an oxidative stress dependent manner. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>96 </em>
                                    (1)
                                     , 39-51. <a href="https://doi.org/10.1016/j.bcp.2015.04.017" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.04.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.04.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DGCDCA%252Bdown-regulates%252Bgene%252Bexpression%252Bby%252Bincreasing%252BSp1%252Bbinding%252Bto%252Bthe%252BNOS-3%252Bpromoter%252Bin%252Ban%252Boxidative%252Bstress%252Bdependent%252Bmanner%26aulast%3DGonz%25C3%25A1lez-Rubio%26aufirst%3DSandra%26date%3D2015%26volume%3D96%26issue%3D1%26spage%3D39%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana B.  Flórez</span>, <span class="hlFld-ContribAuthor ">Susana  Álvarez</span>, <span class="hlFld-ContribAuthor ">Daniel  Zabala</span>, <span class="hlFld-ContribAuthor ">Alfredo F.  Braña</span>, <span class="hlFld-ContribAuthor ">José A.  Salas</span>, <span class="hlFld-ContribAuthor ">Carmen  Méndez</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptional regulation of mithramycin biosynthesis in Streptomyces argillaceus: dual role as activator and repressor of the PadR-like regulator MtrY. </span><span class="cited-content_cbyCitation_journal-name">Microbiology</span><span> <strong>2015,</strong> <em>161 </em>
                                    (2)
                                     , 272-284. <a href="https://doi.org/10.1099/mic.0.080895-0" title="DOI URL">https://doi.org/10.1099/mic.0.080895-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1099/mic.0.080895-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1099%2Fmic.0.080895-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiology%26atitle%3DTranscriptional%252Bregulation%252Bof%252Bmithramycin%252Bbiosynthesis%252Bin%252BStreptomyces%252Bargillaceus%25253A%252Bdual%252Brole%252Bas%252Bactivator%252Band%252Brepressor%252Bof%252Bthe%252BPadR-like%252Bregulator%252BMtrY%26aulast%3DFl%25C3%25B3rez%26aufirst%3DAna%2BB.%26date%3D2015%26volume%3D161%26issue%3D2%26spage%3D272%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shibojyoti  Lahiri</span>, <span class="hlFld-ContribAuthor ">Amrita  Panja</span>, <span class="hlFld-ContribAuthor ">Dipak  Dasgupta</span>. </span><span class="cited-content_cbyCitation_article-title">Association of a Zn2+ containing metallo β-lactamase with the anticancer antibiotic mithramycin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2015,</strong> <em>142 </em>, 75-83. <a href="https://doi.org/10.1016/j.jinorgbio.2014.10.001" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2014.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2014.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2014.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DAssociation%252Bof%252Ba%252BZn2%25252B%252Bcontaining%252Bmetallo%252B%2525CE%2525B2-lactamase%252Bwith%252Bthe%252Banticancer%252Bantibiotic%252Bmithramycin%26aulast%3DLahiri%26aufirst%3DShibojyoti%26date%3D2015%26volume%3D142%26spage%3D75%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sherif I.  Elshahawi</span>, <span class="hlFld-ContribAuthor ">Khaled A.  Shaaban</span>, <span class="hlFld-ContribAuthor ">Madan K.  Kharel</span>, <span class="hlFld-ContribAuthor ">Jon S.  Thorson</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review of glycosylated bacterial natural products. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2015,</strong> <em>44 </em>
                                    (21)
                                     , 7591-7697. <a href="https://doi.org/10.1039/C4CS00426D" title="DOI URL">https://doi.org/10.1039/C4CS00426D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4CS00426D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4CS00426D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DA%252Bcomprehensive%252Breview%252Bof%252Bglycosylated%252Bbacterial%252Bnatural%252Bproducts%26aulast%3DElshahawi%26aufirst%3DSherif%2BI.%26date%3D2015%26date%3D2015%26volume%3D44%26issue%3D21%26spage%3D7591%26epage%3D7697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Mei  Liang</span>, <span class="hlFld-ContribAuthor ">Jia-Heng  Liu</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Bin-Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Hong-Ji  Zhu</span>, <span class="hlFld-ContribAuthor ">Jian-Jun  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">Glycosyltransferases: mechanisms and applications in natural product development. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2015,</strong> <em>44 </em>
                                    (22)
                                     , 8350-8374. <a href="https://doi.org/10.1039/C5CS00600G" title="DOI URL">https://doi.org/10.1039/C5CS00600G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CS00600G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CS00600G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DGlycosyltransferases%25253A%252Bmechanisms%252Band%252Bapplications%252Bin%252Bnatural%252Bproduct%252Bdevelopment%26aulast%3DLiang%26aufirst%3DDong-Mei%26date%3D2015%26date%3D2015%26volume%3D44%26issue%3D22%26spage%3D8350%26epage%3D8374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey  Roth</span>, <span class="hlFld-ContribAuthor ">Cody J.  Peer</span>, <span class="hlFld-ContribAuthor ">Brigitte  Widemann</span>, <span class="hlFld-ContribAuthor ">Diane E.  Cole</span>, <span class="hlFld-ContribAuthor ">Rachel  Ershler</span>, <span class="hlFld-ContribAuthor ">Lee  Helman</span>, <span class="hlFld-ContribAuthor ">David  Schrump</span>, <span class="hlFld-ContribAuthor ">William D.  Figg</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative determination of mithramycin in human plasma by a novel, sensitive ultra-HPLC–MS/MS method for clinical pharmacokinetic application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography B</span><span> <strong>2014,</strong> <em>970 </em>, 95-101. <a href="https://doi.org/10.1016/j.jchromb.2014.08.021" title="DOI URL">https://doi.org/10.1016/j.jchromb.2014.08.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchromb.2014.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchromb.2014.08.021%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520B%26atitle%3DQuantitative%252Bdetermination%252Bof%252Bmithramycin%252Bin%252Bhuman%252Bplasma%252Bby%252Ba%252Bnovel%25252C%252Bsensitive%252Bultra-HPLC%2525E2%252580%252593MS%25252FMS%252Bmethod%252Bfor%252Bclinical%252Bpharmacokinetic%252Bapplication%26aulast%3DRoth%26aufirst%3DJeffrey%26date%3D2014%26volume%3D970%26spage%3D95%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei-Jung  Wu</span>, <span class="hlFld-ContribAuthor ">Wu-Hsiung  Wu</span>, <span class="hlFld-ContribAuthor ">Tzu-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Kuan-Ting  Lin</span>, <span class="hlFld-ContribAuthor ">Jin-Mei  Lai</span>, <span class="hlFld-ContribAuthor ">Chi-Ying F.  Huang</span>, <span class="hlFld-ContribAuthor ">Feng-Sheng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Reconstruction and analysis of a signal transduction network using HeLa cell protein–protein interaction data. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Taiwan Institute of Chemical Engineers</span><span> <strong>2014,</strong> <em>45 </em>
                                    (6)
                                     , 2835-2842. <a href="https://doi.org/10.1016/j.jtice.2014.07.006" title="DOI URL">https://doi.org/10.1016/j.jtice.2014.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtice.2014.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtice.2014.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Taiwan%2520Institute%2520of%2520Chemical%2520Engineers%26atitle%3DReconstruction%252Band%252Banalysis%252Bof%252Ba%252Bsignal%252Btransduction%252Bnetwork%252Busing%252BHeLa%252Bcell%252Bprotein%2525E2%252580%252593protein%252Binteraction%252Bdata%26aulast%3DWu%26aufirst%3DPei-Jung%26date%3D2014%26volume%3D45%26issue%3D6%26spage%3D2835%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolina  Vizcaíno</span>, <span class="hlFld-ContribAuthor ">Luz-Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">José  Portugal</span>, . </span><span class="cited-content_cbyCitation_article-title">Genome-Wide Modulation of Gene Transcription in Ovarian Carcinoma Cells by a New Mithramycin Analogue. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (8)
                                     , e104687. <a href="https://doi.org/10.1371/journal.pone.0104687" title="DOI URL">https://doi.org/10.1371/journal.pone.0104687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0104687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0104687%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DGenome-Wide%252BModulation%252Bof%252BGene%252BTranscription%252Bin%252BOvarian%252BCarcinoma%252BCells%252Bby%252Ba%252BNew%252BMithramycin%252BAnalogue%26aulast%3DVizca%25C3%25ADno%26aufirst%3DCarolina%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D8%26spage%3De104687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azahara  Fernández-Guizán</span>, <span class="hlFld-ContribAuthor ">Sylvia  Mansilla</span>, <span class="hlFld-ContribAuthor ">Francisca  Barceló</span>, <span class="hlFld-ContribAuthor ">Carolina  Vizcaíno</span>, <span class="hlFld-ContribAuthor ">Luz-Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">Segundo  González</span>, <span class="hlFld-ContribAuthor ">José  Portugal</span>. </span><span class="cited-content_cbyCitation_article-title">The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2014,</strong> <em>219 </em>, 123-132. <a href="https://doi.org/10.1016/j.cbi.2014.05.019" title="DOI URL">https://doi.org/10.1016/j.cbi.2014.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2014.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2014.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DThe%252Bactivity%252Bof%252Ba%252Bnovel%252Bmithramycin%252Banalog%252Bis%252Brelated%252Bto%252Bits%252Bbinding%252Bto%252BDNA%25252C%252Bcellular%252Baccumulation%25252C%252Band%252Binhibition%252Bof%252BSp1-driven%252Bgene%252Btranscription%26aulast%3DFern%25C3%25A1ndez-Guiz%25C3%25A1n%26aufirst%3DAzahara%26date%3D2014%26volume%3D219%26spage%3D123%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  Olano</span>, <span class="hlFld-ContribAuthor ">Carmen  Méndez</span>, <span class="hlFld-ContribAuthor ">José A.  Salas</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing Sugar Biosynthesis and Glycosylation to Redesign Natural Products and to Increase Structural Diversity. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 317-339. <a href="https://doi.org/10.1002/9781118794623.ch17" title="DOI URL">https://doi.org/10.1002/9781118794623.ch17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118794623.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118794623.ch17%26sid%3Dliteratum%253Aachs%26atitle%3DHarnessing%252BSugar%252BBiosynthesis%252Band%252BGlycosylation%252Bto%252BRedesign%252BNatural%252BProducts%252Band%252Bto%252BIncrease%252BStructural%252BDiversity%26aulast%3DOlano%26aufirst%3DCarlos%26date%3D2014%26date%3D2014%26spage%3D317%26epage%3D339%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DNatural%252BProducts%26aulast%3DOsbourn%26aufirst%3DAnne%26date%3D2014%26volume%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lidija K.  Gorsic</span>, <span class="hlFld-ContribAuthor ">Amy L.  Stark</span>, <span class="hlFld-ContribAuthor ">Heather E.  Wheeler</span>, <span class="hlFld-ContribAuthor ">Shan S.  Wong</span>, <span class="hlFld-ContribAuthor ">Hae K.  Im</span>, <span class="hlFld-ContribAuthor ">M. Eileen  Dolan</span>, . </span><span class="cited-content_cbyCitation_article-title">EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (12)
                                     , e82220. <a href="https://doi.org/10.1371/journal.pone.0082220" title="DOI URL">https://doi.org/10.1371/journal.pone.0082220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0082220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0082220%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DEPS8%252BInhibition%252BIncreases%252BCisplatin%252BSensitivity%252Bin%252BLung%252BCancer%252BCells%26aulast%3DGorsic%26aufirst%3DLidija%2BK.%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3De82220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nguyen Huy  Thuan</span>, <span class="hlFld-ContribAuthor ">Jae Kyung  Sohng</span>. </span><span class="cited-content_cbyCitation_article-title">Recent biotechnological progress in enzymatic synthesis of glycosides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Industrial Microbiology and Biotechnology</span><span> <strong>2013,</strong> <em>40 </em>
                                    (12)
                                     , 1329-1356. <a href="https://doi.org/10.1007/s10295-013-1332-0" title="DOI URL">https://doi.org/10.1007/s10295-013-1332-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10295-013-1332-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10295-013-1332-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Industrial%2520Microbiology%2520and%2520Biotechnology%26atitle%3DRecent%252Bbiotechnological%252Bprogress%252Bin%252Benzymatic%252Bsynthesis%252Bof%252Bglycosides%26aulast%3DThuan%26aufirst%3DNguyen%2BHuy%26date%3D2013%26date%3D2013%26volume%3D40%26issue%3D12%26spage%3D1329%26epage%3D1356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Zabala</span>, <span class="hlFld-ContribAuthor ">Alfredo F.  Braña</span>, <span class="hlFld-ContribAuthor ">Ana B.  Flórez</span>, <span class="hlFld-ContribAuthor ">José A.  Salas</span>, <span class="hlFld-ContribAuthor ">Carmen  Méndez</span>. </span><span class="cited-content_cbyCitation_article-title">Engineering precursor metabolite pools for increasing production of antitumor mithramycins in Streptomyces argillaceus. </span><span class="cited-content_cbyCitation_journal-name">Metabolic Engineering</span><span> <strong>2013,</strong> <em>20 </em>, 187-197. <a href="https://doi.org/10.1016/j.ymben.2013.10.002" title="DOI URL">https://doi.org/10.1016/j.ymben.2013.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymben.2013.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymben.2013.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DMetabolic%2520Engineering%26atitle%3DEngineering%252Bprecursor%252Bmetabolite%252Bpools%252Bfor%252Bincreasing%252Bproduction%252Bof%252Bantitumor%252Bmithramycins%252Bin%252BStreptomyces%252Bargillaceus%26aulast%3DZabala%26aufirst%3DDaniel%26date%3D2013%26volume%3D20%26spage%3D187%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolina  Vizcaíno</span>, <span class="hlFld-ContribAuthor ">Sylvia  Mansilla</span>, <span class="hlFld-ContribAuthor ">Luz-Elena  Núñez</span>, <span class="hlFld-ContribAuthor ">Carmen  Méndez</span>, <span class="hlFld-ContribAuthor ">José A.  Salas</span>, <span class="hlFld-ContribAuthor ">Francisco  Morís</span>, <span class="hlFld-ContribAuthor ">José  Portugal</span>. </span><span class="cited-content_cbyCitation_article-title">Novel mithramycins abrogate the involvement of protein factors in the transcription of cell cycle control genes. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2012,</strong> <em>84 </em>
                                    (9)
                                     , 1133-1142. <a href="https://doi.org/10.1016/j.bcp.2012.08.003" title="DOI URL">https://doi.org/10.1016/j.bcp.2012.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2012.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2012.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DNovel%252Bmithramycins%252Babrogate%252Bthe%252Binvolvement%252Bof%252Bprotein%252Bfactors%252Bin%252Bthe%252Btranscription%252Bof%252Bcell%252Bcycle%252Bcontrol%252Bgenes%26aulast%3DVizca%25C3%25ADno%26aufirst%3DCarolina%26date%3D2012%26volume%3D84%26issue%3D9%26spage%3D1133%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guojun  Wang</span>, <span class="hlFld-ContribAuthor ">Pallab  Pahari</span>, <span class="hlFld-ContribAuthor ">Madan K.  Kharel</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Haining  Zhu</span>, <span class="hlFld-ContribAuthor ">Steven G.  Van Lanen</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>. </span><span class="cited-content_cbyCitation_article-title">Zusammenwirken zweier difunktionaler Enzyme bei Aufbau und Verknüpfung von Desoxyzuckern des Antitumor-Antibiotikums Mithramycin. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2012,</strong> <em>124 </em>
                                    (42)
                                     , 10790-10794. <a href="https://doi.org/10.1002/ange.201205414" title="DOI URL">https://doi.org/10.1002/ange.201205414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201205414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201205414%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DZusammenwirken%252Bzweier%252Bdifunktionaler%252BEnzyme%252Bbei%252BAufbau%252Bund%252BVerkn%2525C3%2525BCpfung%252Bvon%252BDesoxyzuckern%252Bdes%252BAntitumor-Antibiotikums%252BMithramycin%26aulast%3DWang%26aufirst%3DGuojun%26date%3D2012%26date%3D2012%26volume%3D124%26issue%3D42%26spage%3D10790%26epage%3D10794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guojun  Wang</span>, <span class="hlFld-ContribAuthor ">Pallab  Pahari</span>, <span class="hlFld-ContribAuthor ">Madan K.  Kharel</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Haining  Zhu</span>, <span class="hlFld-ContribAuthor ">Steven G.  Van Lanen</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>. </span><span class="cited-content_cbyCitation_article-title">Cooperation of Two Bifunctional Enzymes in the Biosynthesis and Attachment of Deoxysugars of the Antitumor Antibiotic Mithramycin. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2012,</strong> <em>51 </em>
                                    (42)
                                     , 10638-10642. <a href="https://doi.org/10.1002/anie.201205414" title="DOI URL">https://doi.org/10.1002/anie.201205414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201205414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201205414%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCooperation%252Bof%252BTwo%252BBifunctional%252BEnzymes%252Bin%252Bthe%252BBiosynthesis%252Band%252BAttachment%252Bof%252BDeoxysugars%252Bof%252Bthe%252BAntitumor%252BAntibiotic%252BMithramycin%26aulast%3DWang%26aufirst%3DGuojun%26date%3D2012%26date%3D2012%26volume%3D51%26issue%3D42%26spage%3D10638%26epage%3D10642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of (A) mithramycin (<b>1</b>) and demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin (<b>2</b>) and (B) mithramycin SK (<b>3</b>) and mithramycin SDK (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Depictions of Deoxysugar Biosynthesis Pathways Encoded by pLNBIV (NDP-<span class="smallcaps smallerCapital">l</span>-digitoxose, Gray, Solid Arrows) and pKOL (NDP-4-keto-<span class="smallcaps smallerCapital">d</span>-olivose, Black, Dotted Arrows) and Observed Outcomes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of new mithramycin analogues generated by combinatorial biosynthesis. (A) Compounds with modified glycosylation patterns produced by <i>S. argillaceus</i> M7C1-pFL845: dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldemycarosyl-2-<i>O</i>-β-<span class="smallcaps smallerCapital">d</span>-oliosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-olivosylmithramycin (<b>5</b>), dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldemycarosylmithramycin (<b>6</b>), deoliosyldemycarosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-amicetosylmithramycin (<b>7</b>), and dideolivosyl-6-β-<span class="smallcaps smallerCapital">d</span>-amicetosyldeoliosyldemycarosyl-3C-β-<span class="smallcaps smallerCapital">d</span>-amicetosylmithramycin (<b>8</b>). (B) Compounds with modified glycosylation pattern and different structure of the 3-carbon side chain produced by <i>S. argillaceus</i> M3W1-pMP3*BII: demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SK (<b>9</b>), demicarosylmithramycin SDK (<b>10</b>), and demycarosyl-3D-β-<span class="smallcaps smallerCapital">d</span>-digitoxosylmithramycin SDK (<b>11</b>). Differences from <b>1</b> are highlighted in bold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacokinetics profile of compounds <b>1</b> and <b>9</b>. Mice (<i>n</i> = 3 per group) were injected intravenously with a single dose of 1 mg/kg in the case of compound <b>1</b> (A) or 18 mg/kg of compound <b>9</b> (B). Each time point represents the mean ± SD of three mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/medium/jm-2012-00234t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antitumor activity of compound <b>9</b> in subcutaneous colon and melanoma tumor xenografts. Mice (eight per group) with subcutaneous colon (A) or melanoma (B) tumors were treated with sterile saline solution (control, closed circles) or the indicated doses of compound <b>9</b> given by intravenous injections every 2 days (q2d×10, closed triangles) or 3 days (q3d×10; closed squares). Additionally, mice (eight per group) with subcutaneous colon or melanoma tumors were also intraperitoneally injected with 8 mg/kg cis-platin (A) or doxorubicin (B) every 4 days (q4d×3, open rhombs). Part A represents the tumor volumes over time with colon cancer COLO-205 cell line. Part C represents evolution of the mice weights with COLO-205 cell line. Part B represents the tumor volumes over time with melanoma SK-MEL-2 cell line. Part D represents evolution of the mice weights with SK-MEL-2 cell line. Each point represents the mean ± SD of eight mice. q2d and q3d indicate end of the treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300234t/production/images/large/jm-2012-00234t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300234t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Darnell, J. E.,  Jr.</span><span> </span><span class="NLM_article-title">Transcription factors as targets for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">740</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1038%2Fnrc906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=12360277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=740-749&author=J.+E.+Darnell&title=Transcription+factors+as+targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription factors as targets for cancer therapy</span></div><div class="casAuthors">Darnell, James E., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">740-749</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A limited list of transcription factors are overactive in most human cancer cells, which makes them targets for the development of anticancer drugs.  That they are the most direct and hopeful targets for treating cancer is proposed, and this is supported by the fact that there are many more human oncogenes in signaling pathways than there are oncogenic transcription factors.  But how could specific transcription-factor activity be inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJxyqucgv0aLVg90H21EOLACvtfcHk0ljkvU7WCib1jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbo%253D&md5=239132f634b138965e3a11c63f7cab76</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc906%26sid%3Dliteratum%253Aachs%26aulast%3DDarnell%26aufirst%3DJ.%2BE.%26atitle%3DTranscription%2520factors%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D740%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Germain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D. A.</span><span> </span><span class="NLM_article-title">Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5665</span><span class="NLM_x">–</span> <span class="NLM_lpage">5669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1158%2F1078-0432.CCR-06-2491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=17908954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSntLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=5665-5669&author=D.+Germainauthor=D.+A.+Frank&title=Targeting+the+cytoplasmic+and+nuclear+functions+of+signal+transducers+and+activators+of+transcription+3+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Cytoplasmic and Nuclear Functions of Signal Transducers and Activators of Transcription 3 for Cancer Therapy</span></div><div class="casAuthors">Germain, Doris; Frank, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5665-5669</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Signal transducers and activators of transcription (STAT) are a highly conserved family of transcription factors that are activated by phosphorylation in the cytoplasm, after which they translocate to the nucleus to regulate gene expression.  Among the seven STATs, STAT3 is of particular interest due to its constitutive phosphorylation in a large proportion of human cancers and its ability to induce neoplastic transformation.  Inhibition of STAT3 can reverse tumor growth in exptl. systems while having few effects in normal cells.  These findings have implicated STAT3 as a potentially important target for therapeutic intervention.  In addn. to its well-described role as a transcription factor, STAT3 has been found recently to have important effects in the cytoplasm.  Collectively, these functions of STAT3 directly contribute to tumorigenesis, invasion, and metastasis.  Given the potential importance of STAT3 as a target for cancer therapy, mols. have been developed that can block STAT3 function at a variety of steps.  These drugs show promise as anticancer agents in model systems of a variety of common human cancers.  Thus, elucidating the functions of STAT3 and developing agents to inhibit this protein remain important scientific and clin. challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM6w8Sek_eY7Vg90H21EOLACvtfcHk0ljhYYnfxElhxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSntLzK&md5=7c06b8b398fa29f41b1e2049abbb04ea</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2491%26sid%3Dliteratum%253Aachs%26aulast%3DGermain%26aufirst%3DD.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26atitle%3DTargeting%2520the%2520cytoplasmic%2520and%2520nuclear%2520functions%2520of%2520signal%2520transducers%2520and%2520activators%2520of%2520transcription%25203%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D5665%26epage%3D5669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Page, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Signal transducer and activator of transcription 3 inhibitors: a patent review</span> <span class="citation_source-journal">Expert. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1517%2F13543776.2011.539205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21114420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFyktrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=65-83&author=B.+D.+Pageauthor=D.+P.+Ballauthor=P.+T.+Gunning&title=Signal+transducer+and+activator+of+transcription+3+inhibitors%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transducer and activator of transcription 3 inhibitors: a patent review</span></div><div class="casAuthors">Page, Brent D. G.; Ball, Daniel P.; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-83</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Aberrant activation of signal transducer and activator of transcription (Stat) 3, a member of the STAT family of proteins, is prevalent in numerous human cancers and is now widely recognized as a crit. mol. abnormality and a master regulator of tumor processes.  Thus, the identification of potent and selective Stat3 inhibitors will have a high com. potential as anticancer drugs, given the many tumors in which Stat3 is implicated.  Areas covered in this review: This review covers the structures and activities of direct inhibitors of Stat3 protein activity described in the patent literature since the research field's inception in 2001.  The patents reviewed include peptide and peptidomimetic compds., small mols., oligonucleotides and platinum-based Stat3 inhibitors.  What the reader will gain: Readers will gain an understanding of how Stat3 protein function has been inhibited by a wide variety of structurally diverse therapeutic compds.  Readers will learn about which classes of patented Stat3 inhibitors are most advanced toward clin. trials, and will be exposed to the proposed mechanisms of inhibition and scope of their application in treating human cancers.  Take home message: Numerous groups have shown that in vivo administration of inhibitors of activated Stat3 induce human tumor regression in xenograft models.  Indeed, the growing no. of preclin. studies in numerous cancer types, as well as the first Phase 0 clin. trial of a Stat3 inhibitor, suggest that Stat3 is a valid and exciting therapeutic target for mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogO9J3Yw_G5bVg90H21EOLACvtfcHk0ljhYYnfxElhxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFyktrvJ&md5=338065a442a0de9993a90b1c25a5e084</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.539205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.539205%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DBall%26aufirst%3DD.%2BP.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DSignal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D65%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wilczynski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duechler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czyz, M.</span><span> </span><span class="NLM_article-title">Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I</span> <span class="citation_source-journal">Arch. Immunol. Ther. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1007%2Fs00005-011-0131-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21625848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1ShtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=289-299&author=J.+Wilczynskiauthor=M.+Duechlerauthor=M.+Czyz&title=Targeting+NF-%CE%BAB+and+HIF-1+pathways+for+the+treatment+of+cancer%3A+part+I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting NF-κB and HIF-1 Pathways for the Treatment of Cancer: Part I</span></div><div class="casAuthors">Wilczynski, Jacek; Duechler, Markus; Czyz, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">Archivum Immunologiae et Therapiae Experimentalis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-299</span>CODEN:
                <span class="NLM_cas:coden">AITEAT</span>;
        ISSN:<span class="NLM_cas:issn">0004-069X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  The process of chronic inflammation is a common link which connects different kinds of environmental pollutants and infections with tumorigenesis.  Transcription factor NF-κB is a common final target for many inflammatory and cell proliferation pathways, independent of the source of stimuli (e.g., cytokines, growth factors, environmental carcinogens, radiation, hypoxia, bacteria, and viruses).  Over-activation of NF-κB has been confirmed in many tumors, resulting in worse prognosis for patient survival.  Therefore, inhibition of cellular pathways for NF-κB activation is nowadays considered as a promising anti-cancer therapy and is extensively studied in clin. trials, or even has been adopted as an approved therapy in some kinds of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowOK9I_rALSrVg90H21EOLACvtfcHk0ljhYYnfxElhxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1ShtLo%253D&md5=9b93524a3cfd41b8bed5a8a0ac799c61</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00005-011-0131-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00005-011-0131-4%26sid%3Dliteratum%253Aachs%26aulast%3DWilczynski%26aufirst%3DJ.%26aulast%3DDuechler%26aufirst%3DM.%26aulast%3DCzyz%26aufirst%3DM.%26atitle%3DTargeting%2520NF-%25CE%25BAB%2520and%2520HIF-1%2520pathways%2520for%2520the%2520treatment%2520of%2520cancer%253A%2520part%2520I%26jtitle%3DArch.%2520Immunol.%2520Ther.%2520Exp.%26date%3D2011%26volume%3D59%26spage%3D289%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Albertini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napoli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinaldi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nur-e-Alam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catapano, C. V.</span><span> </span><span class="NLM_article-title">Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer <i>Streptomyces argillaceus</i> exhibits improved transcriptional repressor activity: implications for cancer therapy</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1721-1734&author=V.+Albertiniauthor=A.+Jainauthor=S.+Vignatiauthor=S.+Napoliauthor=A.+Rinaldiauthor=I.+Kweeauthor=M.+Nur-e-Alamauthor=J.+Bergantauthor=F.+Bertoniauthor=G.+Carboneauthor=J.+Rohrauthor=C.+V.+Catapano&title=Novel+GC-rich+DNA-binding+compound+produced+by+a+genetically+engineered+mutant+of+the+mithramycin+producer+Streptomyces+argillaceus+exhibits+improved+transcriptional+repressor+activity%3A+implications+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlbertini%26aufirst%3DV.%26aulast%3DJain%26aufirst%3DA.%26aulast%3DVignati%26aufirst%3DS.%26aulast%3DNapoli%26aufirst%3DS.%26aulast%3DRinaldi%26aufirst%3DA.%26aulast%3DKwee%26aufirst%3DI.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DBergant%26aufirst%3DJ.%26aulast%3DBertoni%26aufirst%3DF.%26aulast%3DCarbone%26aufirst%3DG.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26atitle%3DNovel%2520GC-rich%2520DNA-binding%2520compound%2520produced%2520by%2520a%2520genetically%2520engineered%2520mutant%2520of%2520the%2520mithramycin%2520producer%2520Streptomyces%2520argillaceus%2520exhibits%2520improved%2520transcriptional%2520repressor%2520activity%253A%2520implications%2520for%2520cancer%2520therapy%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3D1721%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Previdi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broggini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catapano, C. V.</span><span> </span><span class="NLM_article-title">Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1016%2Fj.ygyno.2010.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=20452660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=182-188&author=S.+Previdiauthor=A.+Malekauthor=V.+Albertiniauthor=C.+Rivaauthor=C.+Capellaauthor=M.+Brogginiauthor=G.+M.+Carboneauthor=J.+Rohrauthor=C.+V.+Catapano&title=Inhibition+of+Sp1-dependent+transcription+and+antitumor+activity+of+the+new+aureolic+acid+analogues+mithramycin+SDK+and+SK+in+human+ovarian+cancer+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts</span></div><div class="casAuthors">Previdi, Sara; Malek, Anastasia; Albertini, Veronica; Riva, Cristina; Capella, Carlo; Broggini, Massimo; Carbone, Giuseppina M.; Rohr, Jurgen; Catapano, Carlo V.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-188</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Objective: Increased activity of Sp family of transcription factors is a frequent and crit. event in cancer development and progression.  Genes governing tumor growth, invasion and angiogenesis are regulated by Sp factors, like Sp1, Sp3 or Sp4, and are frequently over-expressed in tumors.  Targeting Sp factors has been explored as a therapeutic approach.  Mithramycin (MTM) is a natural antibiotic that binds DNA and inhibit Sp1-dependent transcription.  New analogs, named MTM-SDK and MTM-SK, were recently obtained by genetic engineering of the MTM biosynthetic pathway and have demonstrated improved transcriptional and antiproliferative activity in ovarian cancer cell lines in vitro.  In the present study we evaluated the activity of the new compds. in human ovarian cancer xenografts.  Methods: Expression of Sp1 and target proteins in ovarian cancer specimens and tumor xenografts was assessed by immunohistochem.  Drug-induced silencing of Sp1-regulated genes in cells and tumor xenograft samples was assessed by quant. RT-PCR.  Toxicity and antitumor activity of the compds. were investigated in healthy and tumor-bearing immunocompromised mice, resp.  Results: Expression of Sp1 was frequently increased in human epithelial ovarian cancers.  MTM-SDK and MTM-SK acted as potent inhibitors of Sp1-dependent transcription both in vitro and in tumor xenografts.  Both compds. were well tolerated even after prolonged administration and delayed growth of ovarian tumor xenografts.  MTM-SDK was particularly effective against orthotopic tumors leading to a significant increase of survival and delay of tumor progression.  Conclusions: MTM-SDK and MTM-SK show relevant activity in vivo and represent interesting candidates for treatment of ovarian cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeJTYgFUbvNrVg90H21EOLACvtfcHk0li4Wadc-D59mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGgsrg%253D&md5=598990226414169b2fce6e735fc48801</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2010.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2010.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DPrevidi%26aufirst%3DS.%26aulast%3DMalek%26aufirst%3DA.%26aulast%3DAlbertini%26aufirst%3DV.%26aulast%3DRiva%26aufirst%3DC.%26aulast%3DCapella%26aufirst%3DC.%26aulast%3DBroggini%26aufirst%3DM.%26aulast%3DCarbone%26aufirst%3DG.%2BM.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26atitle%3DInhibition%2520of%2520Sp1-dependent%2520transcription%2520and%2520antitumor%2520activity%2520of%2520the%2520new%2520aureolic%2520acid%2520analogues%2520mithramycin%2520SDK%2520and%2520SK%2520in%2520human%2520ovarian%2520cancer%2520xenografts%26jtitle%3DGynecol.%2520Oncol.%26date%3D2010%26volume%3D118%26spage%3D182%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Safe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelrahim, M.</span><span> </span><span class="NLM_article-title">Sp transcription factor family and its role in cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2438</span><span class="NLM_x">–</span> <span class="NLM_lpage">2448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=2438-2448&author=S.+Safeauthor=M.+Abdelrahim&title=Sp+transcription+factor+family+and+its+role+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSafe%26aufirst%3DS.%26aulast%3DAbdelrahim%26aufirst%3DM.%26atitle%3DSp%2520transcription%2520factor%2520family%2520and%2520its%2520role%2520in%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D2438%26epage%3D2448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Newman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, G. M.</span><span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the last 25 years</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/doi/10.1021/np068054v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=461-477&author=J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+last+25+years"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Last 25 Years</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-477</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review is an updated and expanded version of two prior reviews that were published in this journal in 1997 and 2003.  In the case of all approved agents the time frame has been extended to include the 251/2 years from 01/1981 to 06/2006 for all diseases worldwide and from 1950 (earliest so far identified) to 06/2006 for all approved antitumor drugs worldwide.  We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions.  From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well.  Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 155 small mols., 73% are other than "S" (synthetic), with 47% actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the antiinfective area being dependent on natural products and their structures.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have, in fact, been used in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compd. approved as a drug in this 25 plus year time frame.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpih5kusSUibVg90H21EOLACvtfcHk0li4Wadc-D59mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D&md5=9fc0909750367ccd3b97589aaf087cdf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fnp068054v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp068054v%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%2520last%252025%2520years%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D461%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conforto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratan, R. R.</span><span> </span><span class="NLM_article-title">Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1002%2Fana.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=11261509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVyqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=345-354&author=S.+Chatterjeeauthor=K.+Zamanauthor=H.+Ryuauthor=A.+Confortoauthor=R.+R.+Ratan&title=Sequence-selective+DNA+binding+drugs+mithramycin+A+and+chromomycin+A3+are+potent+inhibitors+of+neuronal+apoptosis+induced+by+oxidative+stress+and+DNA+damage+in+cortical+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons</span></div><div class="casAuthors">Chatterjee, Sukalyan; Zaman, Khalequz; Ryu, Hoon; Conforto, Adriana; Ratan, Rajiv R.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-354</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Global inhibitors of RNA or protein synthesis such as actinomycin D or cycloheximide abrogate neuronal apoptosis induced by numerous pathol. stimuli in vitro and in vivo.  The clin. application of actinomycin D or cycloheximide to human neurol. disease has been limited by the toxicities of these agents.  To overcome these toxicities, strategies must be developed to inhibit selectively the expression of deleterious proapoptotic proteins, while leaving the expression of antiapoptotic, proregeneration, and other crit. homeostatic proteins unperturbed.  Mithramycin A (trade name Plicamycin) is an aureolic acid antibiotic that has been used in humans to treat hypercalcemia and several types of cancers.  This class of agents is believed to act, in part, by selectively inhibiting gene expression by displacing transcriptional activators that bind to G-C-rich regions of promoters.  Here we demonstrate that mithramycin A and its structural analog chromomycin A3 are potent inhibitors of neuronal apoptosis induced by glutathione depletion-induced oxidative stress or the DNA-damaging agent camptothecin.  We correlate the protective effects of mithramycin A with its ability to inhibit enhanced DNA binding of the transcription factors Sp1 and Sp3 to their cognate "G-C" box induced by oxidative stress or DNA damage.  The protective effects of mithramycin A cannot be attributed to global inhibition of protein synthesis.  Together, these results suggest that mithramycin A and its structural analogs may be effective agents for the treatment of neurol. diseases assocd. with aberrant activation of apoptosis and highlight the potential use of sequence-selective DNA-binding drugs as neurol. therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyQUSlsOrb0LVg90H21EOLACvtfcHk0lhy2zNn-vFj9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVyqtLY%253D&md5=96739b4c3a2230b62589e4eefda4d5f9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fana.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.71%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DZaman%26aufirst%3DK.%26aulast%3DRyu%26aufirst%3DH.%26aulast%3DConforto%26aufirst%3DA.%26aulast%3DRatan%26aufirst%3DR.%2BR.%26atitle%3DSequence-selective%2520DNA%2520binding%2520drugs%2520mithramycin%2520A%2520and%2520chromomycin%2520A3%2520are%2520potent%2520inhibitors%2520of%2520neuronal%2520apoptosis%2520induced%2520by%2520oxidative%2520stress%2520and%2520DNA%2520damage%2520in%2520cortical%2520neurons%26jtitle%3DAnn.%2520Neurol.%26date%3D2001%26volume%3D49%26spage%3D345%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span> </span><span class="NLM_article-title">Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4878</span><span class="NLM_x">–</span> <span class="NLM_lpage">4885</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4878-4885&author=Z.+Jiaauthor=J.+Zhangauthor=D.+Weiauthor=L.+Wangauthor=P.+Yuanauthor=X.+Leauthor=Q.+Liauthor=J.+Yaoauthor=K.+Xie&title=Molecular+basis+of+the+synergistic+antiangiogenic+activity+of+bevacizumab+and+mithramycin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DLe%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DK.%26atitle%3DMolecular%2520basis%2520of%2520the%2520synergistic%2520antiangiogenic%2520activity%2520of%2520bevacizumab%2520and%2520mithramycin%2520A%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4878%26epage%3D4885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Jia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span> </span><span class="NLM_article-title">Treatment with combination of mithramycin A and tolfenamic acid promotes degradation of Sp1 protein and synergistic antitumor activity in pancreatic cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1111-1119&author=Z.+Jiaauthor=Y.+Gaoauthor=L.+Wangauthor=Q+Liauthor=J.+Zhangauthor=X.+Leauthor=D.+Weiauthor=J.+C.+Yaoauthor=D.+Z.+Changauthor=S.+Huangauthor=K.+Xie&title=Treatment+with+combination+of+mithramycin+A+and+tolfenamic+acid+promotes+degradation+of+Sp1+protein+and+synergistic+antitumor+activity+in+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DJ.%2BC.%26aulast%3DChang%26aufirst%3DD.%2BZ.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DK.%26atitle%3DTreatment%2520with%2520combination%2520of%2520mithramycin%2520A%2520and%2520tolfenamic%2520acid%2520promotes%2520degradation%2520of%2520Sp1%2520protein%2520and%2520synergistic%2520antitumor%2520activity%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1111%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Fajardo, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parapuram, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leask, A.</span><span> </span><span class="NLM_article-title">Mithramycin reduces expression of fibro-proliferative mRNAs in human gingival fibroblasts</span> <span class="citation_source-journal">Cell Proliferation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=166-173&author=O.+A.+Fajardoauthor=+Thompsonauthor=S.+K.+Parapuramauthor=S.+Liuauthor=A.+Leask&title=Mithramycin+reduces+expression+of+fibro-proliferative+mRNAs+in+human+gingival+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFajardo%26aufirst%3DO.%2BA.%26aulast%3DThompson%26aulast%3DParapuram%26aufirst%3DS.%2BK.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLeask%26aufirst%3DA.%26atitle%3DMithramycin%2520reduces%2520expression%2520of%2520fibro-proliferative%2520mRNAs%2520in%2520human%2520gingival%2520fibroblasts%26jtitle%3DCell%2520Proliferation%26date%3D2011%26volume%3D44%26spage%3D166%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Seznec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silkenstedt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naumann, U.</span><span> </span><span class="NLM_article-title">Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma</span> <span class="citation_source-journal">J. Neuro-Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1007%2Fs11060-010-0266-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=20556479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFCntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2011&pages=365-377&author=J.+Seznecauthor=B.+Silkenstedtauthor=U.+Naumann&title=Therapeutic+effects+of+the+Sp1+inhibitor+mithramycin+A+in+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma</span></div><div class="casAuthors">Seznec, Janina; Silkenstedt, Bjoern; Naumann, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mithramycin A (MitA) is a chemotherapeutic compd. which has been used in the therapy of several types of cancer.  For exptl. cancer it has been shown that MitA mediates the expression of genes involved in tumor progression such as genes involved in immunosurveillance, cell motility or cell death.  MitA works synergistically with Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and with antiangiogenic agents.  We were therefore interested in analyzing whether MitA might be a suitable agent for glioma therapy.  We demonstrate herein that the cell death sensitizing effects of MitA are cell line specific, independent of the endogenous status of the tumor suppressor p53 as well as of the endogenous expression of X-linked inhibitor of apoptosis (XIAP) or basal sensitivity towards death ligand-induced cell death.  In glioma cells, MitA reduced the secretion and activity of the migration-involved matrix metalloproteinases (MMP), diminished vascular endothelial growth factor (VEGF), and increased recepteur d'origine nantais (RON) kinase mRNA, paralleled by a significant redn. of glioma cell migration.  In contrast to other cancer types, in glioma cells MitA did not alter the expression of the immunorelevant genes major histocompatibility complex I class related (MIC)-A, MIC-B or UL16 binding proteins (ULBP).  We conclude that, whereas MitA-mediated redn. of XIAP expression and sensitization to Apo2L/TRAIL are cell line specific, its antimigratory effects are more general and might be the result of altered expression of MMP, VEGF, and/or RON kinase.  Therefore, MitA might be a potential agent to reduce glioma cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppIXp425RWvbVg90H21EOLACvtfcHk0lh8y63g2ril3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFCntg%253D%253D&md5=e36bc57e6d5e79a2e989290ed0eb1197</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs11060-010-0266-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-010-0266-x%26sid%3Dliteratum%253Aachs%26aulast%3DSeznec%26aufirst%3DJ.%26aulast%3DSilkenstedt%26aufirst%3DB.%26aulast%3DNaumann%26aufirst%3DU.%26atitle%3DTherapeutic%2520effects%2520of%2520the%2520Sp1%2520inhibitor%2520mithramycin%2520A%2520in%2520glioblastoma%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2011%26volume%3D101%26spage%3D365%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Grohar, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldemichael, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currier, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helman, L. J.</span><span> </span><span class="NLM_article-title">Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">962</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1093%2Fjnci%2Fdjr156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21653923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2011&pages=962-978&author=P.+J.+Groharauthor=G.+M.+Woldemichaelauthor=L.+B.+Griffinauthor=A.+Mendozaauthor=Q.-R.+Chenauthor=C.+Yeungauthor=D.+G.+Currierauthor=S.+Davisauthor=C.+Khannaauthor=J.+Khanauthor=J.+B.+McMahonauthor=L.+J.+Helman&title=Identification+of+an+inhibitor+of+the+EWS-FLI1+oncogenic+transcription+factor+by+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening</span></div><div class="casAuthors">Grohar, Patrick J.; Woldemichael, Girma M.; Griffin, Laurie B.; Mendoza, Arnulfo; Chen, Qing-Rong; Yeung, Choh; Currier, Duane G.; Davis, Sean; Khanna, Chand; Khan, Javed; McMahon, James B.; Helman, Lee J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">962-978</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Chromosomal translocations generating oncogenic transcription factors are the hallmark of a variety of tumors, including many sarcomas.  Ewing sarcoma family of tumors (ESFTs) are characterized by the t(11;22)(q24;q12) translocation that generates the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) fusion transcription factor responsible for the highly malignant phenotype of this tumor.  Although continued expression of EWS-FLI1 is believed to be crit. for ESFT cell survival, a clin. effective small-mol. inhibitor remains elusive likely because EWS-FLI1 is a transcription factor and therefore widely felt to be "undruggable.  " Methods We developed a high-throughput screen to evaluate more than 50 000 compds. for inhibition of EWS-FLI1 activity in TC32 ESFT cells.  We used a TC32 cell-based luciferase reporter screen using the EWS-FLI1 downstream target NR0B1 promoter and a gene signature secondary screen to sort and prioritize the compds.  We characterized the lead compd., mithramycin, based on its ability to inhibit EWS-FLI1 activity in vitro using microarray expression profiling, quant. reverse transcription-polymerase chain reaction, and immunoblot anal., and in vivo using immunohistochem.  We studied the impact of this inhibition on cell viability in vitro and on tumor growth in ESFT xenograft models in vivo (n = 15-20 mice per group).  All statistical tests were two-sided.  Results Mithramycin inhibited expression of EWS-FLI1 downstream targets at the mRNA and protein levels and decreased the growth of ESFT cells at half maximal inhibitory concns. between 10 (95% confidence interval [CI] = 8 to 13 nM) and 15 nM (95% CI = 13 to 19 nM).  Mithramycin suppressed the growth of two different ESFT xenograft tumors and prolonged the survival of ESFT xenograft-bearing mice by causing a decrease in mean tumor vol.  For example, in the TC32 xenograft model, on day 15 of treatment, the mean tumor vol. for the mithramycin-treated mice was approx. 3% of the tumor vol. obsd. in the control mice (mithramycin vs control: 69 vs 2388 mm3, difference = 2319 mm3, 95% CI = 1766 to 2872 mm3, P < .001).  Conclusion Mithramycin inhibits EWS-FLI1 activity and demonstrates ESFT antitumor activity both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-zpZMmMy4bLVg90H21EOLACvtfcHk0lh8y63g2ril3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cltro%253D&md5=814cc95d2b54de9b275cc1df8a1b19ee</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjr156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjr156%26sid%3Dliteratum%253Aachs%26aulast%3DGrohar%26aufirst%3DP.%2BJ.%26aulast%3DWoldemichael%26aufirst%3DG.%2BM.%26aulast%3DGriffin%26aufirst%3DL.%2BB.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DQ.-R.%26aulast%3DYeung%26aufirst%3DC.%26aulast%3DCurrier%26aufirst%3DD.%2BG.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DKhanna%26aufirst%3DC.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26atitle%3DIdentification%2520of%2520an%2520inhibitor%2520of%2520the%2520EWS-FLI1%2520oncogenic%2520transcription%2520factor%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2011%26volume%3D103%26spage%3D962%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sastry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. J.</span><span> </span><span class="NLM_article-title">Solution structure of the mithramycin dimer–DNA complex</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">6588</span><span class="NLM_x">–</span> <span class="NLM_lpage">6604</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00077a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=6588-6604&author=M.+Sastryauthor=D.+J.+Patel&title=Solution+structure+of+the+mithramycin+dimer%E2%80%93DNA+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbi00077a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00077a012%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26atitle%3DSolution%2520structure%2520of%2520the%2520mithramycin%2520dimer%25E2%2580%2593DNA%2520complex%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D6588%26epage%3D6604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sastry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. J.</span><span> </span><span class="NLM_article-title">Solution structure of mithramycin dimers bound to partially overlapping sites on DNA</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">–</span> <span class="NLM_lpage">689</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1995&pages=674-689&author=M.+Sastryauthor=R.+Fialaauthor=D.+J.+Patel&title=Solution+structure+of+mithramycin+dimers+bound+to+partially+overlapping+sites+on+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DM.%26aulast%3DFiala%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26atitle%3DSolution%2520structure%2520of%2520mithramycin%2520dimers%2520bound%2520to%2520partially%2520overlapping%2520sites%2520on%2520DNA%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D251%26spage%3D674%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Barcelo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Lombardía, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portugal, J.</span><span> </span><span class="NLM_article-title">Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2215</span><span class="NLM_x">–</span> <span class="NLM_lpage">2226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=2215-2226&author=F.+Barceloauthor=C.+Scottaauthor=M.+Ortiz-Lombard%C3%ADaauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Portugal&title=Entropically-driven+binding+of+mithramycin+in+the+minor+groove+of+C%2FG-rich+DNA+sequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarcelo%26aufirst%3DF.%26aulast%3DScotta%26aufirst%3DC.%26aulast%3DOrtiz-Lombard%25C3%25ADa%26aufirst%3DM.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DPortugal%26aufirst%3DJ.%26atitle%3DEntropically-driven%2520binding%2520of%2520mithramycin%2520in%2520the%2520minor%2520groove%2520of%2520C%252FG-rich%2520DNA%2520sequences%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3D2215%26epage%3D2226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Barcelo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Lombardia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martorell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portugal, J.</span><span> </span><span class="NLM_article-title">DNA binding characteristics of mithramycin and chromomycin analogues obtained by combinatorial biosynthesis</span> <span class="citation_source-journal">Biochemistry.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">10543</span><span class="NLM_x">–</span> <span class="NLM_lpage">1055</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi101398s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=10543-1055&author=F.+Barceloauthor=M.+Ortiz-Lombardiaauthor=M.+Martorellauthor=M.+Oliverauthor=C.+Mendezauthor=J.+A.+Salasauthor=J.+Portugal&title=DNA+binding+characteristics+of+mithramycin+and+chromomycin+analogues+obtained+by+combinatorial+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi101398s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi101398s%26sid%3Dliteratum%253Aachs%26aulast%3DBarcelo%26aufirst%3DF.%26aulast%3DOrtiz-Lombardia%26aufirst%3DM.%26aulast%3DMartorell%26aufirst%3DM.%26aulast%3DOliver%26aufirst%3DM.%26aulast%3DMendez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DPortugal%26aufirst%3DJ.%26atitle%3DDNA%2520binding%2520characteristics%2520of%2520mithramycin%2520and%2520chromomycin%2520analogues%2520obtained%2520by%2520combinatorial%2520biosynthesis%26jtitle%3DBiochemistry.%26date%3D2010%26volume%3D49%26spage%3D10543%26epage%3D1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mansilla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ferrer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portugal, J.</span><span> </span><span class="NLM_article-title">Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure–activity relationships</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1418</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1418-1427&author=S.+Mansillaauthor=I.+Garcia-Ferrerauthor=C.+Mendezauthor=J.+A.+Salasauthor=J.+Portugal&title=Differential+inhibition+of+restriction+enzyme+cleavage+by+chromophore-modified+analogues+of+the+antitumour+antibiotics+mithramycin+and+chromomycin+reveals+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMansilla%26aufirst%3DS.%26aulast%3DGarcia-Ferrer%26aufirst%3DI.%26aulast%3DMendez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DPortugal%26aufirst%3DJ.%26atitle%3DDifferential%2520inhibition%2520of%2520restriction%2520enzyme%2520cleavage%2520by%2520chromophore-modified%2520analogues%2520of%2520the%2520antitumour%2520antibiotics%2520mithramycin%2520and%2520chromomycin%2520reveals%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1418%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Yuan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span> </span><span class="NLM_article-title">Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin A correlates directly with potent antiangiogenic effects on human pancreatic cancer</span> <span class="citation_source-journal">Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2007&pages=2682-2690&author=P.+Yuanauthor=L.+Wangauthor=D.+Weiauthor=J.+Zhangauthor=Z.+Jiaauthor=Q.+Liauthor=X.+Leauthor=H.+Wangauthor=J.+Yaoauthor=K.+Xie&title=Therapeutic+inhibition+of+Sp1+expression+in+growing+tumors+by+mithramycin+A+correlates+directly+with+potent+antiangiogenic+effects+on+human+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLe%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DK.%26atitle%3DTherapeutic%2520inhibition%2520of%2520Sp1%2520expression%2520in%2520growing%2520tumors%2520by%2520mithramycin%2520A%2520correlates%2520directly%2520with%2520potent%2520antiangiogenic%2520effects%2520on%2520human%2520pancreatic%2520cancer%26jtitle%3DCancer.%26date%3D2007%26volume%3D110%26spage%3D2682%26epage%3D2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Campbell, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Patterson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayfield, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramoto, R. A.</span><span> </span><span class="NLM_article-title">The G-C specific DNA binding drug, mithramycin, selectively inhibits transcription of the c-myc and c-ha-ras genes in regenerating liver</span> <span class="citation_source-journal">Am. J. Med. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=1994&pages=167-172&author=V.+W.+Campbellauthor=D.+Davinauthor=S.+Thomasauthor=D.+Jonesauthor=J.+Roeselauthor=R.+Tran-Pattersonauthor=C.+A.+Mayfieldauthor=B.+Roduauthor=D.+M.+Millerauthor=R.+A.+Hiramoto&title=The+G-C+specific+DNA+binding+drug%2C+mithramycin%2C+selectively+inhibits+transcription+of+the+c-myc+and+c-ha-ras+genes+in+regenerating+liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DV.%2BW.%26aulast%3DDavin%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DTran-Patterson%26aufirst%3DR.%26aulast%3DMayfield%26aufirst%3DC.%2BA.%26aulast%3DRodu%26aufirst%3DB.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DHiramoto%26aufirst%3DR.%2BA.%26atitle%3DThe%2520G-C%2520specific%2520DNA%2520binding%2520drug%252C%2520mithramycin%252C%2520selectively%2520inhibits%2520transcription%2520of%2520the%2520c-myc%2520and%2520c-ha-ras%2520genes%2520in%2520regenerating%2520liver%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D1994%26volume%3D307%26spage%3D167%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lee, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, T. K.</span><span> </span><span class="NLM_article-title">Mithramycin a sensitizes cancer cells to trail-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2737</span><span class="NLM_x">–</span> <span class="NLM_lpage">2746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1158%2F1535-7163.MCT-06-0426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=17121920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2737-2746&author=T.+J.+Leeauthor=E.+M.+Jungauthor=J.+T.+Leeauthor=S.+Kimauthor=J.+W.+Parkauthor=K.+S.+Choiauthor=T.+K.+Kwon&title=Mithramycin+a+sensitizes+cancer+cells+to+trail-mediated+apoptosis+by+down-regulation+of+XIAP+gene+promoter+through+Sp1+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites</span></div><div class="casAuthors">Lee, Tae-Jin; Jung, Eun Mi; Lee, Jung Tae; Kim, Shin; Park, Jong-Wook; Choi, Kyeong Sook; Kwon, Taeg Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2737-2746</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mithramycin A is a DNA-binding antitumor agent, which has been clin. used in the therapies of several types of cancer and Paget's disease.  In this study, we investigated the combined effect of mithramycin A and tumor necrosis factor-α-related apoptosis-inducing ligand (TRAIL) on apoptosis of cancer cells.  In Caki renal cancer cells, which are resistant to TRAIL, cotreatment with subtoxic doses of mithramycin A and TRAIL resulted in a marked increase in apoptosis.  This combined treatment was also cytotoxic to Caki cells overexpressing Bcl-2 but not to normal mesengial cells.  Moreover, apoptosis by the combined treatment with mithramycin A and TRAIL was dramatically induced in various cancer cell types, thus offering an attractive strategy for safely treating malignant tumors.  Mithramycin A-stimulated TRAIL-induced apoptosis was blocked by pretreatment with the broad caspase inhibitor zVAD-fmk or Crm-A overexpression, showing its dependence on caspases.  We found that mithramycin A selectively down-regulated XIAP protein levels in various cancer cells.  Luciferase reporter assay and the chromatin immunopptn. assay using the XIAP promoter constructs show that mithramycin A down-regulates the transcription of XIAP gene through inhibition of Sp1 binding to its promoter.  Although XIAP overexpression significantly attenuated apoptosis induced by mithramycin A plus TRAIL, suppression of XIAP expression by transfection with its small interfering RNA prominently enhanced TRAIL-induced apoptosis.  We present here for the first time that mithramycin A-induced suppression of XIAP transcription plays a crit. role in the recovery of TRAIL sensitivity in various cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK5M6doV-akLVg90H21EOLACvtfcHk0lgf7keZa1S9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7nF&md5=34085e84a62a4d48f5e119646ff0130e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0426%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%2BJ.%26aulast%3DJung%26aufirst%3DE.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DChoi%26aufirst%3DK.%2BS.%26aulast%3DKwon%26aufirst%3DT.%2BK.%26atitle%3DMithramycin%2520a%2520sensitizes%2520cancer%2520cells%2520to%2520trail-mediated%2520apoptosis%2520by%2520down-regulation%2520of%2520XIAP%2520gene%2520promoter%2520through%2520Sp1%2520sites%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2737%26epage%3D2746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Koutsodontis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardassis, D.</span><span> </span><span class="NLM_article-title">Inhibition of p53-mediated transcriptional responses by mithramycin A</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">9190</span><span class="NLM_x">–</span> <span class="NLM_lpage">9200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=9190-9200&author=G.+Koutsodontisauthor=D.+Kardassis&title=Inhibition+of+p53-mediated+transcriptional+responses+by+mithramycin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoutsodontis%26aufirst%3DG.%26aulast%3DKardassis%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520p53-mediated%2520transcriptional%2520responses%2520by%2520mithramycin%2520A%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D9190%26epage%3D9200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tagashira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isonishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, Y.</span><span> </span><span class="NLM_article-title">Mithramycin represses MDR1 gene expression in vitro, modulating multidrug resistance</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1248%2Fbpb.23.926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=10963297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFams74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=926-929&author=M.+Tagashiraauthor=T.+Kitagawaauthor=S.+Isonishiauthor=A.+Okamotoauthor=K.+Ochiaiauthor=Y.+Ohtake&title=Mithramycin+represses+MDR1+gene+expression+in+vitro%2C+modulating+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin represses MDR1 gene expression in vitro, modulating multidrug resistance</span></div><div class="casAuthors">Tagashira, Motoyuki; Kitagawa, Takanori; Isonishi, Seiji; Okamoto, Aikou; Ochiai, Kazunori; Ohtake, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">926-929</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">The effect of an aureolic acid, mithramycin (MTM) on multidrug resistance (MDR) was investigated.  At a concn. of 0.02-0.1 mg/mL (about 20-90 μM), MTM repressed MDR1 gene transcription of SBC-3/ADM, a MDR-phenotype subline derived from human small cell lung tumor.  Under the same conditions, another aureolic acid, chromomycin A3, showed potent cytotoxicity.  FACS anal. revealed that 5 μM MTM depleted the P-glycoprotein (Pgp) and lowered the efflux activity of SBC-3/ADM cells.  Furthermore, MTM sensitized the cells against adriamycin.  These results suggest that MTM would be a useful modulator of MDR induced by Pgp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUEzU6wPRQzLVg90H21EOLACvtfcHk0lim-QshqgP2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFams74%253D&md5=08874e766fa2354c9b77f18dadf93c1e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1248%2Fbpb.23.926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.23.926%26sid%3Dliteratum%253Aachs%26aulast%3DTagashira%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DT.%26aulast%3DIsonishi%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DOhtake%26aufirst%3DY.%26atitle%3DMithramycin%2520represses%2520MDR1%2520gene%2520expression%2520in%2520vitro%252C%2520modulating%2520multidrug%2520resistance%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2000%26volume%3D23%26spage%3D926%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Sleiman, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payappilly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, J. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahishi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLellan, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratan, R. R.</span><span> </span><span class="NLM_article-title">Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">6858</span><span class="NLM_x">–</span> <span class="NLM_lpage">6870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1523%2FJNEUROSCI.0710-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21543616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFSjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=6858-6870&author=S.+F.+Sleimanauthor=B.+C.+Langleyauthor=M.+Bassoauthor=J.+Berlinauthor=L.+Xiaauthor=J.+B.+Payappillyauthor=M.+K.+Kharelauthor=H.+Guoauthor=J.+L+Marshauthor=L.+M.+Thompsonauthor=L.+Mahishiauthor=P.+Ahujaauthor=W.+R.+MacLellanauthor=D.+H.+Geschwindauthor=G.+Coppolaauthor=J.+Rohrauthor=R.+R.+Ratan&title=Mithramycin+is+a+gene-selective+Sp1+inhibitor+that+identifies+a+biological+intersection+between+cancer+and+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration</span></div><div class="casAuthors">Sleiman, Sama F.; Langley, Brett C.; Basso, Manuela; Berlin, Jill; Xia, Li; Payappilly, Jimmy B.; Kharel, Madan K.; Guo, Hengchang; Marsh, J. Lawrence; Thompson, Leslie Michels; Mahishi, Lata; Ahuja, Preeti; MacLellan, W. Robb; Geschwind, Daniel H.; Coppola, Giovanni; Rohr, Jurgen; Ratan, Rajiv R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6858-6870</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Oncogenic transformation of postmitotic neurons triggers cell death, but the identity of genes crit. for degeneration remain unclear.  The antitumor antibiotic mithramycin prolongs survival of mouse models of Huntington's disease in vivo and inhibits oxidative stress-induced death in cortical neurons in vitro.  We had correlated protection by mithramycin with its ability to bind to GC-rich DNA and globally displace Sp1 family transcription factors.  To understand how antitumor drugs prevent neurodegeneration, here we use structure-activity relationships of mithramycin analogs to discover that selective DNA-binding inhibition of the drug is necessary for its neuroprotective effect.  We identify several genes (Myc, c-Src, Hif1α, and p21waf1/cip1) involved in neoplastic transformation, whose altered expression correlates with protective doses of mithramycin or its analogs.  Most interestingly, inhibition of one these genes, Myc, is neuroprotective, whereas forced expression of Myc induces Rattus norvegicus neuronal cell death.  These results support a model in which cancer cell transformation shares key genetic components with neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4m3lCFV2e-7Vg90H21EOLACvtfcHk0lim-QshqgP2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFSjtrw%253D&md5=6f9d0560b679b6b50b37a982e49cb59f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0710-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0710-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DSleiman%26aufirst%3DS.%2BF.%26aulast%3DLangley%26aufirst%3DB.%2BC.%26aulast%3DBasso%26aufirst%3DM.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DPayappilly%26aufirst%3DJ.%2BB.%26aulast%3DKharel%26aufirst%3DM.%2BK.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DMarsh%26aufirst%3DJ.%2BL%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DMahishi%26aufirst%3DL.%26aulast%3DAhuja%26aufirst%3DP.%26aulast%3DMacLellan%26aufirst%3DW.%2BR.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DCoppola%26aufirst%3DG.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DRatan%26aufirst%3DR.%2BR.%26atitle%3DMithramycin%2520is%2520a%2520gene-selective%2520Sp1%2520inhibitor%2520that%2520identifies%2520a%2520biological%2520intersection%2520between%2520cancer%2520and%2520neurodegeneration%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D6858%26epage%3D6870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wohlert, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machinek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">The structure of mithramycin reinvestigated</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/doi/10.1021/np980355k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=119-121&author=S.+E.+Wohlertauthor=E.+K%C3%BCnzelauthor=R.+Machinekauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=The+structure+of+mithramycin+reinvestigated"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fnp980355k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp980355k%26sid%3Dliteratum%253Aachs%26aulast%3DWohlert%26aufirst%3DS.%2BE.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DMachinek%26aufirst%3DR.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DThe%2520structure%2520of%2520mithramycin%2520reinvestigated%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1999%26volume%3D62%26spage%3D119%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menéndez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives</span> <span class="citation_source-journal">Appl. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2006&pages=1-14&author=F.+Lomb%C3%B3author=N.+Men%C3%A9ndezauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=The+aureolic+acid+family+of+antitumor+compounds%3A+structure%2C+mode+of+action%2C+biosynthesis%2C+and+novel+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DN.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DThe%2520aureolic%2520acid%2520family%2520of%2520antitumor%2520compounds%253A%2520structure%252C%2520mode%2520of%2520action%252C%2520biosynthesis%252C%2520and%2520novel%2520derivatives%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2006%26volume%3D73%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindseil, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frevert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">The novel hybrid antitumor compound premithramycinone H provides indirect evidence for a tricyclic intermediate of the biosynthesis of the aureolic acid antibiotic mithramycin</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">796</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=796-799&author=F.+Lomb%C3%B3author=E.+K%C3%BCnzelauthor=L.+Pradoauthor=A.+F.+Bra%C3%B1aauthor=K.+U.+Bindseilauthor=J.+Frevertauthor=D.+Beardenauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=The+novel+hybrid+antitumor+compound+premithramycinone+H+provides+indirect+evidence+for+a+tricyclic+intermediate+of+the+biosynthesis+of+the+aureolic+acid+antibiotic+mithramycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DPrado%26aufirst%3DL.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DBindseil%26aufirst%3DK.%2BU.%26aulast%3DFrevert%26aufirst%3DJ.%26aulast%3DBearden%26aufirst%3DD.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DThe%2520novel%2520hybrid%2520antitumor%2520compound%2520premithramycinone%2520H%2520provides%2520indirect%2520evidence%2520for%2520a%2520tricyclic%2520intermediate%2520of%2520the%2520biosynthesis%2520of%2520the%2520aureolic%2520acid%2520antibiotic%2520mithramycin%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2000%26volume%3D39%26spage%3D796%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Remsing, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nur-e-Alam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Lozano, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer <i>Streptomyces argillaceus</i> through combinatorial biosynthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">5745</span><span class="NLM_x">–</span> <span class="NLM_lpage">5753</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja034162h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=5745-5753&author=L.+L.+Remsingauthor=A.+M.+Gonz%C3%A1lezauthor=M.+Nur-e-Alamauthor=M.+J.+Fern%C3%A1ndez-Lozanoauthor=A.+F.+Bra%C3%B1aauthor=U.+Rixauthor=M.+A.+Oliveiraauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=Mithramycin+SK%2C+a+novel+antitumor+drug+with+improved+therapeutic+index%2C+mithramycin+SA%2C+and+demycarosyl-mithramycin+SK%3A+three+new+products+generated+in+the+mithramycin+producer+Streptomyces+argillaceus+through+combinatorial+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin SK, A Novel Antitumor Drug with Improved Therapeutic Index, Mithramycin SA, and Demycarosyl-mithramycin SK: Three New Products Generated in the Mithramycin Producer Streptomyces argillaceus through Combinatorial Biosynthesis</span></div><div class="casAuthors">Remsing, Lily L.; Gonzalez, Ana M.; Nur-e-Alam, Mohammad; Fernandez-Lozano, M. Jose; Brana, Alfredo F.; Rix, Uwe; Oliveira, Marcos A.; Mendez, Carmen; Salas, Jose A.; Rohr, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5745-5753</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To gain initial structure-activity relationships regarding the highly functionalized pentyl side chain attached at C-3 of mithramycin (MTM), we focused on a post-polyketide synthase (post-PKS) tailoring step of the MTM biosynthesis by Streptomyces argillaceus ATCC 12956, which was proposed to be catalyzed by ketoreductase (KR) MtmW.  In this last step of the MTM biosynthesis, a keto group of the pentyl side chain is reduced to a secondary alc., and we anticipated the generation of an MTM deriv. with an addnl. keto group in the 3-side chain.  Insertional inactivation of mtmW, a gene located ∼8 kb downstream of the mithramycin-PKS genes, yielded an S. argillaceus mutant, which accumulated three new mithramycin analogs, namely mithramycin SA, demycarosyl-mithramycin SK, and mithramycin SK (MTM-SK).  The structures of these three compds. confirmed indirectly the proposed role of MtmW in MTM biosynthesis.  However, the new mithramycin derivs. bear unexpectedly shorter 3-side chains (Et or butyl) than MTM, presumably caused by nonenzymic rearrangement or cleavage reactions of the initially formed pentyl side chain with a reactive β-dicarbonyl functional group.  The major product, MTM-SK, was tested in vitro against a variety of human cancer cell lines, as well as in an in vitro toxicity assay, and showed an improved therapeutic index, in comparison to the parent drug, MTM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNPA1wWdO_uLVg90H21EOLACvtfcHk0lh1fGq-iaH71A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFGnsr0%253D&md5=030ab7acf1d1e6315ae6273120193bc0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja034162h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja034162h%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DA.%2BM.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez-Lozano%26aufirst%3DM.%2BJ.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DOliveira%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DMithramycin%2520SK%252C%2520a%2520novel%2520antitumor%2520drug%2520with%2520improved%2520therapeutic%2520index%252C%2520mithramycin%2520SA%252C%2520and%2520demycarosyl-mithramycin%2520SK%253A%2520three%2520new%2520products%2520generated%2520in%2520the%2520mithramycin%2520producer%2520Streptomyces%2520argillaceus%2520through%2520combinatorial%2520biosynthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D5745%26epage%3D5753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Baig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomathinayagam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damodaran, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/doi/10.1021/np0705763" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=199-207&author=I.+Baigauthor=M.+Perezauthor=A.+F.+Bra%C3%B1aauthor=R.+Gomathinayagamauthor=C.+Damodaranauthor=J.+A.+Salasauthor=C.+M%C3%A9ndezauthor=J.+Rohr&title=Mithramycin+analogues+generated+by+combinatorial+biosynthesis+show+improved+bioactivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fnp0705763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp0705763%26sid%3Dliteratum%253Aachs%26aulast%3DBaig%26aufirst%3DI.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DGomathinayagam%26aufirst%3DR.%26aulast%3DDamodaran%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DMithramycin%2520analogues%2520generated%2520by%2520combinatorial%2520biosynthesis%2520show%2520improved%2520bioactivity%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2008%26volume%3D71%26spage%3D199%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Pérez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2295</span><span class="NLM_x">–</span> <span class="NLM_lpage">2304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2295-2304&author=M.+P%C3%A9rezauthor=I.+Baigauthor=A.+F.+Bra%C3%B1aauthor=J.+A.+Salasauthor=J.+Rohrauthor=C.+M%C3%A9ndez&title=Generation+of+new+derivatives+of+the+antitumor+antibiotic+mithramycin+by+altering+the+glycosylation+pattern+through+combinatorial+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DBaig%26aufirst%3DI.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DGeneration%2520of%2520new%2520derivatives%2520of%2520the%2520antitumor%2520antibiotic%2520mithramycin%2520by%2520altering%2520the%2520glycosylation%2520pattern%2520through%2520combinatorial%2520biosynthesis%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D2295%26epage%3D2304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">García, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Sabín, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menéndez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morís, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">The chromomycin CmmA acetyltransferase: a membrane-bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin</span> <span class="citation_source-journal">Microb. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1111%2Fj.1751-7915.2010.00229.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=21342468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1Wqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=226-238&author=B.+Garc%C3%ADaauthor=J.+Gonz%C3%A1lez-Sab%C3%ADnauthor=N.+Men%C3%A9ndezauthor=A.+F.+Bra%C3%B1aauthor=L.+E.+N%C3%BA%C3%B1ezauthor=F.+Mor%C3%ADsauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=The+chromomycin+CmmA+acetyltransferase%3A+a+membrane-bound+enzyme+as+a+tool+for+increasing+structural+diversity+of+the+antitumour+mithramycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The chromomycin CmmA acetyltransferase: a membrane-bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin</span></div><div class="casAuthors">Garcia, Beatriz; Gonzalez-Sabin, Javier; Menendez, Nuria; Brana, Alfredo F.; Nunez, Luz Elena; Moris, Francisco; Salas, Jose A.; Mendez, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Microbial Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-238</span>CODEN:
                <span class="NLM_cas:coden">MBIIB2</span>;
        ISSN:<span class="NLM_cas:issn">1751-7915</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mithramycin and chromomycin A3 are two structurally related antitumor compds., which differ in the glycosylation profiles and functional group substitutions of the sugars.  Chromomycin contains two acetyl groups, which are incorporated during the biosynthesis by the acetyltransferase CmmA in Streptomyces griseus ssp. griseus.  A bioconversion strategy using an engineered S. griseus strain generated seven novel acetylated mithramycins.  The newly formed compds. were purified and characterized by MS and NMR.  These new compds. differ from their parental compds. in the presence of one, two or three acetyl groups, attached at 3E, 4E and/or 4D positions.  All new mithramycin analogs showed antitumor activity at micromolar of lower concns.  Some of the compds. showed improved activities against glioblastoma or pancreas tumor cells.  The CmmA acetyltransferase was located in the cell membrane and was shown to accept several acylCoA substrates.  All these results highlight the potential of CmmA as a tool to create structural diversity in these antitumor compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohBEOoyC707LVg90H21EOLACvtfcHk0lgVGOu4rtpNtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1Wqu78%253D&md5=9fc271fec554c4a1e51d9c344c66fdf8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-7915.2010.00229.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-7915.2010.00229.x%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%26aufirst%3DB.%26aulast%3DGonz%25C3%25A1lez-Sab%25C3%25ADn%26aufirst%3DJ.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DN.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DL.%2BE.%26aulast%3DMor%25C3%25ADs%26aufirst%3DF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DThe%2520chromomycin%2520CmmA%2520acetyltransferase%253A%2520a%2520membrane-bound%2520enzyme%2520as%2520a%2520tool%2520for%2520increasing%2520structural%2520diversity%2520of%2520the%2520antitumour%2520mithramycin%26jtitle%3DMicrob.%2520Biotechnol.%26date%3D2011%26volume%3D4%26spage%3D226%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Remsing, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahadori, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuffie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catapano, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">Inhibition of c-src transcription by mithramycin: structure–activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">8313</span><span class="NLM_x">–</span> <span class="NLM_lpage">8324</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi034091z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=8313-8324&author=L.+L.+Remsingauthor=H.+R.+Bahadoriauthor=G.+M.+Carboneauthor=E.+M.+McGuffieauthor=C.+V.+Catapanoauthor=J.+Rohr&title=Inhibition+of+c-src+transcription+by+mithramycin%3A+structure%E2%80%93activity+relationships+of+biosynthetically+produced+mithramycin+analogues+using+the+c-src+promoter+as+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi034091z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi034091z%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DBahadori%26aufirst%3DH.%2BR.%26aulast%3DCarbone%26aufirst%3DG.%2BM.%26aulast%3DMcGuffie%26aufirst%3DE.%2BM.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520c-src%2520transcription%2520by%2520mithramycin%253A%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520biosynthetically%2520produced%2520mithramycin%2520analogues%2520using%2520the%2520c-src%2520promoter%2520as%2520target%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D8313%26epage%3D8324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Mir, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, D.</span><span> </span><span class="NLM_article-title">Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2791</span><span class="NLM_x">–</span> <span class="NLM_lpage">2801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2791-2801&author=M.+A.+Mirauthor=S.+Majeeauthor=S.+Dasauthor=D.+Dasgupta&title=Association+of+chromatin+with+anticancer+antibiotics%2C+mithramycin+and+chromomycin+A3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMir%26aufirst%3DM.%2BA.%26aulast%3DMajee%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DDasgupta%26aufirst%3DD.%26atitle%3DAssociation%2520of%2520chromatin%2520with%2520anticancer%2520antibiotics%252C%2520mithramycin%2520and%2520chromomycin%2520A3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2791%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Majee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, D.</span><span> </span><span class="NLM_article-title">Differential interactions of the Mg<sup>2+</sup> complexes of chromomycin A3 and mithramycin with poly(dG-dC) × poly(dC-dG) and poly(dG) × poly(dC)</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2291</span><span class="NLM_x">–</span> <span class="NLM_lpage">2299</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi9613281" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=2291-2299&author=S.+Majeeauthor=R.+Senauthor=S.+Guhaauthor=D.+Bhattacharyyaauthor=D.+Dasgupta&title=Differential+interactions+of+the+Mg2%2B+complexes+of+chromomycin+A3+and+mithramycin+with+poly%28dG-dC%29+%C3%97+poly%28dC-dG%29+and+poly%28dG%29+%C3%97+poly%28dC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi9613281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9613281%26sid%3Dliteratum%253Aachs%26aulast%3DMajee%26aufirst%3DS.%26aulast%3DSen%26aufirst%3DR.%26aulast%3DGuha%26aufirst%3DS.%26aulast%3DBhattacharyya%26aufirst%3DD.%26aulast%3DDasgupta%26aufirst%3DD.%26atitle%3DDifferential%2520interactions%2520of%2520the%2520Mg2%252B%2520complexes%2520of%2520chromomycin%2520A3%2520and%2520mithramycin%2520with%2520poly%2528dG-dC%2529%2520%25C3%2597%2520poly%2528dC-dG%2529%2520and%2520poly%2528dG%2529%2520%25C3%2597%2520poly%2528dC%2529%26jtitle%3DBiochemistry%26date%3D1997%26volume%3D36%26spage%3D2291%26epage%3D2299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Sugar biosynthesis and modification</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=277-307&author=F.+Lomb%C3%B3author=C.+Olanoauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=Sugar+biosynthesis+and+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DOlano%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DSugar%2520biosynthesis%2520and%2520modification%26jtitle%3DMethods%2520Enzymol.%26date%3D2009%26volume%3D458%26spage%3D277%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">González, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remsing, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span> </span><span class="NLM_article-title">The <i>mtmVUC</i> genes of the mithramycin gene cluster in <i>Streptomyces argillaceus</i> are involved in the biosynthesis of the sugar moieties</span> <span class="citation_source-journal">Mol. Gen. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1007%2Fs004380000372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=11254130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslyntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=2001&pages=827-835&author=A.+Gonz%C3%A1lezauthor=L.+L.+Remsingauthor=F.+Lomb%C3%B3author=M.+J.+Fern%C3%A1ndezauthor=L.+Pradoauthor=A.+F.+Bra%C3%B1aauthor=E.+K%C3%BCnzelauthor=J.+Rohrauthor=C.+M%C3%A9ndezauthor=J.+A.+Salas&title=The+mtmVUC+genes+of+the+mithramycin+gene+cluster+in+Streptomyces+argillaceus+are+involved+in+the+biosynthesis+of+the+sugar+moieties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The mtmVUC genes of the mithramycin gene cluster in Streptomyces argillaceus are involved in the biosynthesis of the sugar moieties</span></div><div class="casAuthors">Gonzalez, A.; Remsing, L. L.; Lombo, F.; Fernandez, M. J.; Prado, L.; Brana, A. F.; Kunzel, E.; Rohr, J.; Mendez, C.; Salas, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and General Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">827-835</span>CODEN:
                <span class="NLM_cas:coden">MGGEAE</span>;
        ISSN:<span class="NLM_cas:issn">0026-8925</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Mithramycin is a glycosylated arom. polyketide produced by Streptomyces argillaceus, and is used as an antitumor drug.  Three genes (mtmV, mtmU and mtmC) from the mithramycin gene cluster have been cloned, and characterized by DNA sequencing and by anal. of the products that accumulate in nonproducing mutants, which were generated by insertional inactivation of these genes.  The mtmV gene codes for a 2,3-dehydratase that catalyzes early and common steps in the biosynthesis of the three sugars found in mithramycin (D-olivose, D-oliose and D-mycarose); its inactivation caused the accumulation of the nonglycosylated intermediate premithramycinone.  The mtmU gene codes for a 4-ketoreductase involved in D-oliose biosynthesis, and its inactivation resulted in the accumulation of premithramycinone and premithramycin A1, the first glycosylated intermediate which contains a D-olivose unit.  The third gene, mtmC, is involved in D-mycarose biosynthesis and codes for a C-methyltransferase.  Two mutants with lesions in the mtmC gene accumulated mithramycin intermediates lacking the D-mycarose moiety but contg. D-olivose units attached to C-12a in which the 4-keto group is unreduced.  This suggests that mtmC could code for a second enzyme activity, probably a D-olivose 4-ketoreductase, and that the glycosyltransferase responsible for the incorporation of D-olivose (MtmGIV) shows some degree of flexibility with respect to its sugar co-substrate, since the 4-ketoanalog is also transferred.  A pathway is proposed for the biosynthesis of the three sugar moieties in mithramycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp7T9VoSnesbVg90H21EOLACvtfcHk0lhDwj1K11ujGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslyntLw%253D&md5=a38f2669856f390138162fd21deb6ceb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs004380000372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004380000372%26sid%3Dliteratum%253Aachs%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DA.%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DM.%2BJ.%26aulast%3DPrado%26aufirst%3DL.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520mtmVUC%2520genes%2520of%2520the%2520mithramycin%2520gene%2520cluster%2520in%2520Streptomyces%2520argillaceus%2520are%2520involved%2520in%2520the%2520biosynthesis%2520of%2520the%2520sugar%2520moieties%26jtitle%3DMol.%2520Gen.%2520Genet.%26date%3D2001%26volume%3D264%26spage%3D827%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Remsing, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bernardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearden, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span> </span><span class="NLM_article-title">Ketopremithramycins and ketomithramycins, four new aureolic acid-type compounds obtained upon inactivation of two genes involved in the biosynthesis of the deoxysugar moieties of the antitumor drug mithramycin by <i>Streptomyces argillaceus</i>, reveal novel insights into post-PKS tailoring steps of the mithramycin biosynthetic pathway</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1606</span><span class="NLM_x">–</span> <span class="NLM_lpage">1614</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0105156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=1606-1614&author=L.+L.+Remsingauthor=J.+Garcia-Bernardoauthor=A.+Gonzalezauthor=E.+K%C3%BCnzelauthor=U.+Rixauthor=A.+F.+Bra%C3%B1aauthor=D.+W.+Beardenauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=Ketopremithramycins+and+ketomithramycins%2C+four+new+aureolic+acid-type+compounds+obtained+upon+inactivation+of+two+genes+involved+in+the+biosynthesis+of+the+deoxysugar+moieties+of+the+antitumor+drug+mithramycin+by+Streptomyces+argillaceus%2C+reveal+novel+insights+into+post-PKS+tailoring+steps+of+the+mithramycin+biosynthetic+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja0105156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0105156%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DGarcia-Bernardo%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DBearden%26aufirst%3DD.%2BW.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DKetopremithramycins%2520and%2520ketomithramycins%252C%2520four%2520new%2520aureolic%2520acid-type%2520compounds%2520obtained%2520upon%2520inactivation%2520of%2520two%2520genes%2520involved%2520in%2520the%2520biosynthesis%2520of%2520the%2520deoxysugar%2520moieties%2520of%2520the%2520antitumor%2520drug%2520mithramycin%2520by%2520Streptomyces%2520argillaceus%252C%2520reveal%2520novel%2520insights%2520into%2520post-PKS%2520tailoring%2520steps%2520of%2520the%2520mithramycin%2520biosynthetic%2520pathway%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D1606%26epage%3D1614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Pérez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr., J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas., J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Combining sugar biosynthesis genes for the generation of <span class="smallcaps smallerCapital">l</span>- and <span class="smallcaps smallerCapital">d</span>-amicetose and formation of two novel antitumor tetracenomycins</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">1604</span><span class="NLM_x">–</span> <span class="NLM_lpage">1606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=1604-1606&author=M.+P%C3%A9rezauthor=F.+Lomb%C3%B3author=L.+Zhuauthor=M.+Gibsonauthor=A.+F.+Bra%C3%B1aauthor=J.+Rohr.author=J.+A.+Salas.author=C.+M%C3%A9ndez&title=Combining+sugar+biosynthesis+genes+for+the+generation+of+l-+and+d-amicetose+and+formation+of+two+novel+antitumor+tetracenomycins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DGibson%26aufirst%3DM.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRohr.%26aufirst%3DJ.%26aulast%3DSalas.%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DCombining%2520sugar%2520biosynthesis%2520genes%2520for%2520the%2520generation%2520of%2520l-%2520and%2520d-amicetose%2520and%2520formation%2520of%2520two%2520novel%2520antitumor%2520tetracenomycins%26jtitle%3DChem.%2520Commun.%26date%3D2005%26spage%3D1604%26epage%3D1606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Pérez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Combinatorial biosynthesis of antitumor deoxysugar pathways in <i>Streptomyces griseus</i>: reconstitution of “unnatural natural gene clusters” for the biosynthesis of four 2,6-<span class="smallcaps smallerCapital">d</span>-dideoxyhexoses</span> <span class="citation_source-journal">Appl. Environ. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">6644</span><span class="NLM_x">–</span> <span class="NLM_lpage">6652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=6644-6652&author=M.+P%C3%A9rezauthor=F.+Lomb%C3%B3author=I.+Baigauthor=A.+F.+Bra%C3%B1aauthor=J.+Rohrauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=Combinatorial+biosynthesis+of+antitumor+deoxysugar+pathways+in+Streptomyces+griseus%3A+reconstitution+of+%E2%80%9Cunnatural+natural+gene+clusters%E2%80%9D+for+the+biosynthesis+of+four+2%2C6-d-dideoxyhexoses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DBaig%26aufirst%3DI.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DCombinatorial%2520biosynthesis%2520of%2520antitumor%2520deoxysugar%2520pathways%2520in%2520Streptomyces%2520griseus%253A%2520reconstitution%2520of%2520%25E2%2580%259Cunnatural%2520natural%2520gene%2520clusters%25E2%2580%259D%2520for%2520the%2520biosynthesis%2520of%2520four%25202%252C6-d-dideoxyhexoses%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2006%26volume%3D72%26spage%3D6644%26epage%3D6652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span> </span><span class="NLM_article-title">Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=91-109&author=M.+R.+Boydauthor=K.+D.+Paull&title=Some+practical+considerations+and+applications+of+the+national+cancer+institute+in+vitro+anticancer+drug+discovery+screen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26atitle%3DSome%2520practical%2520considerations%2520and%2520applications%2520of%2520the%2520national%2520cancer%2520institute%2520in%2520vitro%2520anticancer%2520drug%2520discovery%2520screen%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D34%26spage%3D91%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Malek, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magistri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morís, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catapano, C. V.</span><span> </span><span class="NLM_article-title">Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cáncer</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_elocation-id">e35130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=A+Malekauthor=L.+E.+N%C3%BA%C3%B1ezauthor=M.+Magistriauthor=L.+Brambillaauthor=S.+Jovicauthor=G.+M.+Carboneauthor=F.+Mor%C3%ADsauthor=C.+V.+Catapano&title=Modulation+of+the+activity+of+Sp+transcription+factors+by+mithramycin+analogues+as+a+new+strategy+for+treatment+of+metastatic+prostate+c%C3%A1ncer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DA%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DL.%2BE.%26aulast%3DMagistri%26aufirst%3DM.%26aulast%3DBrambilla%26aufirst%3DL.%26aulast%3DJovic%26aufirst%3DS.%26aulast%3DCarbone%26aufirst%3DG.%2BM.%26aulast%3DMor%25C3%25ADs%26aufirst%3DF.%26aulast%3DCatapano%26aufirst%3DC.%2BV.%26atitle%3DModulation%2520of%2520the%2520activity%2520of%2520Sp%2520transcription%2520factors%2520by%2520mithramycin%2520analogues%2520as%2520a%2520new%2520strategy%2520for%2520treatment%2520of%2520metastatic%2520prostate%2520c%25C3%25A1ncer%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Torti, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aston, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, B. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannigan, J. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billingham, M. E.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3722</span><span class="NLM_x">–</span> <span class="NLM_lpage">3727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=3458531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A280%3ADyaL283hslyisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=3722-3727&author=F.+M.+Tortiauthor=M.+M.+Bristowauthor=B.+L.+Lumauthor=S.+K.+Carterauthor=A.+E.+Howesauthor=D.+A.+Astonauthor=B.+W.+Brownauthor=J.+F.+Hanniganauthor=F.+J.+Meyersauthor=E.+P.+Mitchellauthor=M.+E.+Billingham&title=Cardiotoxicity+of+epirubicin+and+doxorubicin%3A+assessment+by+endomyocardial+biopsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy</span></div><div class="casAuthors">Torti F M; Bristow M M; Lum B L; Carter S K; Howes A E; Aston D A; Brown B W Jr; Hannigan J F Jr; Meyers F J; Mitchell E P; et al</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3722-7</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Forty-two evaluable endomyocardial biopsies were obtained from 29 patients treated with epirubicin, the 4'-epimer of doxorubicin in cumulative doses ranging from 147 mg/m2 to 888 mg/m2.  In this study of the Northern California Oncology Group, myofibrillar loss and sarcoplasmic vacuolization were identified and shown to be identical to those previously described for doxorubicin.  However, when these biopsies were compared to 119 biopsies obtained from 98 patients treated with doxorubicin, milligram for milligram, epirubicin caused less endomyocardial injury than doxorubicin (P = 0.0013).  Age, sex, type of primary malignancy, prior cardiac disease, and hypertension did not influence the degree of histologically demonstrated anthracycline injury induced by epirubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGZOur-e2pIzDnmmyUf5qOfW6udTcc2ebltxFzUMyX6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL283hslyisw%253D%253D&md5=4dbc6ca5846a328fc885cb3c0a0b429a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DBristow%26aufirst%3DM.%2BM.%26aulast%3DLum%26aufirst%3DB.%2BL.%26aulast%3DCarter%26aufirst%3DS.%2BK.%26aulast%3DHowes%26aufirst%3DA.%2BE.%26aulast%3DAston%26aufirst%3DD.%2BA.%26aulast%3DBrown%26aufirst%3DB.%2BW.%26aulast%3DHannigan%26aufirst%3DJ.%2BF.%26aulast%3DMeyers%26aufirst%3DF.%2BJ.%26aulast%3DMitchell%26aufirst%3DE.%2BP.%26aulast%3DBillingham%26aufirst%3DM.%2BE.%26atitle%3DCardiotoxicity%2520of%2520epirubicin%2520and%2520doxorubicin%253A%2520assessment%2520by%2520endomyocardial%2520biopsy%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D3722%26epage%3D3727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Gebregiorgis, M.; Woldemichael, G.; He, M.; Kang, M. H.; Núñez, L. E.; Morís, F.; Smith, M. A.; Helman, L. J.; Grohar, P. J.</span><span> </span><span class="NLM_article-title">Identification of Mithramycin Analogues with Increased Potency and More Selective Inhibition of EWS-FLI1 for the Treatment of Ewing Sarcoma</span>. Presented at the AACR Annual Meeting, March 31–April 4,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>Chicago, IL; Poster.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Gebregiorgis&author=G.+Woldemichael&author=M.+He&author=M.+H.+Kang&author=L.+E.+N%C3%BA%C3%B1ez&author=F.+Mor%C3%ADs&author=M.+A.+Smith&author=L.+J.+Helman&author=P.+J.+Grohar&title=Identification+of+Mithramycin+Analogues+with+Increased+Potency+and+More+Selective+Inhibition+of+EWS-FLI1+for+the+Treatment+of+Ewing+Sarcoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGebregiorgis%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Mithramycin%2520Analogues%2520with%2520Increased%2520Potency%2520and%2520More%2520Selective%2520Inhibition%2520of%2520EWS-FLI1%2520for%2520the%2520Treatment%2520of%2520Ewing%2520Sarcoma%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Fernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weibbach, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez Reillo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span> </span><span class="NLM_article-title">Identification of two genes from <i>Streptomyces argillaceus</i> encoding two glycosyltransferases involved in the transfer of a disaccharide during the biosynthesis of the antitumor drug mithramycin</span> <span class="citation_source-journal">J. Bacteriol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">4929</span><span class="NLM_x">–</span> <span class="NLM_lpage">4937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=9733697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADyaK1cXmt1Sns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=1998&pages=4929-4937&author=E.+Fern%C3%A1ndezauthor=U.+Weibbachauthor=C.+S%C3%A1nchez+Reilloauthor=A.+F.+Bra%C3%B1aauthor=C.+M%C3%A9ndezauthor=J.+Rohrauthor=J.+A.+Salas&title=Identification+of+two+genes+from+Streptomyces+argillaceus+encoding+two+glycosyltransferases+involved+in+the+transfer+of+a+disaccharide+during+the+biosynthesis+of+the+antitumor+drug+mithramycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two genes from Streptomyces argillaceus encoding glycosyltransferases involved in transfer of a disaccharide during biosynthesis of the antitumor drug mithramycin</span></div><div class="casAuthors">Fernandez, Ernestina; Weissbach, Ulrike; Reillo, Cesar Sanchez; Brana, Alfredo F.; Mendez, Carmen; Rohr, Jurgen; Salas, Jose A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4929-4937</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mithramycin is an antitumor polyketide drug produced by Streptomyces argillaceus that contains two deoxysugar chains, a disaccharide consisting of two d-olivoses and a trisaccharide consisting of a d-olivose, a d-oliose, and a d-mycarose.  From a cosmid clone (cosAR3) which confers resistance to mithramycin in streptomycetes, a 3-kb PstI-XhoI fragment was sequenced, and two divergent genes (mtmGI and mtmGII) were identified.  Comparison of the deduced products of both genes with proteins in databases showed similarities with glycosyltransferases and glucuronosyltransferases from different sources, including several glycosyltransferases involved in sugar transfer during antibiotic biosynthesis.  Both genes were independently inactivated by gene replacement, and the mutants generated (M3G1 and M3G2) did not produce mithramycin.  High-performance liq. chromatog. anal. of Et acetate exts. of culture supernatants of both mutants showed the presence of several peaks with the characteristic spectra of mithramycin biosynthetic intermediates.  Four compds. were isolated from both mutants by preparative high-performance liq. chromatog., and their structures were elucidated by physicochem. methods.  The structures of these compds. were identical in both mutants, and the compds. are suggested to be glycosylated intermediates of mithramycin biosynthesis with different nos. of sugar moieties attached to C-12a-O of a tetracyclic mithramycin precursor and to C-2-O of mithramycinone: three tetracyclic intermediates contg. one sugar (premithramycin A1), two sugars (premithramycin A2), or three sugars (premithramycin A3) and one tricyclic intermediate contg. a trisaccharide chain (premithramycin A4).  It is proposed that the glycosyltransferases encoded by mtmGI and mtmGII are responsible for forming and transferring the disaccharide during mithramycin biosynthesis.  From the structures of the new metabolites, a new biosynthetic sequence regarding late steps of mithramycin biosynthesis can be suggested, a sequence which includes glycosyl transfer steps prior to the final shaping of the aglycon moiety of mithramycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrNmPNrzf1vLVg90H21EOLACvtfcHk0liQTWd15v0LQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmt1Sns7Y%253D&md5=38358e0a6e09a181b69cb3c73ddfbb1f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DWeibbach%26aufirst%3DU.%26aulast%3DS%25C3%25A1nchez%2BReillo%26aufirst%3DC.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520two%2520genes%2520from%2520Streptomyces%2520argillaceus%2520encoding%2520two%2520glycosyltransferases%2520involved%2520in%2520the%2520transfer%2520of%2520a%2520disaccharide%2520during%2520the%2520biosynthesis%2520of%2520the%2520antitumor%2520drug%2520mithramycin%26jtitle%3DJ.%2520Bacteriol.%26date%3D1998%26volume%3D180%26spage%3D4929%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kieser, T.; Bibb, M. J.; Buttner, M. J.; Chater, K. F.; Hopwood, D. A.</span> <span class="citation_source-book">Practical Streptomyces Genetics</span>; <span class="NLM_publisher-name">The John Innes Foundation</span>: <span class="NLM_publisher-loc">Norwich, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=T.+Kieser&author=M.+J.+Bibb&author=M.+J.+Buttner&author=K.+F.+Chater&author=D.+A.+Hopwood&title=Practical+Streptomyces+Genetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKieser%26aufirst%3DT.%26btitle%3DPractical%2520Streptomyces%2520Genetics%26pub%3DThe%2520John%2520Innes%2520Foundation%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Sambrook, J.; Russell, D. W.</span> <span class="citation_source-book">Molecular Cloning: A Laboratory Manual</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Cold Spring Harbor Laboratory</span>: <span class="NLM_publisher-loc">Cold Spring Harbor, NY, U.S.</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+Sambrook&author=D.+W.+Russell&title=Molecular+Cloning%3A+A+Laboratory+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSambrook%26aufirst%3DJ.%26btitle%3DMolecular%2520Cloning%253A%2520A%2520Laboratory%2520Manual%26pub%3DCold%2520Spring%2520Harbor%2520Laboratory%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Rodríguez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirrezabalaga, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span> </span><span class="NLM_article-title">Engineering deoxysugar biosynthetic pathways from antibiotic-producing microorganisms. A tool to produce novel glycosylated bioactive compounds</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1016%2FS1074-5521%2802%2900154-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=12079784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFOisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=721-729&author=L.+Rodr%C3%ADguezauthor=I.+Aguirrezabalagaauthor=N.+Allendeauthor=A.+F.+Bra%C3%B1aauthor=C.+M%C3%A9ndezauthor=J.+A.+Salas&title=Engineering+deoxysugar+biosynthetic+pathways+from+antibiotic-producing+microorganisms.+A+tool+to+produce+novel+glycosylated+bioactive+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering Deoxysugar Biosynthetic Pathways from Antibiotic-Producing Microorganisms. A Tool to Produce Novel Glycosylated Bioactive Compounds</span></div><div class="casAuthors">Rodriguez, Leticia; Aguirrezabalaga, Ignacio; Allende, Nerea; Brana, Alfredo F.; Mendez, Carmen; Salas, Jose A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">721-729</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A plasmid (pLN2) was generated in which genes involved in the biosynthesis of L-oleandrose in the oleandomycin producer Streptomyces antibioticus ATCC 11891 were cloned.  Plasmid pLN2 was used to direct the biosynthesis of different deoxysugars by exchanging and/or adding genes from other antibiotic biosynthetic clusters.  Transfer of the synthesized deoxysugars to the tetracenomycin C aglycon, 8-demethyl-tetracenomycin C, through the use of the "sugar flexible" glycosyltransferase ElmGT, validated the system.  Several pLN2 derivs. were constructed by replacement of the oleU 4-ketoreductase gene by different 4-ketoreductase genes.  Some of them, such as EryBIV and UrdR, reduced the keto group of the 4-keto intermediates, generating L-olivosyl and D-olivosyl derivs., resp.  The system was also used to generate an L-rhamnosyl deriv. (through a two-gene deletion) and an L-rhodinosyl deriv. (through a combination of a gene replacement and a gene addn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NBOjQjMK8rVg90H21EOLACvtfcHk0li3KxEcZni1tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFOisLk%253D&md5=17068efca43f7df131eb896165fb1b37</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900154-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900154-0%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DL.%26aulast%3DAguirrezabalaga%26aufirst%3DI.%26aulast%3DAllende%26aufirst%3DN.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DEngineering%2520deoxysugar%2520biosynthetic%2520pathways%2520from%2520antibiotic-producing%2520microorganisms.%2520A%2520tool%2520to%2520produce%2520novel%2520glycosylated%2520bioactive%2520compounds%26jtitle%3DChem.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D721%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Lombó, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelfattah, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Elucidation of oxygenation steps during oviedomycin biosynthesis and generation of derivatives with increased antitumor activity</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=296-303&author=F.+Lomb%C3%B3author=M.+S.+Abdelfattahauthor=A.+F.+Bra%C3%B1aauthor=J.+A.+Salasauthor=J.+Rohrauthor=C.+M%C3%A9ndez&title=Elucidation+of+oxygenation+steps+during+oviedomycin+biosynthesis+and+generation+of+derivatives+with+increased+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLomb%25C3%25B3%26aufirst%3DF.%26aulast%3DAbdelfattah%26aufirst%3DM.%2BS.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DElucidation%2520of%2520oxygenation%2520steps%2520during%2520oviedomycin%2520biosynthesis%2520and%2520generation%2520of%2520derivatives%2520with%2520increased%2520antitumor%2520activity%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D296%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Menéndez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braña, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, C.</span><span> </span><span class="NLM_article-title">Biosynthesis of the antitumor chromomycin A<sub>3</sub> in <i>Streptomyces griseus</i>: analysis of the gene cluster and rational design of novel chromomycin analogues</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=15112992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXps1yntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=21-32&author=N.+Men%C3%A9ndezauthor=N.+Mohammadauthor=A.+F.+Bra%C3%B1aauthor=J.+Rohrauthor=J.+A.+Salasauthor=C.+M%C3%A9ndez&title=Biosynthesis+of+the+antitumor+chromomycin+A3+in+Streptomyces+griseus%3A+analysis+of+the+gene+cluster+and+rational+design+of+novel+chromomycin+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of the antitumor chromomycin A3 in Streptomyces griseus. analysis of the gene cluster and rational design of novel chromomycin analogs</span></div><div class="casAuthors">Menendez, Nuria; Nur-e-Alam, Mohammad; Brana, Alfredo F.; Rohr, Jurgen; Salas, Jose A.; Mendez, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-32</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The biosynthetic gene cluster of the aureolic acid type antitumor drug chromomycin A3 from S. griseus subsp. griseus has been identified and characterized.  It spans 43 kb and contains 36 genes involved in polyketide biosynthesis and modification, deoxysugar biosynthesis and sugar transfer, pathway regulation and resistance.  The organization of the cluster clearly differs from that of the closely related mithramycin.  Involvement of the cluster in chromomycin A3 biosynthesis was demonstrated by disrupting the cmmWI gene encoding a polyketide reductase involved in side chain redn.  Three novel chromomycin derivs. were obtained, named chromomycin SK, chromomycin SA, and chromomycin SDK, which show antitumor activity and differ with respect to their 3-side chains.  A pathway for the biosynthesis of chromomycin A3 and its deoxysugars is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE-1NGDbwV_7Vg90H21EOLACvtfcHk0li3KxEcZni1tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXps1yntA%253D%253D&md5=f08961a261e3557c7520ede71f9c52e8</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DN.%26aulast%3DMohammad%26aufirst%3DN.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DBiosynthesis%2520of%2520the%2520antitumor%2520chromomycin%2520A3%2520in%2520Streptomyces%2520griseus%253A%2520analysis%2520of%2520the%2520gene%2520cluster%2520and%2520rational%2520design%2520of%2520novel%2520chromomycin%2520analogues%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D21%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Mosmann, T.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm300234t&amp;key=10.1016%2F0022-1759%2883%2990303-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm300234t&amp;key=6606682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300234t&amp;key=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1983&pages=55-63&author=T.+Mosmann&title=Rapid+colorimetric+assay+for+cellular+growth+and+survival%3A+application+to+proliferation+and+cytotoxicity+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span></div><div class="casAuthors">Mosmann T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation.  The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells.  This method can therefore be used to measure cytotoxicity, proliferation or activation.  The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision.  No washing steps are used in the assay.  The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope.  We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbRLMWf0dI3thwrmtH4OBfW6udTcc2eYw_s32obmTlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D&md5=c1116f4ca7a7d2b79fab2a0bd2c2d439</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2883%2990303-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252883%252990303-4%26sid%3Dliteratum%253Aachs%26aulast%3DMosmann%26aufirst%3DT.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cellular%2520growth%2520and%2520survival%253A%2520application%2520to%2520proliferation%2520and%2520cytotoxicity%2520assay%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1983%26volume%3D65%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i25"><a href="/doi/suppl/10.1021/jm300234t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_58248"></div></div></div></div></div><hr /></hr><p class="last">HPLC chromatograms of <i>S. argillaceus</i> compared to <i>S. argillaceus</i> (pKOL), <i>S. argillaceus</i> M3W1 compared to <i>S. argillaceus</i> M3W1-pKOL, <i>S. argillaceus</i> M3C1-pFL845, and <i>S. argillaceus</i> M3W1-pMP3*BII; NMR data and spectra of novel compounds; apoptosis data for wash-out experiments; listing of abbreviations used. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300234t/suppl_file/jm300234t_si_001.pdf">jm300234t_si_001.pdf (5.35 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300234t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm300234t%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-12%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300234t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997e8dda5bd1df","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
